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of this apparatus is not intended to be an integral part of this work and only 'a 
very brief outline of it will be given here. 
After a description of some preliminary results the thesis is divided into 
two parts for convenience of description. 
Part I is concerned with the identification of adenosine triphosphate released 
from skeletal muscle. 
Part II deals with the assay of acetylcholine released from skeletal muscle. 
An Appendix describes a technique developed for the separation'and 
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INTRODUCTION 
Bioassay techniques are used to test compounds which have either a specific action 
in vivo or exist in such small concentrations that their estimation is beyond the 
limits of chemical analysis. 
In the case of acetylcholine (ACh), the chemical synthesis and analysis was 
achieved almost one hundred years ago, but because of the small amounts involved 
in synaptic and neuromuscular transmission, any investigator wishing to measure the 
ACh produced at these sites must resort to methods of bioassay. The response of a 
particular tissue to ACh must be evaluated by comparing it to the response given by 
a known amount of ACh. 
More precisely, the bioassay principle consists of measuring the product of 
one enzyme system by judging its effect upon another, similar enzyme system. 
Enzyme reactions are affected by many factors: hydrogen ion concentration, 
temperature and the availability of energy for the system. These reactions can be 
accelerated, depressed or even reversed by various interfering substances. 
Since a naturally-occurring enzyme system is being used as a "tool" to 
identify and assess the concentration of a particular compound, it is essential that 
the limitations of the "tool" are clearly defined. The point was put succintly by 
Jerne and Wood - "... substantial biological research must precede any attempt 
to set up a bioassay technique for routine use . 
In any quantitative estimation 'of ACh which may be released at the 
neuromuscular junction, three main factors have to be considered in a 
pharmacological approach to' the problem. Firstly, the number of nerve impulses 
passing into the endplate region must be known. Secondly, the diffusion pathway of 
ACh from the endplate regions to the exterior must offer the minimum of'obstruction 
so that nearly all of'the ACh will diffuse into'the solution surrounding the 
preparation. Thirdly, the method of measurement of the released ACh should be' 
reliable, and should not be unduly susceptible to interference from other substances 
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which might be released From the tissues during stimulation of the muscle. Any one 
of these unknown substances may interfere directly with the assay procedure, or 
indirectly by altering the sensitivity of the bioassay preparation to the compound 
under survey. 
A classical example of direct interference in a bioassay procedure was outlined 
by Dale and Dudley in 1929. While assaying the quantity of the histamine-like 
substance in extracts of spleen on the cat blood pressure they found a large, but 
constant, discrepancy in their results. Histamine depresses the blood pressure of 
the cat. Dale and Dudley found that the spleen extract caused depression of blood 
pressure which was too great to account for the expected concentration of 
histamine. They found that an interfering substance, whose action could be blocked 
by atropine, was causing the excess fall in the cat blood pressure. In other words, 
their results, obtained with regard to histamine, were falsely high because of the 
interference of the hitherto unrecognized presence of ACh in the extract. 
Other examples of direct interference in bioassays have been noted by 
Von Euler and Gaddum (1931), Amin, Crawford and Gaddum (1954) and more 
recently by Lazlo (1963). 
An example of indirect interference has been shown by Frommel et al. (1944). 
They found that the common constituent of tissue extracts, histamine, could 
sensitize leech muscle, helix heart and frog rectus abdominis preparations to ACh, 
the increase in sensitivity being analogous to that produced by eserine. Any 
quantitative estimation of ACh on those preparations in the presence of histamine 
would be too high, unless the same amount of histamine present in the test solution 
was deliberately added to the solutions used for comparison. 
The present work was initiated in order to investigate the release of ACh 
from the neuromuscular junction and to produce, if possible, a more accurate 
correlation of the pharmacological evidence with the electrophysiological evidence 
of the quantities of ACh which are needed for the natural transmission of the nerve 
impulse into skeletal muscle. However, the identification in this work of adenosine 
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triphosphate as a predominant interfering substance released from skeletal muscle 
has raised the question of whether previous methods of measuring released ACh 
were specific, or whether unknown substances distorted previous bioassays of 
ACh liberated from the neuromuscular junction. This opens up the broader issue 
of whether other substances released from skeletal muscle could also be acting as 
depolarizing agents on the endplate region. 
The Experimental Design 
This work was initiated with the intention of measuring the output of ACh 
from active frog sartorius muscle on the very sensitive frog heart perfusion system 
of Boyd and Eadie (1961). The ACh released from the muscle would be collected 
in a surrounding bathing solution and this solution would be assayed for ACh using 
the frog heart. 
The frog sartorius muscle was chosen because (a) the number and situation 
of the endplates was known, and (b) this muscle has a region at the pelvic end 
which is devoid of any other motor nerves, and is thus suitable for direct 
stimulation of the muscle fibres without any inadvertent stimulation of intramuscular 
motor nerve fibres. This feature of the sartorius muscle provided the opportunity 
to investigate whether ACh could be released from muscle fibres by direct 
stimulation. 
The output of ACh from a sartorius muscle was not expected to be very great; 
the following calculation was kindly supplied by Professor Katz: 
A frog sartorius muscle contains approximately 1,000 endplates, 
If, say, 106 molecules of ACh are released per endplate per impulse, 
1,000 impulses given to a sartorius muscle would give 1012 molecules of 
ACh. Collected into a1 ml. volume, this would give a concentration of 
3x 10-10 g/mI. ACh. 




or lower concentrations between the months of December and March in Scotland 
(Boyd and Pathak, 1965). Thus it was theoretically possible to assay the small 
quantity of ACh which was expected to be released from frog sartorius muscle on 
"winter" frog hearts. Other conventional preparations used for the bioassay of 
ACh are either too insensitive, for example frog rectus abdominis muscle 
(threshold 10-8 g/mI., Chang and Gaddum 1933), eserinized leech muscle 
(threshold 10-9 g/ml., Minz 1932), too unstable, for example frog lung (threshold 
10-16 g/ml., Corsten, 1941), or require a specialized medium to retain their 
sensitivity to ACh, like clam heart (threshold 10-11 g/ml., Welsh and Taub, 1948), 
whelk heart (threshold 10-11 g/ml., We! sh, 1954), and muscle strips of 
echinodermata (threshold 10-9 g/ml. - 10-1 
1 
g/ml., Bacq, 1939). 
Any preparation which requires a special medium would involve conversion 
of the test solution obtained from the frog sartorius muscle and hence dilution of 
the contained ACh. Since the concentration expected from the sartorius muscle is 
so small, no dilution factor could really be afforded in an accurate assay 
procedure using some of the suitably sensitive preparations previously mentioned. 
The perfused frog heart was thus advantageous since the same species was to 
be used for both the source and the measurement of the ACh. No dilution of the 
test solution would be necessary and the small concentration of ACh expected 
would not be diluted beyond the threshold sensitivity of the frog heart. 
Although the frog heart can respond to a great many biological compounds, 
the advantages of its great sensitivity and long-term stability to ACh seemed to 
outweigh the disadvantages of non-specificity. 
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HISTORICAL SURVEY 
Claude Bernard, while investigating the properties of curare, showed that 
while curare had no effect on the condition in nerve and muscle fibres, it blocked 
the transmission of nerve impulses to the muscle. These observations, made in the 
1840's, first outlined the special properties which the neuromuscular junction 
possessed. 
Acetylcholine (ACh) was first prepared artificially by Baeyer in 1867. It 
retained a chemical interest only until Hunt and Taveau in 1909 found that it had 
a very high biological activity, much more so than choline itself. Three years 
prior to this Dixon (1906) had demonstrated that inhibition of the heart by vagal 
stimulation was associated with the liberation of an acetylcholine-like substance 
in intimate relation to the heart muscle fibres. This work supported the then 
astonishing suggestion in 1877 by Du-Bois-Reymond who considered that the 
excitation of a muscle fibre might be due to the release of a chemical stimulant 
when the impulse arrived at the nerve ending. 
In 1907 Langley found that the junctional region of a muscle was highly 
sensitive to many substances and Reisser and Neuschloss (1921) found that when a 
gastrocnemius muscle of a frog was exposed to a solution containing ACh it gave a 
transient contraction, but this only happened when the ACh was applied to the 
junctional region; the ACh had no effect when applied separately to the nerve 
or the muscle. 
In 1921 Le Heux observed that the action of choline on an isolated loop of 
intestine was enhanced by the presence of acetates and thought that ACh could 
be the final activator. It was also in 1921 that Loewi initiated his classical 
experiments on frog heart perfusates after vagal stimulation and suggested that 
a substance was released which had the properties of a choline ester. 
In 1923 - 1926 several observers (Hess, 1923, Brinkman and Ruiter, 1924 - 
1925; Shimidzu, 1926) had obtained evidence of the liberation of an acetylcholine- 
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like substance from perfused frog skeletal muscles when these were stimulated 
through the nerve. However, all of them had stimulated a mixed nerve and they 
did not definitely associate the effect with the motor fibres, or with the 
transmission of the impulse to the muscle fibres from nerve. Hoet in 1925 observed 
that the atropine-sensitive rhythm of isolated intestinal muscle was enhanced by 
strong post mortem stimulation of the vagus nerves before excision of the intestine. 
While investigating the identity of the histamine-like constituent of spleen 
extracts, Dale and Dudley (1929) found a large but constant discrepancy in their 
results. They used for their bioassay object the blood pressure of the cat under 
ether or urethane anaesthetic. They found that a surprisingly large proportion of 
the original effect of the extract was eliminated in the presence of atropine. The 
activity of this proportion could also be eliminated by raising the pH of the extract. 
They found also that this some proportion of activity was lost when the extract was 
brought into contact with "the cells and juices of the whole minced organ". 
Dale and Dudley were eventually able to extract chemically fairly constant 
amounts of ACh from ox and horse spleens. This was the first occasion on which ACh 
had been found to occur naturally in the animal body. 
Earlier, Dale, working with Ewins (1914), had become interested in ACh 
because it was able to reproduce parasympathetic effects intensely and faithfully 
in various organs. When these effects were blocked with atropine the ACh in 
larger doses stimulated ganglion cells in a manner similar to nicotine. This led 
Dale and Dudley to speculate on the possibility that ACh might occur in the body 
and be physiologically functional; however, they could not explain the function 
of large amounts of ACh found in the spleens. 
In 1930 Dale and Gaddum examined the evidence for a chemical intermediary 
in the parasympathetic nerve endings and for its identification as ACh. They 
concluded that the vasodilator effects of parasympathetic nerves and of sensory 
fibres stimulated antidromically (and the contractions of denervated muscle 
accompanying these actions) were due to peripheral liberation of ACh. 
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In 1933 Adrian wrote - "It is by no means certain that the humoral 
transmission of the vagal effect differs in kind from the transmission of activity 
from the motor nerve to striated muscle. An exciting substance liberated at a 
nerve ending but destroyed within a few thousandths of a second would have little 
chance of spreading by diffusion and would account well enough for the known 
properties of the nerve ending. It is equally likely that the more direct kinds of 
transmission depend, as in nerve fibre, on electric forces disturbing the balanced 
reactions of surface membranes". 
These views were at least one year in advance of any experimental evidence 
in favour of a chemical transmitter of excitation from motor nerve to skeletal 
muscle. 
In 1934 a preliminary note appeared from Dale and Feldberg stating that they 
had identified ACh in the perfusate of cat tongue and dog leg muscles in the 
presence of eserine whilst stimulating the motor nerves. About the some time 
Feldberg, Minz and Tsudzimura produced strong evidence that ACh was liberated 
when a nerve impulse reached the adrenal medulla. Also at this time it was shown 
that ACh was released from ganglia when nervous impulses reached them (Feldberg 
and Gaddum, 1934; Feldberg and Vartiainen, 1934; Barsoum, Gaddum and 
Khayyal, 1934). Thus the classical work performed by Dale, Feldberg and Vogt 
and published in 1936 formed a natural link in the sequence of events leading to the 
modern conceptions of neuromuscular transmission. 
Previously it had been assumed by Frank and his co-workers (Frank and 
Katz, 1921; Frank, Nothmann and Hirch-Kauffman, 1922) that there was a 
secondary parasympathetic nerve supply to the skeletal muscle fibres themselves, 
responsible for maintenance of muscle tone. They regarded the release of ACh 
from skeletal muscle as perhaps having little connection with motor nerve impulses, 
since al I the fibres of a mixed nerve had been stimulated previously. 
Dale, Feldberg and Vogt set out to find whether stimulation of the motor 
nerve fibres innervating skeletal muscle (excluding antonomic and sensory fibres) 
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caused the liberation of ACh in appreciable quantities, and, if so, set out to 
define a site of release. They were aware of the difficulties involved in the 
identification and possible quantitative estimation of ACh if indeed it was 
released at the neuromuscular junction. They anticipated that any ACh obtained 
from a perfused muscle mass would inevitably be greatly diluted. This was in 
contrast to previous investigations involving ganglia where the small perfusion 
volume together with the large concentration of synapses helped to raise the 
ACh level up to easily estimable concentrations. 
Another unexpected difficulty arose during the course of their investigation. 
To ensure successful recovery of ACh they found that perfusion with an eserinized 
saline solution was necessary. Previously Feldberg (1933) had failed to detect 
any ACh in the lingual vein when he stimulated the motor hypoglossal nerve of 
the dog. Franel (1935) also failed to detect ACh in venous blood or in eserinized 
Locke's solution coming from a perfused limb. Dale et al. (1936) at that time 
thought it possible that perfusion with saline facilitated in some unknown way the 
release of ACh from the site of its origin in the blood vessels. Later, Dale 
supported the work of F. C. Macintosh (1938) who found that the doses of 
physostigmine used were insufficient to counteract the blood cholinesterase (see 
below). 
Dale et al. also encountered irregular results at the commencement of their 
perfusion experiments. This is best reviewed in their own words: - "After the rather 
prolonged dissection and manipulation the early perfusion samples usually showed 
detectable amounts of a substance acting like ACh as Hess (1923) observed in his 
perfusions of frog muscles". Only after half-an-hour of perfusion did this activity 
disappear. This happened during the perfusion of the cat tongue, cat gastrocnemius 
muscle, dog gastrocnemius muscle and frog hind limbs. This aspect of the perfusion 
experiments with saline aroused some criticism at that time. There were suggestions 
that the release of ACh under such conditions was unphysiological and could perhaps 
be equated with tissue damage. (Fleisch, Sibul and Kaelin, 1936; Lorente de No, 
1938; and more recently, Nachmansohn 1946). However, only after the perfusate 
showed no ACh-like activity did Dale et al. commence stimulation and collection 
of ACh. 
A disadvantage of saline perfusion, they stated, was the increasing 
insensitivity of the muscles to motor impulses developed over a long period of time. 
When perfused for a further period the muscles became oedematous. 
In the case of frog hind limbs, during the period of stimulation a rapid 
decline in twitch was evident in 2-3 minutes. The muscle was rested and 
stimulation again resumed at a frequency of five impulses per second. Fatigue 
followed more quickly than in the first period of stimulation. They noticed that 
as the muscle twitch grew weaker, so the amount of acetylcholine-like activity 
of the perfusate, tested on leech muscle, grew less. 
In order to ensure that the ACh was indeed coming from the motor nerve 
terminals and was not being released directly from active skeletal muscle, Dale 
paralysed the musculature of a perfused cat tongue with curare and found that 
stimulation of the motor nerve still had the effect of releasing a similar quantity of 
ACh into the perfusing fluid. 
It is interesting to note at this point the observations of Dale et al. on the 
vasodilatation occurring during the muscle perfusion. They noted that the venous 
outflow from perfused muscle was accelerated at the onset of motor nerve 
stimulation. This was taken as an index of increased vasodilatation. The presence 
of eserine enhanced this phenomenon. In order to separate the vasodilatation due 
to muscle "metabolites" from vasodilatation caused by ACh released from the motor 
nerve terminals, they used curare to block the contraction process. It was found 
that 90% of the increase in bloodflow was abolished by this procedure, indicating 
that the vasodilatation observed was principally due to "products of the contractile 
mechanism". 
The tests employed by Dale et al. in 1936 for the identification of ACh have 
not been improved upon since that time. With concentrations of the order of 
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10-8 g/ml. ACh available it was possible for them to use multiple bioassay 
techniques. 
They established that the unknown substance was: 
(a) stable in acid solution but was destroyed in solutions of dilute alkali; 
(b) consistently protected from the tissue esterases by eserine; 
(c) effective in reducing the blood pressure of a cat; this effect was 
enhanced by eserine and blocked by atropine; 
(d) capable of producing a contraction of leech muscle in the presence of 
eserine; this action could be blocked by curare. 
These tests were taken to indicate that the hitherto unknown compound released from 
active motor nerve terminals was ACh, or a substance very similar to it. 
One of the initial problems of the ACh transmitter theory was whether the 
ACh could be removed quickly enough to subserve its function as the transmitter of 
discrete, high frequency nerve impulses into the muscle fibre. Hydrolysis of ACh 
occurs in many tissues by-the enzyme acetylcholinesterase (Stedman, Stedman and 
Easson, 1932). Marnay and Nachmansohn (1937) showed that the concentration of 
cholinesterase at the endplates was many thousands of times higher than that found 
in muscle tissue. They estimated that the ACh could be split by this concentration 
of cholinesterase within the refractory period of the muscle, i. e. around one 
millisecond. Histochemical methods have revealed cholinesterase at the motor 
endplate (Koelle and Friedenwald, 1949), and more recently Couteaux (1958) has 
shown that it is concentrated on the subsynaptic membrane of the neuromuscular 
junction, especially in the region of the junctional folds. 
In 1938 Gopfert and Schaefer established the existence of an endplate 
potential using an extracellular recording technique. Kuffler (1942) suggested that 
the threshold for the initiation of a propagated action potential was about a third 
of the normal endplate potential height. 
In 1950 Fatt and Katz showed that the endplate region of a muscle fibre is 
the site for many small electrical changes, the spontaneous "miniature" endplate 
-- 13 - 
potentials (m. e. p. p. s). These m. e. p. p. s closely resemble the local potentials 
which are produced by applying ACh to the endplate region (Fatt and Katz, 1952; 
del Castillo and Katz, 1955,1957; Miledi, 1962). It is widely accepted that 
the m. e. p. p. s are depolarisations produced by the result of packets, or "quanta" 
of ACh released from the nerve terminal impinging on the endplate receptors. The 
work of del Castillo and Katz (1954), Boyd and Martin (1956), Liley (1956) and 
Katz and Miledi (1965) has shown that the endplate potential can be accurately 
equated to the sum of the m. e. p. p. s which occur over a similar period of time. 
This suggested that all the quanta of ACh are simultaneously released from the 
nerve terminal upon the arrival of the nerve impulse. 
The theory of quantal release of ACh has been supported by the finding with 
the electron microscope that the motor nerve terminal is crowded with "vesicles" 
all of approximately 500Ä in diameter (Birks, Huxley and Katz, 1960). The 
process of release of a quantum of ACh must involve the coalescence of two 
membranes, the one surrounding the vesicle and the limiting membrane of the 
nerve terminal. Evidence of this coalescence occurring in a central synapse has 
been demonstrated by the electron microscope (Gray, 1963). 
In 1951 Nastuk applied small quantities of ACh to a single endplate region. 
He used an electrode of less than 0.5ju external diameter and drove the ACh out 
of the pipette with a short, single electrical pulse (iontophoresis). 
He noted that as the micro jet of ACh was directed nearer to the endplate, so the 
depolarization of the muscle membrane increased. Del Castillo and Katz (1955) 
successfully applied ACh to both sides of the endplate membrane using the iontophoresis 
technique and showed that the intracellular application of ACh did not produce an 
endplate potential. 
Two main experimental approaches have been used in an attempt to find out 
the number of ACh molecules in each quantum; the assay of solutions which have 
surrounded active muscle preparations and the technique of iontophoresis. 
Results obtained from these two approaches are in the same order of 
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magnitude. Miledi (1961) has shown that it is necessary for 105 molecules of ACh 
to be discharged from a micropipette to produce a depolarization equal to that of 
a miniature endplate potential. Krnjevic and Mitchell (1961) calculate from their 
assay of ACh spontaneously released from rat diaphragm that 3.6 x 105 molecules 
of ACh are contained in each quantum. However, calculations show that if a 
vesicle of 500 
Ä in diameter did in fact contain 105 molecules, the unlikely 
concentration of 10 M ACh would be present within the vesicle (del Castillo 
and Katz, 1956). 
METHODS 
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SETTING UP THE FROG HEART FOR PERFUSION 
Both Rana temporaria and Rana pipiens of either sex were used. 
After stunning, decapitation and pithing the frog was pinned down in the 
supine position. The skin of the abdominal and thoracic walls was removed. The 
abdominal musculature was then removed and the thoracic cavity was entered, 
avoiding damage to the pericardial cavity. By cutting through the shoulder 
girdle on both sides a segment of the anterior wall of the thorax was lifted and 
cut off exposing the heart lying within the pericardial cavity. After tying off 
any prominent portal veins, the venous cannula was introduced into the exposed 
posterior vena cava through a small flap in the ventral wall of this vessel. The 
cannula was securely ligatured into the vein. In order to prevent excessive 
clot formation at this stage frog Ringer's solution was perfused into the posterior 
vena cava at a low pressure. 
The two aortae were now cannulated, the first cannula leading to a mercury 
manometer, the other cannula leading to the peripheral resistance unit, the drop 
counter, and connected to the lead from the first cannula in order to preserve 
the same pressure in both leads. (Figure 1 ). 
The perfusion pressure was kept between 25 - 35 mm H2O depending upon 
the particular heart being perfused. 
Calibration of the equipment is dealt with in previous work and is not 
included as part of this thesis. (Pathak, 1962). 
Motor driven Venous Pressure 
carriage transducer Live plate 
Arterial 
Standpipe cannulae Venous 
cannula 
Horizonte 
burette r---ý Mercury 
Frog board capacitance manometer 
Drop counter 
plates 
Venous Heart Capacitance Drop 
Pressure Rate Meter Counter and 
Recorder Integrator II Integrator 
Venous Heart Arterial Cardiac 
Pressure Rate Pressure Output 
Pen 4 Pen 3 Pen 2 Pen 1 
Figure 1. 
A block diagram to show the general layout of the frog heart perfusion system 
of Boyd and Eadie (1961). 
At the top left of the diagram the solutions to be tested lie in a horizontal 
burette which leads into the venous capsule. Because of the small amounts of the 
test samples in this work a positive pressure system had to be developed. Figure 3 
shows the pressure system used in the present work and replaces the horizontal 
burette scheme depicted here. 
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DISSECTION OF THE FROG SARTORIUS MUSCLE 
The sartorius muscles were obtained from both Rana temporaria and Rana 
i iens of either sex. After stunning, decapitation and pithing the frog was laid 
in the supine position and the skin was removed from the lower left limb and the 
anterior abdominal wall. The inferior part of the rectus abdominis muscle was 
pinched up and a V-shaped incision was made into the abdominal cavity. The 
rectus was then stripped up towards the rib margin, exposing the viscera. The 
rectum was cut through and by incising the peritoneum and mesentery the viscera 
was carefully stripped off the posterior abdominal wall towards the diaphragm 
until this procedure could be followed no further. This revealed the large nerve 
trunks lying on either side of the spinal column. 
Attention was then turned to the tendinous insertion of the left sartorius 
muscle. The tendon was removed from a point as near as possible to its insertion 
using fine scissors and forceps under the dissecting microscope. The muscle 
belly was then freed from underlying structures on the lateral side. This was 
extended up the whole length of the muscle to its origin at the fascia of the 
anterior abdominal wall. The proximal part of the muscle belly was then 
mobilized and the origin of the muscle was then removed from the medial part 
of the pubis and the lateral abdominal fascia. With the proximal and lateral 
parts of the muscle thus mobilized, it was possible to turn the muscle over in a 
medial and downward direction, preserving the lower and medial half; this is 
the part of the muscle where the nerve enters the muscle belly from the medial 
side. With the muscle turned down at its origin and at a safe distance from 
the symphysis pubis, it was then possible to split the symphysis pubis with a 
strong scalpel blade. The left half of the pubic bone was then turned laterally 
and the sciatic nerve with its obturator branch was seen to hook round the 
sciatic notch of the split pelvis, passing into the thigh musculature. The bony 
projection of the sciatic notch was then modified with coarse scissors and the 
thigh was pinned out in the laterally-rotated position. The course of the nerve 
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to sartorius could then be traced backwards to the exposed nerve trunk by 
splitting the fascia between the muscle planes with a blunt probe under the 
dissecting microscope. Throughout the procedure frog Ringer's solution was 
poured over the parts. 
The nerve trunks of L2,3,4 and 5 were cut as close to the spinal column 
as possible and then mobilized from the posterior abdominal wall fascia until 
the main branch to the sartorius muscle was reached. At this point the nerve 
to sartorius bends at a right angle into the muscle, running across the muscle 
planes. Great care was necessary under the dissecting microscope to free this 
final section of nerve. Both nerve and muscle were then completely free from 
the underlying tissues. 
After washing the muscle thoroughly with Ringer's solution while it was 
still lying on the thigh, the nerve-muscle preparation was then immediately 
transferred to a container of Ringer's solution, gently shaken for a few moments, 
then transferred to a 2ml. container of Ringer's solution and left to "equilibrate" 
for 10 minutes. After this the muscle was then put into the container with 2ml, 
of Ringer's solution and its nerve trunk laid gently over the stimulating 
electrodes (see Figure 2 ). All transfers were done by holding the sartorius muscle 
by its tendon with fine forceps. This ensured that no muscle fibres were damaged 
in transit. The nerve trunk was allowed to adhere to the muscle belly by 
capillary attraction during the transfer process. All Ringer's solutions contained 
10-6 g/ml. eserine sulphate. 
Stimulation of the Muscle 
It was found that with a pulse width of 1 millisecond the threshold of 
stimulation required to make the muscle twitch was usually 0.5 volts. In every 
case the sartorius muscles were stimulated at 4V with a pulse width of 1 msec at 
2 impulses per second for a period of half an hour. The sartorius muscle usually 
responded to every impulse throughout the period of stimulation. After this half 
hour period the muscle was left to soak in the 2misolution for 10 minutes in order 
Figure 2. 
Apparatus used for the indirect stimulation of the frog sartorius muscle. The 
photograph shows a pulse generator connected to a bank of four output points 
connected in parallel. Four stimulated muscle solutions could be obtained at the 
same time. A muscle is being stimulated from the left hand output point. Two 
stimulated muscle solutions are seen standing on the right. 
The line drawing shows the frog sartorius muscle which lies unsupported in 
2 ml. Ringer's solution. The nerve to the muscle lies over platinum electrodes 
which protrude into the glass container through a cork stopper. The electrical 
impedance across the nerve does not affect the pulse amplitude. Leads from the 
electrodes are inserted into the stimulating bank. 
The rat hemidiaphragm preparation was also stimulated in this way, oxygenation 
was effected via a capillary tube (not shown) which passed through the cork 
stopper. An outlet tube was also present. 
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to allow time for diffusion of any released acetylcholine into the surrounding 
bathing solution. The muscle was then removed with fine forceps and the solution 
was ready for assay on the frog heart perfusion system. This solution will be 
referred to as the "stimulated muscle solution" throughout the text. 
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INJECTION OF SOLUTION INTO THE FROG HEART 
On account of the small quantity (lml) of each test sample to be assayed, 
it was necessary to devise a system of injection of this volume into the frog heart 
perfusion system since dilution of the test sample to a suitable volume for the 
horizontal burette system would dilute the expected ACh in this solution beyond 
the threshold of the frog heart. 
A positive pressure system was adopted (Figure 3 ). Air pressure in a closed 
container was matched to the pressure of the normal perfusion Ringer's solution. 
A iml. "tuberculin" syringe containing the test sample was connected between the 
closed container and the venous pressure capsule (Figure 3 ), so that the sample 
would be driven into the heart by a similar pressure to that of the perfusing 
Ringer's solution. 
As a precaution, the closed pressure system was linked by a three-way tap 
to the atmosphere via a fine needle, and to another closed container which was 
at a pressure slightly higher than that of the optimum perfusion pressure. By 
means of this tap the perfusion pressure of the 1ml. sample could be regulated if 
necessary during the course of the injection. 
Procedure : The syringe was filled via a needle with the test sample and fitted 
between the venous pressure capsule and the air pressure system. The tap from 
the perfusion reservoir was closed and at the same time the tap allowing the air 
pressure to reach the syringe was opened. The pressure in the venous capsule 
was now kept constant at the original perfusion pressure by the three-way tap, 
momentarily turning towards either the atmosphere or the high-pressure container 
as required. When the test sample had almost completely entered the venous 
capsule, the tap from the perfusion resevoir was turned on and the tap between 
the air-pressure system and the syringe was closed. In practice, small 
fluctuations in the perfusion pressure occurred (Figure 11) as the test sample was 
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the cardiac output, heart rate and blood pressure slightly and by the time the 
sample had reached the heart the pressure from the normal perfusion reservoir 
was again in operation;, thus any effect on the heart caused by the test sample 
occurred when the perfusion pressure was constant. 
Some dilution of the sample in the venous capsule may occur, but it is 
probable that when the sample is entering the capsule it pushes the Ringer's 
solution in front of it into the posterior vena cava cannula without much 
mixing taking place at the interface. Similarly, when the Ringer's solution from 
the reservoir again flows into the capsule, it pushes the last part of the sample 
into the cannula. 
It has been assumed that the amount of dilution occurring in the venous 
capsule is the same for all samples injected into the heart. 
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MEASUREMENT OF POTASSIUM 
Measurements were carried out by flame photometry. The sample to be 
measured was diluted 1 in 50 with distilled water and then measured (using the 
E. E. L. flame photometer). Six readings were made of each sampel and a 
mean of those was taken. Similar methods were adopted to measure the 
concentration of potassium of various Ringer solutions in which the muscles were 
rested and stimulated. The standard solution of potassium used for comparison 
was 0.1 pEq/mI. At this order of concentration the response of the flame 
photometer is directly proportional to the concentrations of K+ applied. 
Example 
Standard reading = 39 = 0.1 juEq/mI. 
Muscle solution readings = 20.20.21.21.21.21. mean - 21. 




x To = 2.7 mM 
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METHOD OF ESTIMATING CALCIUM CONCENTRATION 
The complexiometric titration method was used (Wilkinson, 1957). The 
dyestuff ammonium purpurate ('Murexide') turns red in alkaline solution in the 
presence of calcium ions. When the calcium is removed by chelation with 
ethyl ene-diamine tetra-acetic acid (E, D. T, A. ) the dye returns to its normal blue 
colour. The end-point of this titration cannot be judged accurately with the eye, 
so that the use of a photo-electric titrator is necessary. 
Reagents 
1. E. D. T. A. -A stock solution of 0.36% was diluted 10 times for use. 
2. Murexide -A stock solution of 0.6% was diluted 1 in 200 with 
distilled water. 
3. Sodium hydroxide -A decinormal solution was made up from a 2N 
solution for each batch of test solutions. 
4. Calcium standard -A stock di Iution of 100 mg Ca++/100 mis was 
diluted by 10 to give a 2.5 mM solution. 
Preparation of Solution for Titration 
0.5 ml. of test sample was pipetted into a 10 ml. glass curvette along with 
3 ml-of Murexide solution and 6.0 ml decinormal sodium hydroxide solution. An 
electro-magnetic stirrer was placed in the cuvette before putting it on the 
titrator platform. The stirring mechanism was switched on. 
The burette containing E. D. T. A. was adjusted so that its tip was just below 
the meniscus of the liquid in the cuvette, taking care not to obstruct the pathway 
of light through the solution. 
A 606 yellow filter was placed in the titrator; the galvanometer reading 
was adjusted to zero against a blank. The calcium standard solution was then 
measured, (mean of 3 results, before and after the test samples) followed by the 
test solutions. 
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Method of Titration 
0.1 ml. amounts of E. D. T. A. were run in until the colour of the solution 
started to change. Then 0.01 ml. amounts were run in while another observer 
gauged the movement of the galvanometer spot. The end-point was reached when 
the spot was not deflected. This was impossible to accomplish with only one 
person carrying out the titration, since the end-point was reached in effect when 
the spot failed to move when more E. D. T. A. was run in. 
r i,., 
Standard calcium solution = 2.5 mM. Test solution =? mM. 
Reading on galvanometer = 1.33 Galvo. reading = 0.58 
millimolarity of test solution = 
0.58 
x 2.5 = 1.09 mM. 1.33 
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THE ESTIMATION OF PROTEIN 
The method described by Lowry et al. (1951) was used. They recommended 
that this reaction was especially useful in measuring small amounts of mixed 
tissue proteins, particularly when absolute values were not required. 
Reagents 
1.2% Na2CO3 in 0.1 N NaOH. 
2.0.5% CuSO4.5H20 in 1% sodium tartrate. 
3. Folin-Ciocalteu phenol reagent diluted to 1 N. 
4. Standard solution of bovine serum albumen diluted to a concentration 
of 50 ; ig/m I. 
Principle 
When protein is added to a copper solution in an alkaline medium, a blue 
colour is developed. This colour change is due almost entirely to the tyrosine and 
tryptophan content of the protein chains. When the Folin reagent is added to 
copper-treated protein at pH 10, reduction of the reagent takes place and the 
blue colour is intensified. At this pH value the reagent is only active for a very 
short time, so that even a few seconds delay in mixing will reduce the final colour 
intensity. The colour intensity developed is proportional to the concentration of 
protein present in the test solution. 
Method 
50 ml of the alkaline copper reagent is made up as follows : - 
49 ml No2CO3/NaOH reagent, 0.5 ml. of CuSO4.5H20 and 0.5 ml. of 
sodium tartrate solution are mixed together. 5 ml of this alkaline copper solution 
is added to 1 ml. of the solution to be tested for protein. This mixture is allowed 
to stand for exactly 10 minutes. Then 0.5 ml. of 1N Folin-Ciocalteu reagent is 
added and the whole shaken during and immediately after the addition of the 
reagent. The solution is then left to stand for exactly30minutes. During this time 
a blue colour slowly develops, and this is compared to the blue colour developed 
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by the standard solution. The comparison was carried out be measuring the 
absorption of light of the solutions at 625 mit wavelength on a Zeiss type PMQ 11 
spectrophotometer. The standard solution of bovine serum albumen was read 




Bovine serum albumen solution =8 10 (Mean 9) 
Test solution = 16 
Reading of 9= 50 ug/m I. 
Reading of 16 =2x 16 ug/ml. = 89 pg/mI. in test solution. 
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THE PREPARATION OF APYRASE SOLUTIONS 
2 mg of potato apyrase (adenosine - 5' - triphosphatase and adenosine - 5' - 
diphosphatase, Sigma) crystals were weighted out and placed in a small watch- 
glass. A stimulated muscle solution was obtained, volume 2 ml. (see Methods 
section). The apyrase crystals were then brushed carefully off the watch-glass 
surface into the bottle containing the stimulated muscle solution. These quickly 
dissolved after gentle shaking of the bottle. The solution was then incubated in 
a waterbath at 30°C for quarter of an hour. After cooling to room temperature, 
the solution was then perfused through the frog heart. 
On some occasions the stimulated muscle solution was divided into two 1 ml, 
portions. Then 1 ml. of the solution was incubated with I mg of apyrase, the 
other 1 ml. portion thus being available as a control. 
Adenosine triphosphate solutions of suitable concentrations were also made 
up in frog Ringer's solution and incubated with apyrase in exactly the same 
manner. 
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THE FIREFLY LUMINESCENCE PROCEDURE 
Materials 
Powdered firefly extract (Sigma FLE 50). 
Adenosine triphosphate solutions made up in frog Ringer's solution. 
Narrow-width glass cuvettes of 0.5 ml. capacity. 
Photomultiplier tube with guiding lens system, reflecting cone and covering 
cannister. 
Powerpack and potentiometer. 
"Devices" single-channel pen recorder. 
The photomultiplier tube is mounted in a Iight-proof alcove and the whole 
procedure is performed in a photographic dark room with illumination, when 
necessary, from a red safety light. 
ATP solutions are made up in frog Ringer's solution which match the expected 
concentration of ATP in the stimulated muscle solution as measured on the frog heart 
perfusion system (see Figure 1 ). 
The powdered firefly extract is taken out of the deep freeze and allowed to 
stand until room temperature is attained. It is then reconstituted by pipetting 
5 ml. of distilled water into the bottle. With gentle shaking the powder dissolves 
in a few minutes and insoluble parts of the firefly material are allowed to settle 
to the base of the container. 
0.25 ml. of the supernatant is then pipetted into a narrow-width glass 
cuvette, the base of which is smeared with "optical glue". 
The pen recorder motor is switched on, the speed used is 2.5 mm per second. 
All light sources are switched off and the red safety light is switched on. With 
the voltage of the powerpack adjusted to a low value, the copper cannister 
covering the top of the photomultiplier tube is removed, revealing the reflector 
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cone. 
At this point 0.25 ml. of the stimulated muscle solution is added to the 
cuvette containing 0.25 ml. of the firefly extract. The reflector cone is now 
removed from the photomultiplier tube and the cuvette mounted by hand on to 
the guiding lens. The "optical glue" smeared on the base of the cuvette ensures 
that a good contact is made with the lens. The reflector cone is then quickly 
replaced over the top of the tube, enclosing the mounted cuvette. The red safety 
light is then switched off and the voltage of the powerpack adjusted to 1300 V. 
After a trace has been obtained on the pen recorder, the high voltage is switched 
off, the reflecting cone lifted and the cuvette removed. The cone is then 
replaced and the high voltage is switched on again. This then gives the true 
base line on the record for a voltage of 1300 V. 
From the time when the test solution is added to the firefly extract, till the 
time when a recording is actually obtained the procedure is carried out as quickly 
as possible and usually takes about 10 - 15 seconds. This means that the record 
unfortunately does not encompass the initial 15 seconds of the I ight emission, so 
that the initial "flash" of light emitted when ATP first contacts the firefly extract 
has not been recorded by this method. However, both stimulated muscle solution 
and a test solution of ATP have similar rates of light signal decay (Figure 36 ) 
and the some amplitude of small scintillations, indicating that although the light 
is probably being reflected in a constant pattern from the inner surface of the 
relfecting cone, the light-producing reaction is taking place in a random fashion. 
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COMPOSITION OF RINGER'S SOLUTIONS 
Frog Ringer's Solution 
Stock Concentration Other Components 
NaCI 70 g/l (isotonic x 10) 
KCI 9 g/1 (isotonic) 
NaHCO3 10 g/l (isotonic) 
Glucose 1 g/l 
Neostigmine 10 g/ml. COO26H2O 18.8 g/I (isotonic) 
NaH2PO42H2O 18.72 g/I (isotonic) 
Method 
The stock solutions were made up from "Analar" reagents supplied by British 
Drug Houses Ltd. The Ringer's solution was made up in the following way: - 
400 ml. stock NaCl solution was diluted to 4,000 ml. with distilled water. 
To this amount was added the other stock solutions: - 100 mI. stock KCI, 90 ml. 
stock NaHCO3,60 ml. stock CaCI26H2O and 30 ml. NaH2PO42H2O and the 
whole shaken thoroughly. 4.28 g of glucose and 4.3 mg of neostigmine were 
added to give final concentrations of glucose: 1 g/l and neostigmine; 10-6 g/ml. 
pH adjustment to 7.4 (if needed) was made by adding either N HCI or N NaOH. 
The final concentrations were 109 mM NaCl, 4.3 mM NaHCO3,3.8 mM KCI, 
1.6 mM CaCl 2' 0.22 mM NoH2PO4. 
Kreb's Solution 
Stock Concentration 
NaCl 90 g/l 
KCI 11.5g/l 
NaHCO3 12.94 g/I 
KH2PO4 21 g/I 
MgS O47H 2O 18.54 g/I 
CaC 1 26H2O 24.1 g/I 
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Method 
80 ml. of the stock NaCl solution was diluted to ten with distilled water to 
800 ml. To this was added 32 ml. of stock KC I, 8 ml. of stock NaHCO3 and 
16.8 ml. of stock KH2PO4. The solution was shaken thoroughly and then bubbled 
with a mixture of 95% 02 and 5% CO2 for fifteen minutes. Then 8 ml. of stock 
MgSO47H2O and 24 ml. of stock CaCI26H2O were added. 
Locke's Solution 
Stock Concentration 
NaC I 250 0 
NaHCO3 509/1 
CaCI26H2O 1000 
KCI 150 g/I 
Method 
One litre of solution was made up by mixing 36 ml. stock NaCl, 10 ml. stock 
NaHCO3,2.4 ml. stock CaCI26H2O and 2.8 ml. stock KCI. This was made up to 
1,000 ml. with distilled water and 1g of glucose added. The final concentrations 
were 154 mM NaCl, 5.6 mM KCI, 2.2 mM CaC12,6.0 mM NaHCO3. 
Leech Solution 
Stock solutions as for Locke's solution. 
Method 
1,000 ml. of Locke's mammalian solution were made up without adding 
glucose or eserine. This solution was diluted 1: 1.4 by adding 400 ml. distilled 
water. Glucose was added to a concentration of 1 g/litre and eserine, 10-5 g/ml. 
The pH of the resulting solution was lowered to 7.0 by bubbling the solutions for 
a few minutes with 5% CO2. The final concentrations were 110 mM NaCl, 4.3mM 
NaHCO3,1.6 mM CaCI2,4 mM KCI. 
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Cleansing of Glassware 
All glassware was cleaned by the Calgon-metasilicate method (Boyd 
and Pathak, 1964) and sterilized in sealed nylon packages which were opened 
immediately prior to the use of their contents. 
COMPOSITION OF RINGER'S SOLUTION USED (mM) 
NaCl KCI CaCl 2 NaHCO3 KH2PO4 NaH2PO4 MgSO4 
Krebs 119 4.7 2.5 24.8 1.2 - 1.2 
Frog 109 3.8 1.6 4.3 - 0.22 - 
Locke 154 5.6 2.2 6.0 - - - 
Leech 110 4.0 1.6 4.3 - - - 
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MAKING UP THE ACETYLCHOLINE SOLUTIONS 
Sealed ampoules of 200 mg acetylcholine chloride (powder form) were 
specially supplied by Roche Products Ltd. Each ampoule of acetylcholine 
chloride was accompanied by an ampoule of distilled water. 
Method 
Both ampoules were filed and broken open; 2 ml. of distilled water was 
transferred by syringe into the ampoule containing 200 mg acetylcholine 
chloride. The powder dissolved quickly. The solution was then sucked back 
into the syringe and transferred to a clean, dry 250 ml. graduated cylinder. This 
was made up to 200 ml. with frog Ringer's solution, giving a concentration of 
10-3 g/ml. of acetylcholine chloride in frog Ringer's solution. 
By transferring 1 ml. of this stock solution of 10-3 g/mI. acetylcholine 
chlordie to a 100 ml. flask and making up to the mark with frog Ringer's solution, 
a concentration of 10-5 g/ml. was obtained. Dilution of 1: 100 from this flask 
resulted in a concentration of 10-7 g/ml. From this flask a dilution of 1: 10 gave 
10-8 g/ml., and a dilution of 1: 100 gave 10-9 g/ml. In this way a range of 
concentrations from the stock solution of 10-3 g/ml. to 10-13 g/ml. were obtained. 
Intermediate Concentrations 
The concentration of 5x 10-5 g/ml. was prepared by making up 5 m1. of 
10-3 g/ml. to 100 ml. with Ringer's solution. From this concentration the intermediate 
concentrations of 5x 10-7 g/ml., 5x 10-8 g/ml., 5x 10-9 g/ml. were made up. 
Further intermediate concentrations of 1.5 x 10-9 g/ml., 2.5 x 10-9 g/ml, 
3.5 x 10-9 g/ml. and 7.5 x 10-9 g/ml. were made up when required in 100 ml. 
flasks. 
Acetylcholine Solutions for Leech Experiments 
The procedure for making up graded acetylcholine chloride solutions for the 
leech experiments was essentially the same as that for the frog heart experiments. 
Eserinized I eech Ringer's solution was used throughout. 
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LIST OF DRUGS 
Adrenaline British Drug Houses Ltd. In sealed 1 ml ampoules 
of 1: 1,000 concentration. 
Noradrenaline : Bayer Products Ltd. Supplied as the bitartrate in 
sealed 2 ml ampoules of 1: 1,000 concentration. 
Adenosine triphosphate : British Drug Houses Ltd. In powder form as the 
disodium dihydrogen salt; also supplied by Pabst 
Laboratories 
. 
Adenosine diphosphate : Manufactured by Pabst Laboratories. 
Adenosine monophosphate : Manufactured by Pabst Laboratories. 
Atropine sulphate : Solution supplied in 1 ml. sealed ampoules by 
Evans Ltd., each ampoule containing .6 mg. 
Acetylcholine chloride : The powder was supplied specially by Roche Ltd. 
in sealed 200 mg ampoules. 
Curare : 50 mg d-tubocurarine chloride in 5 ml. solution. 
Supplied by Duncan Lockhart & Co. Ltd. 
Ergotamine tartrate : Sandoz Products Ltd. Sealed ampoules of 1 ml., 
each ampoule containing 0.5 mg. 
Morphine hydrochloride : Supplied in powdered form by Burroughes Wellcome 
& Co. 
Neostigmine (eserine) : Roche Products Ltd. Supplied as neostigmine 
methyl sulphate in concentrations of 2.5 mg mer 
ml. in 5 mI ampoules. 
Physostigmine sulphate : Supplied in powder form by Macfarlan Smith Ltd. 
Pronethalol : Supplied as a special sample in powder form by 
I. C. I. Ltd. 
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MOLECULAR SIEVE CHROMATOGRAPHY PROCEDURE 
Introduction 
J. Porath (1959) introduced a crossed-I inked dextran gel in order to 
separate out chromatographically the protein fraction from the blood plasma. His 
interest lay in the further investigation of the protein and polypeptide molecules. 
This column separation technique has been adopted commercially ("Sephadex", 
Pharmacia, Uppsala, Sweden) and there are now available many cross-linked 
dextran gels capable of separating out large molecules in different ranges of 
molecular weight. 
The type of Sephadex column used was G-25 of particle size 20W - 80. u in 
diameter. It has the property of being able to separate molecules of 5,000 molecular 
weight and less from molecules having a larger molecular weight. 
Principle 
The Sephadex particles are supplied in dry form and have to be soaked in 
the solvent liquid before use. After the soaking procedure, the particles swell up, 
the extent of the swelling depending upon the nature of the solvent and the 
architecture of the gel matrix. Solute molecules can penetrate the dextran 
network according to the steric relationships between the molecular structure of 
the dextran gel and the solute particles. Thus the shape and size of the solute 
molecules largely determine their penetration, and hence their distribution between 
gel particles, and solvent lying between these gel particles, is determined. If a 
substance is able to penetrate the gel matrix completely, it will be maximally 
retarded in its elution through the column. If a substance has such a large 
molecular size that it cannot penetrate the gel matrix at all, then no retardation 
will take place and the substance will be eluted through the column very quickly 
(Figure 4 ). 
Sephadex columns in general will increase the retardation as the molecular 
weight of the solute molecule diminishes, but there are some molecules which are 
Diagrammatic representation of solute 
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Figure 4. (After Tiselius et al. 1963) 
Sephadex particles of cross-linked dextran gel are represented by equal-sized 
circles. Solute molecules are represented by small, medium-sized and large dots. 
The size of the gaps (pores) between the cross-linkages in the particles vary 
according to the type of Sephadex. Sephadex G-25 has a pore size which will 
just prevent admission of molecules of molecular weight 5000 or over. The shape 
of the solute molecule will also determine whether penetration into the dextran 
matrix is possible. 
- 35 - 
specifically retarded more than they should be according to their molecular weight 
(e. g. adenosine compounds). These anomalies can be due to one or both of the 
following: - 
1. the shape of the molecule does not fit the gap in the dextran matrix 
2. the molecule is highly charged and the gel is repellant. 
It is generally better not to elute the column with distilled water, since 
charged solutes then exhibit inconsistent behaviour. In the present work done with 
Sephadex G-25, various Ringer's solutions were used for elution. 
Construction of Glass Column Container 
Three problems naturally arise during the task of setting up a fractionating 
column. 
1. The column material must be packed evenly. 
2. The material supporting the base of the column must be rigid, porous 
to water but not to the column material. 
3. The top of the column must be perfectly horizontal and preserved as 
such. 
The second requirement was met by the adaptation of a special glass tube. 
This contained a disc of sintered glass with a suitable pore size which was welded 
across the lumen of the tube. The glass tube was cut as near to the partition of 
sintered glass as possible and a spout was fashioned on one side. On to the other 
side was welded a glass column container of 1.4 cms diameter and length 17 cms. 
The third problem was dealt with in the following way. A circle of filter 
paper (Whatman's No. 1) of slightly smaller diameter than that of the glass tube 
was allowed to sink gently on to the surface of the column through the fluid above 
it. This was found to give adequate stability to the column surface when test 
solutions were added carefully by Pasteur pipette. 
Packing the Column 
The Sephadex particles are put into a beaker with Ringer's solution and 
allowed to stand for half-an-hour during which time they swell up. 
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After vigorous stirring the mixture is poured into the large filter funnel with 
the connection between the funnel and the glass tube closed (Figure 5 ). The 
stirring mechanism is now switched on. This swirls the Sephadex particles around 
in the funnel, allowing a few of them to descend into the neck of the funnel. 
The glass column container is now attached to the rubber tubing around the filter 
funnel neck and the connection is opened. This creates a continuous column of 
liquid from the sintered glass bottom to the surface of the liquid in the funnel. 
When the stirrer is switched on, Sephadex particles swirl around in the funnel and 
descend infrequently into the glass tube. When the stirrer is switched off, the 
descent of particles down into the tube increases rapidly. The rate of packing 
and the length of the column could be adequately controlled by this regulating 
method. This method ensures that the particles are packed in an even fashion so 
that separations effected by the column can be repeated and standardized. 
When the appropriate height was reached (13.5 cm), the rubber connecting 
tubing was closed off and gei tly removed from the top of the glass column 
container. This procedure usually caused some disturbance of the particles at 
the top of the column, but this settled within a few minutes after the column was 
transferred to another clamp stand. 
As soon as the Sephadex particles settled in a horizontal plane at the top 
of the column, a disc of filter paper (Whatman's No. 1), cut to fit the internal 
diameter of the glass tube, was allowed to float down on top of the Sephadex 
particles. This gave stability to the column top, since the particles are very 
easily disturbed without this restriction. Every column was packed to a height of 
13.5 cm in a tube of internal diameter 1.4 cm. 
Fluid was eluted through the column using the hydrostatic pressure developed 
by the column of Ringer's solution contained in the glass tube above the level of 
the horizontal plane at the top of the column. The height of this column of solvent 
varied with each glass container, but was usually of the order of 4 cm. 
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a) The glass tube to contain the Sephadex is inserted into a rubber tube which 
connects it with the filter funnel containing solvent + Sephadex particles. 
Solvent - the particles pass through the sintered glass partition into a beaker. 
With the rubber connecting tube open and the electric stirrer switched on, 
Sephadex particles swirl round in the funnel and descent infrequently into the 
glass tube. When the stirrer is switched off, the descent of particles down into 
the tube increases rapidly. When the appropriate height of Sephadex was 
reached (13.5 cm), the connecting tube was then closed and the glass tube 
removed from the rubber connecting tube. 
b) The dimensions of the completed column are shown. Discs of filter paper 
ensure that the extremities of the column are kept horizontal. 
---ýJ 
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column was allowed to run down through the Sephadex particles until the base of 
the meniscus just reached the level of the filter paper. Then the 2 ml. sample was 
carefully pipetted on to the surface of the filter paper by Pasteur pipette. The 
sample was allowed to run into the Sephadex until the meniscus reached the 
filter paper level, at which time the Ringer's solution was added carefully until 
the glass column container was filled completely with the solvent. During the 
elution and collection of the fractions, the column container was constantly 
topped up with Ringer's solution. 
After collection of the fractions, the elution was stopped by inserting rubber 
bungs into the basal spout and the top of the glass tube. 
Equilibration of the Column 
Before each experiment the column was eluted with Ringer's solution 
either leech or frog Ringer's solution, for two hours before a test sample was 
put through. This ensured that the ionic composition of the Ringer's solution was 
not altered in any way, since over a period of two hours presumably the solute 
ions completely penetrate the dextran matrix and are distributed evenly between 
the inside of the particles and the space surrounding them. 
Standardizing the Sephadex Column 
In order to facilitate the procedure of standardizing the column, the 
properties of the substance "blue dextran" (Dextran 2000, Pharmacia) were 
utilized. This substance has a molecular weight of around two million and is 
therefore eluted through the Sephadex column at a maximum rate. Even when it 
is present in very small concentrations, blue dextran imparts a distinct blue colour 
to a solution. The makers recommend a 2% solution for the measurement of void 
volumes inSephadex column chromatography. Blue dextran does not react in any 
way with the column material, although it is said to be slightly adsorbed on to 
Sephadex G-25 particles. The recommended way to remove this adsorbed blue 
dextran is to run a solution of serum albumin through the column. 
Presuming that the blue dextran does not react in any way with the test 
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solution, it is convenient to elute a mixture of the two through the column. 
Adsorption of the blue dextran on to the particles of Sephadex will be counter- 
acted by the protein in the test solution (See protein section). 
The volume of the solution surrounding the active sartorius muscle was 
2 ml; by a process of trial and error it was found that when a solution of 2 ml. of 
blue dextran was put through a column of dimensions 13.5 cm x 1.4 cm the blue 
dextran was eluted into a volume of exactly 3 ml. The passage of the blue 
dextran through the column is easily followed (See Figure 6 ). 
The volume of fluid required to elute the 2 ml. solution of blue dextran 
(or any substance which does not enter the pores in the Sephadex particles) through 
the column is termed the "void volume". Nine columns of height 13.5 cm were 
packed in distilled water and 2 ml. solutions of blue dextran (approximately 5% 
concentration) were put through them. 
The mean void volume of the nine columns was 11.4 mI. (range 10.75 ml. - 
11 . 75 ml). Thus, 
for any substance of molecular weight greater than 5,000, it 
would take approximately 11 .4 ml. of Ringer's solution to carry it through the 
column when it was contained in an initial volume of 2 ml. A newly-packed 
column was only accepted for use when 2 ml. of blue dextran solution was eluted 
into a3 ml. fraction. 
Because of the slight variation in the void volume from column to column, 
it was decided to mix the blue dextran with the test solution and then to follow 
the course of the blue dextran through the column visually. Only after the column 
was seen to be clear of the blue dextran were subsequent fractions collected. 
The initial 3 ml. fraction containing the blue dextran is termed the "blue 
dextran fraction", and contains any substances of molecular weight greater than 
5,000 that are present in the test solution e. g. protein molecules. 
It was for the purpose of isolating ACh from other substances found in the 
test solution that the properties of the Sephadex column were adopted. The 
fractions collected after the initial blue dextran fraction were deliberately adjusted 
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in volume so that most of the ACh could be recovered in one fraction. It was 
found that a3 ml. fraction coming 4.5 ml. after the blue dextran fraction 
contained most of the ACh present in an initial 2 ml. volume eluted through the 
column. 
The behaviour of the other substances in the column was studied to 
ensure that a column of this dimension could effect a different pattern of elution 
with substances of different molecular weights. It was convenient to use coloured 
substances for this study. Figure 6 (coloured plate) shows the various stages in 
one such experiment. 2 ml. of potassium ferricyanide in a concentration of 
20mg/ml. were mixed with 0.1 ml. of blue dextran. This mixture was then put 
through the column. The fractions collected were those normally collected for 
the ACh recovery. The estimation of the potassium ferricyanide was made by 
comparing the intensity of the fraction colours with known concentrations of 
potassium ferricyanide using a Hawksley colorimeter. 
The right hand column of Figure 7 shows the percentage recovery of the 
substances cupric sulphate, cobalt sulphate and potassium ferricyanide. The left 
hand column indicates for comparison the percentage recovery of ACh-chloride in 
the same fractions as measured on the leech muscle from five Sephadex columns. 
F 
Figure 6. 
S. ,. Iý. 
r :i1. r. . 
The separation of a substance of large molecular weight (blue dextran : M. W. 
5,000) from a substance of small molecular weight (potassium ferricyanide : M. W. _ 
329) by the Sephadex column. 
On the left of the plate are cylinders containing solutions of potassium 
ferricyanide (yellow) and blue dextran. The cylinder in the foreground contains a 
2 ml. mixture of the two substances. When this mixture is placed at the top of the 
column and allowed to gravitate through, the blue dextran is seen to advance 
immediately ahead of the potassium ferricyanide. The second column shows the 
separation at a later stage. When the subsequent fractions are collected, the blue 
dextran is eluted into the first 3 ml. and the potassium ferricyanide comes into 
fractions 2,3 and 4, most of it being in fraction 3. Neither substance appears in 
fraction 1. 
Figure 7. 
Left Hand Column 
The percentage recovery of ACh-chloride in column fractions which were 
pdjusted to contain most of the ACh in fraction 3. Each histogram is constructed 
from a separate column experiment. The columns were eluted with leech Ringer's 
solution and the initial ACh solution was made up in the same type of Ringer's 
solution. Assay of these fractions was done on the leech muscle strip. Note 
that no acetylcholine appears in fractions 1,4,5 and 6. 
The volume of fractions 1-6 was, respectively, 2 ml., 2.5 ml., 3 ml., 2.5 
ml,, 2 ml 2 ml.. 
Right Hand Column 
Substances of different molecular weight were put through the column and 
the same fractions were collected. Note the different distribution of the some 
substance when distilled water is used as the solvent. 
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SETTING UP THE LEECH PREPARATION 
The method used is a modified version of that used by Murnaghan (1958), who 
noted that morphine facilitates the quicker relaxation of the leech strip of muscle. 
The leech muscle was soaked in solutions of morphine before being set up in the 
bath. This differs from the original method in that Murnaghan set up the leech 
strip ready to record contractions at the beginning of the morphinization 
procedure. 
A live leech is taken from a tank where the store of leeches were kept in 
loch water. After crushing the ganglia just posterior to the anterior sucker, the 
leech is pinned out on a cork board with the ventral side lying upwards. A midline 
ventral incision is made starting caudally and ending by opening the anterior 
sucker. Thus the whole of the muscular body wall is eventually pinned flat out 
with the outside surface next to the cork board. This position displays the grey- 
white walls of the coelom. Using fine forceps and fine scissors the coelomic wall 
is completely removed, revealing the dark, chocolate brown inner layer of the 
body wall musculature. This layer represents collections of large cells containing 
ingested red blood corpuscles which have migrated from the gut. The dark brown 
colour is presumably caused by the breakdown products of the haemoglobin pigment 
within the corpuscles. This layer is very difficult to remove without inflicting 
some damage upon the actual muscle layer and in practice was never completely 
removed. 
After the process of "cleaning" the inner surface of the body wall, the 
pinned-out preparation is turned over and pinned out again, this time with the 
outer surface uppermost. It is convenient to use the natural markings on the dorsum 
of the leech as a rough guide to the breadth of the strip of muscle removed. On 
each side of the dorsum of the leech, running longitudinally, are two black lines 
enclosing a thin yellow line. The strip which lies in between these longitudinal 
patterns proved to be a suitable breadth. The anterior half of the leech was used 
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as a rough guide to the length of the strip required, to suit the dimensions of 
the leech bath. 
Having removed this size of segment from the dorsum of the body wall 
musculature, the strip is then pinned out without any undue tension, on a small 
cork board and floated upside down in a Ringer's solution containing 5x 10-5g/ml. 
morphine sulphate. After an hour it was then transferred to a Ringer's solution 
containing 2x 10-5 g/ml. morphine sulphate (see Table 1) and left to soak for 
a further hour. The preparation is now transferred to the 2 ml. leech bath. The 
muscle strip is unpinned and a loop of thread is tied to one end. A long thread 
is tied to the other. The loop is then passed around the hook of the syringe 
needle while the long piece of thread is attached to the tension transducer. In 
this way the strip of leech muscle is suspended in the tubular bath, which is 
now filled with leech Ringer's solution. After the bath is filled with the Ringer's 
solution the muscle strip should not touch the sides of the bath (Figure 8 ). 
At this stage the tension of the muscle strip can be adjusted to a suitable 
value for the particular piece of muscle in the bath by the control attached to 
the transducer (Figure 8 ). 
The tension developed by the muscle strip will always approach an optimum 
value, provided that the muscle is not overstretched. If the muscle is suddenly 
stretched, then it will immediately relax until the original level of tension is 
reached. If the strip is suddenly shortened passively, the muscle will contract 
until the original tension value is achieved once again. Amplification is 
adjusted so that an excursion of 1 mm by the leech muscle will cause a movement 
of 30 mm on the pen recorder. The tension recording is calibrated by hanging 
weights on the thread attached to the transducer. 
The following procedure is adopted in order to apply a test solution to the 
muscle strip. The leech bath is drained of fluid by the tap at the base of the 
needle (Figure 8 ). A new solution is added by syringe at the top of the bath. 
During the procedure of changing the solutions in the bath, the leech muscle is 
Table 1 
THE PRESENT METHOD COMPARED WITH THAT OF MURNAGHAN 
SAME LEECH RINGER'S SOLUTION USED 
D--6 AA-4k J 
Strip soaked in morphine sulphate for 1 hour Strip soaked in 4 or 5x 10-5 g/ml 
(concentration =5x 10-5 g/ml) Strip soaked morphine sulphate. Left for up to 3 
for another hour in 2x 10-5 g/ml morphine hours. Strip soaked for a further 30 mins. 
sulphate and 10-5 g/ml eserine sulphate. in 4 or 5x 10 
5 
g/ml morphine sulphate 
and 10 
5 
g/ml eserine sulphate solution. 
Strip was pinned on to a cork board, being Strip was set up in an isotonic fashion in 
slightly stretched. Board was transferred from leech bath. The tension being "equivalent 
one solution to another to 2 grammes" . Then solutions above 
were put into bath. 
Washing between acetylcholine solutions was Morphine-eserine Ringer's solution was 
done with eserinized leech Ringer's solution used for washing throughout. 
(10-5 g/ml). 
Acetylcholine solutions made up in Test solutions consisted of mammalian- 
eserinized Ringer's solution (10-5 g/ml). Ringer perfusates of 10 
5 
g/ml eserine 
diluted 1: 1.4 before assay. 
Each solution allowed to act for 45 secs. Solutions allowed to act for 2-3 mins. I 
Isometric system, tension measured. 
I Isotonic system, change of length measured. 
Thresholds mostly 10 -9 g/ml. Sensitivity Thresholds mostly 10- 
9 
g/ml. "In no case 
maintained over 24 hr. period. did the sensitivity fall off after 5 hours". 
Non-oxygenated Ringer's solution. Oxygenated Ringer's solution. pH = 7.3. 
pH = 7.0. 
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Figure 9. The apparatus used for the estimation of ACh by the isometric leech 
muscle preparation. 
The clamp-stand on the right supports the force displacement transducer 
(type FTO 3C, Grass Instrument Co. ) and the leech muscle bath. The muscle 
strip is attached to the transducer by a thread. On the other side of the stand 
is attached the ratchet system for altering the length of the muscle strip. The 
central piece of apparatus is the Devices preamplifier unit which is linked to 
a power supply (not seen). The Everett Edgecumbeduo"channel pen recorder, 
seen on the left, records tension of the leech muscle strip on one channel and 
length of the strip on the second channel. Amplification of the system was 
adjusted so that a change in tension of 5 mg could easily be recorded. 
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momentarily suspended in air and usually sticks to the side of the bath until the 
new solution fills the bath. The small amount of tension produced by the leech 
sticking to the bath is always indicated on the record by an unusual, but 
regular, increment in tension before the effect of each test solution. 
Every test solution in this work was applied to the muscle strip for a period 
of 45 seconds; a clear response could be detected after this short period of time 
and the effects of ACh solutions could be quickly washed out after this period 
in contact with the muscle. 
RESULTS 
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THE RESULT OF PERFUSING A STIMULATED MUSCLE SOLUTION THROUGH 
A FROG HEART 
When the solution in which the frog sartorius muscle twitched was perfused 
through the frog heart, an unexpected finding occurred. Instead of producing the 
expected slowing of the heart beat, typical of ACh, a sharp stimulatory effect 
resulted from the solution (Figure 10 ). The cardiac output, systolic, diastolic 
and pulse pressure were all increased. In some cases a late increase in the heart 
rate occurred. In no case, out of forty-one undiluted test solutions perfused 
through thirty-three frog hearts, was an ACh-like effect seen on the frog heart 
(Table 2 ). All solutions stimulated the frog heart. Clearly the effect of any 
ACh present in the test solution was being completely masked by the effect of 
other interfering substances. 
Figure 10 shows the effect of perfusing a frog heart with a solution in 
which a sartorius muscle has twitched. The cardiac output (in ml/min), arterial 
pressure (in mm Hg), heart rate (in beats/min) and the venous pressure (in mm 
H2O) are monitored simultaneously. The marker indicates the time taken for a 
test solution to be perfused into the frog heart. "Sx" indicates the time of 
perfusion of a stimulated muscle solution into the heart, the "S" referring to the 
unknown stimulatory substance, or substances, and the "x" indicating that there 
is an unknown quantity present. The venous pressure recording indicates the 
pressure at which the heart is being perfused with frog Ringer's solution from a 
large reservoir. The slight irregularity of the venous, or perfusion, pressure 
recorded during the time of injection of the test solution into the venous capsule 
is due to the pressure in the positive pressure system being adjusted manually by 
tap in order to keep the perfusion pressure during the injection as close to the 
original perfusion pressure as possible (See Methods). 
As soon as the solution reaches the heart there is an initial sharp rise in the 
systolic pressure, not quite matched by the sharp rise in diastolic pressure. At the 
Figure 10. 
The effect of perfusing a frog heart with a stimulated muscle solution. 
Note the sharp rise in the systolic, diastolic and pulse pressures in the arterial 
pressure recording. At the same time the cardiac output rises very rapidly to 
reach a peak about one minute later. A further minute later the heart rate 
reaches a peak value; this effect is slow to pass off. Note the irregularity of 
the perfusion pressure during the injection. A control injection of Ringer's 
solution is seen at the right of the trace. 
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Figure 11 
, 
The effect of perfusing a solution in which a sartorius mucle has rested 
for 30 minutes through a frog heart. "Rx" indicates the time of perfusion of 
the undiluted resting muscle solution. Note the increase in cardiac output 
and blood pressure. No effect is seen on the heart rate. "Rx" diluted 10 
times has no effect on the heart. 
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HE EFFECT OF RESTING AND STIMULATED MUSCLE SOLUTIONS WHEN PERFUSED 
THROUGH FROG HEARTS 
RESTING MUSCLE SOLUTIONS STIMULATED MUSCLE SOLUTIONS 
Heart % Output Increase % Rate Increase Heart % Output Increase % Rate Increase 
1 -13 1 1 25 25 same 
-14 3.5 18 25 muscle 






3-77 4 32 heart stopped 
-2 -12 100 33 5 24 20 
400 6 6 7 
5 11 0 7 14 28 
10 0 8 7 10 
15 0 9 28 - 
31 2 
600 10 28 25 
75 33 30 14 
45 11 12 13 
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10 -60 -40 56 irregular 
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Five solutions gave no effect 29 18 10 
30 35 15 
31 28 - 
32 36 8* 
33 18 15 
* two pooled solutions 
Rate increase was measured as a maximum after injection of the test 
solution. This usually occurred 2 minutes afterwards. 
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same time the cardiac output is suddenly increased and reaches a peak value about 
one minute later. The heart rate increases from 30 beats/min to a peak value of 
50 beats/min about two minutes later and only returns to a normal value a further 
ten minutes later. The heart beat has been rendered irregular for seven minutes 
by the injection of the test solution, but soon assumes the former regular rhythm. 
A control injection of frog Ringer's solution shown at the right of the trace is 
without effect on any parameter. 
This particular sartorius muscle was stimulated under isometric conditions and 
it was noted that some degree of tissue damage was likely to occur at the fixed ends 
of the muscle. This would contribute unknown products of tissue damage to the 
surrounding solution which could markedly affect the response of the heart. In order 
to minimise this risk every subsequent stimulated muscle solution was obtained from 
a muscle which was allowed to lie in the bathing solution withoutlhaving any 
support at the ends of the muscle (Figure 2). 
It was important to exclude the possibility that the effect was produced by a 
sartorius muscle which had only soaked in the bathing solution without stimulation 
taking place. Figure 11 shows the effect of perfusing a solution in vii ich a 
sartorius muscle had rested for half-an-hour through a frog heart. "Rx" indicates 
the time of perfusion of the undiluted resting muscle solution. A slight increase 
in the systolic and diastolic pressures has occurred, with a simultaneous increase in 
the cardiac output. No obvious effect is seen on the heart rate. When this 
solution was diluted ten times, "R 10-1 x", the effect was abolished. Out of 
twenty-three resting muscle solutions perfused through fourteen hearts, five 
solutions gave no effect, six solutions produced an inhibition of cardiac output 
and twelve gave a mean increase in cardiac output of 8% (Table 2). Thus the 
substance, or substances, which cause the stimulation of the frog heart does not 
cause as great an effect when it comes from a resting muscle solution as it does 
when it comes from a stimulated muscle solution. 
It seems that the effect is produced by a twitching muscle rather than by a 
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resting one. 
The Effect of Curarizing the Preparation 
In order to exclude the possibility that the stimulatory effect was produced 
from substances liberated from nerve terminals, the sartorius muscle was curarized 
and then stimulated in the usual way via the nerve. Thus the nerve terminals 
remained active while the muscle did not actually contract. When the resultant 
stimulated, curarized muscle solution was perfused through the heart, the effect 
produced was the slight stimulatory one associated with the resting muscle solution 
(compare Figures 11 & 15). Although the curarization procedure did reduce the 
interference phenomenon, an ACh-like effect was still not apparent. 
It was found that the effect produced by the resting muscle solution could 
be diluted out more easily than the effect from the stimulated muscle solution. 
Thus the curarization procedure would allow less dilution of any ACh contained 
in the stimulated muscle solution. Since any test solution obtained in this way 
would contain curare, it was important to verify that curare had no effect on the 
sensitivity of the frog heart to ACh. 
Figure 12a shows the response of an insensitive frog heart to graded 
concentrations of ACh. The threshold response occurred when a concentration of 
10-9 g/mI. ACh was perfused through this heart. The heart was just arrested by a 
concentration of 2.5 x 10-8 g/ml. ACh. It was found that a concentration of 
5x 10-6 g/ml. d-tubocurarine was enouch to prevent the isolated sartorius 
muscle from twitching. Figure 12b shows the response of the same heart to ACh in 
the presence of 5x 10-6 g/ml . 
d-tubocurarine. This concentration of curare was 
present in both the perfusing Ringer's solution and in the solution containing the 
graded concentrations ofACh. Again the threshold response is at 10-9 g/ml. ACh 
with cardiac arrest occurring when 2.5 x 10-8 g/ml. ACh is perfused through the 
heart. Figure 13 shows graphs of the concentration - response relationship of 
the same frog heart to ACh for cardiac output and heart rate. On the part of the 
curve useful for bioassay of ACh, from 10-9g/ml. to 5x 10 
8g/ml. 
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Figure 12. 
The response of an insensitive frog heart to graded concentrations of ACh. 
(a) Shows the response to graded concentrations of ACh. 
(b) Shows the response of the same heart to ACh in the presence 
of 5x 10-6 g/ml curare. The response of the frog heart to 
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Figure 13. 
Graphs of the concentration-response relationship of a frog heart to 
acetylcholine in the absence and in the presence of curare. There is little 
difference in the response of the heart to ACh in the presence of curare. 
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Table 3. 
H t 
Before Curare After Curare 
ear 
Theshold Arrest Threshold Arrest 
1. 10-9 2.5 x 10-8 10-9 2.5 x 10-8 
2. 10-9 5.0 x 10-8 10-9 5.0 x 10-8 
3. 10-9 -- 10-9 2.5 x 10 
8 
Concentrations of ACh (g/ml) required to produce threshold responses and 
cardiac arrest in the absence and presence of curare. 
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there is little difference in response of the heart to ACh either in cardiac output 
or in heart rate in the presence of curare. The threshold response of two other 
hearts was not altered in the presence of this concentration of curare (Table 3). 
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A PILOT ASSAY ON A VERY SENSITIVE FROG HEART 
One experiment was done with an extremely sensitive frog heart in order 
to find out whether assay of the ACh output from a frog sartorius muscle was 
possible or not. At a frequency of stimulation of 2/sec for 30 minutes, according 
to the calculation quoted in the introduction, the theoretical output of ACh from 
a sartorius muscle should be approximately 10-9 g. The muscle was stimulated in 
a2 ml. volume, so the concentration of ACh in the surrounding bathing solution 
should be 5x 10-10 g/ml. 
Result 
The response of a very sensitive frog heart to concentrations of ACh in 
the presence of curare is shown in Figure 14. The threshold response of this heart 
occurred when a concentration of 2.5 x 10-13 g/ml. ACh was perfused through 
it. A concentration of 10-12 g/ml. ACh stopped the heart. Finely-graded 
responses are seen between these tests, showing an increasing fall in the heart 
rate and cardiac output with increasing concentrations of ACh. 
The ACh solutions perfused through the heart were made up from Ringer's 
solution containing 5x 10-6 g/mI. d-tubocurarine. This does not affect the 
sensitivity of the heart to ACh (Figure 13). 
When a stimulated, curarized muscle solution was perfused through the 
sensitive frog heart, an effect equivalent to the effect seen when a resting, 
non-curarized muscle solution was put through the heart was evident. This 
is shown in Figure 15 (Compare to Figure 11). The solution "Sx" (third test) was 
obtained from a curarized sartorius muscle which had been stimulated at 2/sec 
for 30 minutes in 2 mi. of frog Ringer's solution containing 5x 10 
6 
g/ml. 
d-tubocurarine. When this was perfused through the heart it produced an 
initial slight bradycardia followed by an increase in heart rate and 
cardiac output, with a rise in systolic and diastolic pressures. When this 
solution was diluted by half, the slight stimulatory effect disappeared, and an 
Figure 14. 
The response of a very sensitive frog heart to concentrations of ACh in 
the presence of curare. A concentration of 2.5 x 10-13 g/ml. ACh produced a 
threshold response. 10-12 g/ml. ACh stopped the heart. All ACh solutions were 
made up containing a concentration of 5x 10-6 g/ml. d-tubocurarine. 
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Figure 15. 
An assay of a stimulated muscle solution on the some frog heart as in Figure 
14. "Sx" = solution obtained from a curarized sartorius muscle stimulated 
indirectly at 2/sec for 30 minutes in 2 ml. Ringer's solution. Note the similarity of 
the effect of "Sx" to the effect of the resting muscle solution in Figure 11 . "S 5x 
10-1 x" (the solution diluted bY half) reveals an ACh-like effect which is matched 
by a concentration of 5x 10-13 g/ml. ACh. The sudden fall in the blood pressure 
which occurred during the effect of this solution was due to a leak in the perfusion 
system lasting for a few seconds only. Note the drop in the venous, or perfusion 
at this pressure point also. 
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ACh-like effect was revealed (first test): S5x 10-1. This effect was closely 
matched to a known concentration of ACh, 5x 10-13 g/ml. (second test). The 
stimulated muscle solution when diluted 10 times matched 10-13 g/ml. ACh. The 
standard tests for the identification of ACh were not performed on this solution, 
partly because of the small volume available and partly because any "manipulation" 
of the ionic content of such a test solution (e. g. raising the pH to 10, heating the 
solution to 90°C and restoring to the normal pH and temperature again) might have 
interfered with the quantitative response of this heart to ACh. 
Calculated Output of ACh from the Sartorius Muscle 
Test solution diluted by half -5x 10-13 g/ml. ACh. 
therefore undiluted test solution =_ 10-12 g/mI. ACh. 
Muscle was stimulated in 2 ml. volume, 
therefore output of ACh from muscle =2x 10-12 g. 
Test solution diluted 10 times = 10-13 g/ml. ACh. 
therefore undiluted test solution =_ 10-12 g/ml. ACh. 
therefore output of ACh from muscle again =2x 10-12 g. 
The output per impulse per nerve ending is calculated below: 
number of impulses delivered = 3,600 (2/sec for 30 minutes) 
amount of ACh released per impulse = 0.6 x 10-15 g. 
since there are about 1,000 endplates per muscle, 
amount of ACh released/impulse/ending = 0.6 x 10-18 g=0.5 x 10-1 
moles. 
This amount is considerably less than that obtained by other workers for 
mammalian muscle. Krnjevic and Mitchell (1961) calculated an output of 10-17 
mole/impulse/ending and Krnjevic and Straughan (1963) calulated an output 
of 10-18 mole/impulse/ending using rat diaphragm muscle. 
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AN ATTEMPTED ASSAY OF ACh RELEASED FROM RAT DIAPHRAGM ON THE 
PERFUSED FROG HEART 
Since the output of ACh had been estimated by other workers from the rat 
hemidiaphragm preparation (Bulbring, 1946) the author was curious to know whether 
a solution which had surrounded a twitching hemidiaphragm could produce the 
same interference phenomenon on the frog heart as the solution obtained from the 
twitching sartorius muscle. 
Result 
When a frog heart is perfused with Locke's mammalian solution, its 
sensitivity to ACh is little altered. Figure 16 shows the comparison of 
concentration-response curves of a frog heart to ACh for cardiac output and heart 
rate when it was perfused with frog Ringer's solution and Locke's mammalian solution. 
A rat hemidiaphragm was stimulated via the phrenic nerve at twenty impulses 
per second for twenty minutes in 4 ml of Locke's solution and the resulting solution 
was injected into a frog heart which was being continuously perfused with Locke's 
solution. No evidence of an ACh-like effect is seen, even although the hemi- 
diaphragm muscle is expected to release 3.5 x 10-8 g ACh (Krnjevic and Mitchell 
1961). Instead the test solution caused an increase in the force of contraction of 
the heart with a concomitant bradycardia and a late increase in the heart rate. 
Since the threshold response of this heart to ACh was 10 
9 
g/ml, and the 
concentration of ACh in the 4 ml test solution was expected to be 10-9 g/ml, 
clearly an interference phenomenon similar to that encountered with the frog 
sartorius muscle solutions was taking place (Figure 17) . 
Figure 16. 
The response of a frog heart to graded concentrations of ACh when perfused 
with frog and mammalian Ringer's solutions. The upper figure shows the com- 
parison of the percentage inhibition of cardiac output caused by various con- 
centrations of ACh during perfusion of the heart with frog Ringer's solution and 
Locke's mammalian solution. The lower figure shows the comparison of the 
percentage inhibition of heart rate. The sensitivity of the heart to ACh is virtually 






























10° I0" 10° 107 
Concentration of acetylcholine (0/ml) 









Ep 41 Ul C )- 4 Ln 
LAJ 
404 
I The result of perfusing a solution in which a rat hemidiaphragm has twitched 
through a frog heart. 
The frog heart is continuously perfused with Locke's mammalian solution. 
This does not affect the sensitivity of the heart to acetylcholine. The rat hemi- 
diaphragm was stimulated indirectly in 4 ml. Locke's mammalian solution and the 
resulting solution was perfused through the frog heart. 
After a satisfactory control injection, the test solution is seen to cause an 
increase in the force of contraction of the heart with a concomitant bradycardia 
and a late rate increase. No evidence of an acetylcholine effect is seen. 
An interference phenomenon similar to that encountered with the frog 
sartorius muscle makes the direct assay of acetylcholine from diaphragm muscle 
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DISCUSSION 
In order to measure the output of ACh from the frog sartorius muscle using 
the present method, an exceedingly sensitive and stable heart preparation is 
required. Obviously the sartorius muscle liberates more than ACh into the 
surrounding bathing solution. In order to detect the ACh present, the frog heart 
must be sensitive enough to respond to the concentration of ACh in the test 
solution after the interfering substances have been diluted to an ineffective 
concentration. 
However, in the presence of a depressant substance (ACh) it can never be 
wholly guaranteed that a stimulatory substance has had its effect completely 
abolished by dilution ; the only satisfactory way to assay the ACh without this 
interference would be to elucidate the cause of the stimulation and specifically 
remove it. 
The interference phenomenon of heart stimulation in contrast to the heart 
inhibition produced by ACh may be the factor responsible for producing such a 
low result for the output of ACh in comparison to the results of other workers. 
The result obtained with the rat hemidiaphragm muscle also suggests that a falsely 
Iow result for ACh output would be obtained using the frog heart preparation for 
the assay. 
The nature of this particular interference phenomenon is an interesting one. 
Why should a "metabolic product" liberated from contracting muscle be capable of 
stimulating the frog heart? All known compounds classified as "metabolites" such 
as carbon dioxide, pyruvic acid, hydrogen ions, carbonic acid, adenylic acid 
etc., would be expected to have either no effect or perhaps a depressant effect 
on the frog heart. 
The following section of this thesis describes investigation into the cause of 
the stimulatory effect, with a view to removing it, thus allowing assay of the 
ACh released from sartorius muscle to procede without this interference. 
PART I 
THE IDENTIFICATION OF ADENOSINE TRIPHOSPHATE 
RELEASED FROM ACTIVE SKELETAL MUSCLE. 
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INTRODUCTION 
When a solution in which a frog sartorius muscle has twitched is perfused 
through a frog heart, a pronounced augmentation of the heart beat occurs 
(Figure 10). This section describes the identification of the substance released 
from active sartorius muscle which was the cause of the heart stimulation. 
At the onset of this investigation it appeared that any alteration in the 
composition of the solution bathing the activesartoriusmuscle might be responsible 
for the phenomenon, for example, a change in the hydrogen ion concentration 
of the solution. Another obvious change in the surrounding bathing solution 
would be an increase in the concentration of potassium resulting from the efflux 
of intracellular K+ from skeletal muscle during the active state. Whether 
excessive K+ in the test solution would, in fact, stimulate the frog heart is 
doubtful, but the possibility had to be excluded. 
The frog heart is known to be very sensitive to changes in the Ca 
++ 
concentration of perfusing Ringer's solutions and MacLean and Hastings (1934) 
utilized this sensitivity in order to determine the levels of ionized Ca++ in the 
body fluids. They could detect differences in Ca 
++ 
concentration of 0.1 mM 
by this method. It was not known whether any change in Ca++ concentration 
would occur in the test solution after stimulation of the sartorius muscle, or, if 
such a change took place, whether it would cause a stimulatory effect. 
Many biologically active substances can become protein-bound if they do 
not already exist in this form. Also, chemical radicals can become attached to 
proteins of the simplest nature by "high-energy" bonds. Examples of this have 
been shown in the investigations of Boyer et al. (1962). They found that the 
histidine component in a peptide chain could adopt the phosphate radical by way 
of a high-energy bond similar to those associated with purine or pyrimidine 
nucleotides. An investigation into the protein content, if any, of the stimulated 
muscle solution was thus necessary as a preliminary "screening" procedure. 
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A class of biological compounds which would obviously stimulate the heart 
are the catecholamines; however, it is unlikely that the adrenergic supply to the 
blood vessels contained in a single sartorius muscle could release quantities of 
catecholamines necessary to cause the typical stimulatory effect seen on the frog 
heart, nevertheless it was necessary to eliminate this possibility. 
Other substances which could possibly be liberated from active skeletal 
muscle into a surrounding bathing solution, such as carnosine, 5-hydroxytryptamine, 
histamine and plasma contents such as bilirubin were excluded as candidates for 
causing stimulation of the frog heart by experiments not reported here and in 
previous work (Pathak, 1962). 
Specific investigations into pH changes, potassium changes, calcium changes, 
protein content and catecholamine content of the test solution now follows. 
Changes in Hydrogen Ion Concentration of Fluid Surrounding an Active Sartorius 
Muscle 
In this work the pH of 22 stimulated muscle solutions was measured and the 
range was found to be 7.2 - 7.9. It has previously been established that 
alterations in the pH of the perfusing Ringer's solution within this range do not 
have any direct effect on the frog heart preparation (Boyd and Pathak, 1965). 
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THE OUTPUT OF POTASSIUM FROM ACTIVE SKELETAL MUSCLE 
Ten sartorius muscles were soaked in 2 ml. volumes of Ringer's solution with 
varying concentrations of K+. The K+ concentration did not alter significantly 
after a 30 minute period of soaking (Figure 18). 
Seventeen sartorius muscles were stimulated at 2 impulses per second in 
2 ml. volumes of Ringer's solution and the concentration of K+ in each solution 
was measured before and after the period of stimulation. An average increase in 
K concentration in the surrounding bathing solution of 21% was found (Figure 18). 
Figure 19 shows the effect of perfusing a frog heart with frog Ringer's 
solution containing 2.9 mM K+, a stimulated muscle solution which contained 
3.6 mM K and a frog Ringer's solution which contained 3.7 mM K It is 
clearly seen that the high K+ Ringer's solution does not stimulate the heart, whilst 
the test solution, containing a low concentration of K+, gives a sharp increase of 
the cardiac output with a concomitant bradycardia. Five other frog hearts were 
perfused with samples of Ringer's solution containing up to twice the normal 
amount of K+ and in no case did a stimulatory effect occur similar to that caused 
by the test solution. 
It is concluded from these experiments that the stimulatory effect is not due 
to the potassium efflux from active skeletal muscle. 
Figure 18. 
(a) The potassium concentrations of Ringer's solutions in which frog 
sartorius muscles were allowed to rest for 30 minutes. Black columns 
indicate the potassium concentration of the solutions before soaking. 
The grey columns show the K+ concentration after soaking the 
muscle. No change in the K+ concentration occurs. No difference 
occurs in the K+ concentration of the solution after a sartorius 
muscle rests for 30 minutes. 
(b) The K+ concentrations of Ringer's solutions in which frog sartorius 
muscles have twitched for 30 minutes. The black column indicates 
the K+ concentration of various Ringer's solutions. The grey columns 
indicate the K+ concentration after stimulation of the sartorius 
muscle. 
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Figure 19. 
The effect of perfusing a frog heart with a Ringer's solution containing a 
high concentration of K+ and a stimulated muscle solution. The Ringer's solution 
continually perfusing the heart contained 2.9 mM K+. When the stimulated 
muscle solution, "Sx" is perfused through the heart the stimulatory effect is clearly 
seen. This particular solution had a K+ concentration of 3.6 mM. When a 
Ringer's solution containing 3.7 mM K+ was perfused through the same heart, no 
effect equivalent to the stimulatory effect was seen. "Drain and refill" indicates 
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CHANGES IN CALCIUM CONCENTRATION IN THE SOLUTION SURROUNDING 
THE ACTIVE SARTORIUS MUSCLE 
Considerable data has accumulated from studies on calcium entering skeletal 
muscle fibres during their contraction. Fenn, Cobb, Manery and Bloor (1938) 
showed that there is no change in the calcium content of muscle after stimulation. 
Bianchi and Shanes (1959), however, indicated that although there may be no 
net alternation in intracellular calcium content, both influx and efflux take place 
simultaneously during contraction. They also suggested that perhaps the influx of 
calcium is so small that it cannot be measured accurately, nevertheless they 
thought it large enough to initiate contraction. According to this postulate, it 
is conceivable that a significant amount of Ca 
++ 
could be taken up by an active 
muscle, eventually depleting the bathing solution of Ca++. 
Results 
Fourteen experiments were performed where the Ca++ concentration of a 
stimulated muscle solution (2 ml) was measured before and after the period of 
stimulation (2/sec for 30 minutes). Seven muscles out of the fourteen showed no 
difference in Ca ++ concentration after stimulation. The mean concentration of 
Ca++ in Ringer's solutions before stimulation was 1.08 mM; the mean concentration 
of Ca 
++ in the some solutions after stimulation was also 1.08 mM (Figure 20a). 
The range of Ca 
+ 
millimolarity in the solutions after stimulation was 
0.92 mM - 1.22 mM. The effects of perfusing Ringer's solutions containing 
0.9 mM Ca 
++ 
and 1.4 mM Ca 
++ through the frog heart are shown in Figure 20b 
An injection control solution containing 1.2 mM Ca++ has no effect. The 
solution containing 0.9 mM Cc 
++ 
caused a very slight initial increase in cardiac 
output and rate, but this was followed by a depression of output and rate. The 
Ringer's solution containing 1.4 mM Ca 
++ did not have any effect on this heart. 
A stimulated muscle solution perfused through the heart 4 minutes later gave a 
typical sharp rise in cardiac output, systolic, diastolic and pulse pressures. This 
is followed by a rise in rate 2 minutes later. An injection control after flushing 
Figure 20. 
a) Measurement of the Ca concentrations of Ringer's solutions in which 
sarWrius muscles were stimulated indirectly.. White columns indicate the 
Ca concentrations in solutions before muscle stimulation. Black columns 
indicate the Ca++concentrations of the bathing solutions after muscle 
stimulation. Range of concentrations of Ca++ after stimulation were 
0.92 mM - 1.22 mM. 
b) Comparison of the effect of perfusing the Ringer's solutions of 0.9 mM 
and 1.4 mM Ca++ through a frog heart with that of a stimulated muscle 
solution. No change in blood pressure is produced by the low Ca++ 
solutions. A small increase in the heart rate is produced with the solution 
containing 0.9 mM Ca++. However no effect on the force of concentration 
comparable to the effects of a stimulated muscle solution is produced by 
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out the venous capsule was satisfactory. The effect of perfusing Ringer's solutions 
containing differing Ca++ concentrations through three frog hearts is shown in 
Table 4. 
The results of this small series can do no more than suggest that, within 
the sensitivity of the method for measuring Ca concentration, there is no net 
loss of Co 
++ from the bathing Ringer's solution when a skeletal muscle is allowed 
to contract in it. However, as a cause of the stimulatory effect change of 
calcium concentration in the Ringer's solution surrounding the sartorius muscle 
can now be discounted. 
Table 4. 
Heart Ca ++ Conc. % Change in % Change in 
in Ringer's Output Rate 
so ution 
1 0.9 mm - 29/o 
1.3mM -8% -4% 
0.9 mm -24% - 1% 2 
1.3mM -8% - 2% 
3 1.3mM -5% -6% 
In each case the heart was slowed and the cardiac output tended to fall. 
Each heart was being continuously perfused with Ringer's solution containing 
1.2mMCa+. 
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THE LIBERATION OF PROTEIN FROM ACTIVE SKELETAL MUSCLE 
As part of the investigation of the stimulatory effect, the stimulated muscl e 
solution was tested for its protein content. As the sensitive Lowry test for protein 
was strongly positive, it was decided to study further the liberation of protein 
from resting and active sartorius muscles; protein itself, or perhaps some protein- 
linked substance could be the source of the stimulatory effect. 
Results 
Protein liberation was measured from resting and stimulated muscle every 
hour over a period of 2 hours. In the resting series there was a decrease in the 
liberation from 47. u, g/ml. in the first I hour to 16, ug/ml. in the fourth 2 hour 
(Figure 21 ). In the stimulated series there was a more noticeable decrease in 
efflux from 72ugml, in the first 'z hour to 20,. ig/ml. in the fourth '-z hour (Figure 21 ). 
A series of measurements of protein liberation was also done where the 
sartorius muscles were placed in 1ml. Ringer's solution and the container shaken 
for I hour (Table 5 ). The mean protein liberation from these "agitated" muscles 
was 90ug/m I. 
Protein liberation was also measured every '-z hour from agitated muscles for 2 
hours. The protein levels in the solutions became very high, probably indicating 
that the muscle was macerating. 
Subsequently it was possible to separate out the total protein content of the 
stimulated muscle solution into one fraction using the Sephadex chromatography 
procedure (Methods). Since the type of column used (G-25) is able to differentiate 
molecules of molecular weight of 5,000 and over from smaller molecules, the 
protein which is liberated from the muscle cannot have peptide chains of a 
molecular weight of less than 5,000, most probably the protein molecules 
liberated have a much greater molecular weight. 
When the column fraction containing the protein was perfused through the 
frog heart, no augmentation of the heart beat occurred. The fractions from the 
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column suceeding the protein-containing fraction did not contain any protein 
when tested by the Lowry technique. 
It is clear that the stimulatory effect is not due to protein. 
It is unlikely 
that the substance is protein bound, although it is conceivable that it is separated 




Protein liberation from resting, active and "agitated" sartorius muscles (Ag/ml). 
Sartorius muscles rested in 2ml. Ringer's solution for '-z hour or were stimulated at 
2/sec for 30 minutes. 
Resting Muscles Stimulated Muscles "Agitated" Muscles 
50 136 122 
91 167 108 
78 160 111 
50 40 57 
85 115 119 
67 138 104 
50 103 67 
60 160 69 
68 181 92 
78 150 97 
59 120 79 
74 60 69 
90 41 92 
67 97 97 
58 47 79 
57 58 
52 Mean = 90, ug/ml 
55 Mean = 111 population = 15 
28 population = 16 range = 57 - 122 
43 range = 40 - 181 
Mean = 63 
population = 20 
range = 28 - 91 
Figure 21. The rate of protein liberation from frog sartorius muscle. 
a) Upper diagram shows the amount of protein liberated into a2 ml. 
volume from seven stimulated sartorius muscles over a period of two 
hours. The muscles were twitching at a rate of 2/sec. 
b) Lower diagram shows the protein liberation from five sarforius 
muscles resting in bathing solutions for two hours. 
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THE ACTION OF CATECHOLAMINES ON THE FROG HEART 
The stimulated muscle solution was obtained by twitching a sartorius muscle 
in a bathing solution by stimulation of the whole sciatic nerve bundle. Under the 
supramaximal conditions of stimulation, all the nerve fibres in this large nerve 
bundle are probably stimulated. This of course includes the efferent post- 
ganglionic sympathetic nerve supply to the blood vessels of the lower limb, 
including the blood vessels of the sartorius muscle. These fibres are adrenergic 
and their stimulation might result in the release of small amounts of catecholamines 
into the Ringer's solution surrounding the sartorius muscle. 
It has long been known that both adrenaline and noradrenaline cause an 
increase in the force of contraction of the myocardium (Oliver and Schafer, 1895). 
This is the case when these substances are perfused through the frog heart 
preparation (Figures 22,23 and 24). 
Results 
Using the adrenergic blocking drugs pronethalol and ergot, the following 
experiment was performed. A frog heart was continuously perfused with Ringer's 
solution containing 10-6 g/ml. pronethalol and 10-6 g/ml. ergotamine tartrate 
(P/E Ringer's solution) in order to block both alpha and beta adrenergic receptors 
which may both be present in the frog heart (Ahlquist, 1948). The action of the 
heart was completely unaffected by this procedure. After perfusion of the heart 
with this Ringer's solution had lasted for an hour or longer, adrenaline (or 
noradrenaline) was then perfused into the heart. It was found that the action of 
the catecholamines was blocked by the blocking agents; however, when the 
stimulated muscle solution was perfused through the same frog heart a few minutes 
later, its effect on the heart was unaltered. 
Figure 22 shows the effect of perfusing a frog heart with 10-6 g/ml. 
adrenaline. The effect is obviously a prolonged stimulatory one; the cardiac 
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output, blood pressure and heart rate were all raised for 6 minutes after the 
perfusion of the adrenaline into the heart. After perfusing the heart with P/E 
Ringer's solution for 1 hour, the effect of 10-6 g/ml adrenaline was almost 
completely blocked. 
Figure 23 shows the effect of perfusing a stimulated muscle solution through 
the same frog heart as that shown in Figure 22 . There is a sharp increase in the 
cardiac output and blood pressure. A rise in heart rate is also seen. However, 
these changes are short-lived, in contrast to the action of the adrenaline on the 
same frog heart. After perfusion of the heart with P/E Ringer's solution for 2 hours, 
the effect of the stimulated muscle solution is still apparent. In this experiment 
three tests were made from one stimulated muscle solution of 2 ml. volume. The 
test made on this heart after the adrenergic blocking seems to have a smaller 
effect than those effects previously produced, but this is because a much smaller 
amount of the test solution was available for perfusion and can be gauged by 
comparing the lengths of the respective time marker traces, 30 seconds for solutions 
before the blocking, 15 seconds for the solution after the blocking. 
Figure 24 shows the response of a frog heart to a solution of noradrenaline 
and a stimulated muscle solution before and after adrenergic blockade. The 
stimulated muscle solution produced a sharp rise and fall of the cardiac output 
and blood pressure; there was no obvious rise in heart rate. Again this isin contrast 
to the effects of perfusion with noradrenaline. 10-7 g/m I. noradrenaline produced 
a similar increase in cardiac output to that of the stimulated muscle solution, but 
this increase was more prolonged. A slight increase in heart rate was produced 
by both. The effect of perfus i ng the heart with 10-6 g/m I. noradrenal i ne was 
profound. An exceedingly large and rapid increase in the blood pressure and 
cardiac output was accompanied at the same time by a rate increase which had 
two phases; this effect persisted for 7 minutes. The rapid increase in cardiac 
output was enough to overcome the drop-counting system of recording. 
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Figure 24. 
The response of a frog heart to noradrenaline and to a stimulated muscle 
solution. The upper trace shows the effect of perfusing the heart with a 
stimulated muscle solution. Note the sharp rise and fall of the cardiac output and 
blood pressure; there is no obvious rise in the heart rate. 10-7 g/ml. 
noradrenaline did not produce a marked stimulatory effect, but 10-6 g/ml. produced 
a very great effect. The cardiac output trace is irregular here because the 
sudden large increase in the cardiac output overcame the drop-counting system of 
recording. 
The lower trace shows the modified effect of 10-6 g/ml. noradrenaline 
after perfusion of the heart with P/E Ringer's solution for 2 hours. No change 
occurs in the effect of the same stimulated muscle solution. 
The effect of perfusing a solution of 5x 10-7 9/m 1. adenosine triphosphate 
(ATP) through the heart is seen. Note the similarity of this effect to that of the 
stimulated muscle solution. The action of ATP is also unaffected by the 
adrenergic blocking agents. 
St, -I. tsd 
Itfsdaan mu. e Infection 10ýQ, 4& 








f I- ý 
Cardiac output 
(mljmin) . w r + 
C 
l ý pressure Arteria + i i (mmHg) fC - 
ý I f 
Heart rate 
(bau/min) 
i 2 ° ' ý' -; n m 
s h. +. P/t 
.. i 
--iýý, iN 




___ ., !ý :. t- .. F 
--- -" ---iý -ý- I 
ýi 






2 min 1__J 01 
Stimubt. d 
Off P/E Irjictwn 10'9/ml uaclr. 
Rmgar mntrW No u, obn. ulutan 
Table 6. 
THE EFFECT OF ADRENERGIC BLOCKADE ON THE CARDIAC OUTPUT WHEN 
CATECHOLAMINES AND STIMULATED MUSCLE SOLUTIONS ARE PERFUSED 
THROUGH THE FROG HEART 
HEART % OUTPUT INCREASE 
Before Adrenergic Blockade After Adrenergic Blockade 
1. 10-7 g/ml. adrenaline 30% 
Test solution - 
0% 
35% 
2. 10-7 g/m I. adrenal i ne - 
Test solution 36% 
0% 
38% 
3. 10-7 g/m I. adrenal i ne - 0% 
4. 10-7 g/ml. adrenaline 65% - 
5. 10-6 g/m I. adrenaline 50% 
Test solution 12% 
7% 
6% 
6. 10-6g/ml. noradrenaline 200% 
Test solution 64% 
21% 
53% 
* half the amount injected, see Figure 23. 
- 60 - 
of 10-6 g/ml. noradrenal ine was greatly modified. Perfusion of the same 
stimulated muscle solution 5 minutes later showed no change in its effect. 
Stimulated muscle solutions were perfused through two other hearts and in 
neither case was the action of the stimulated muscle solution reduced by the 
adrenergic blocking agents. (Table 6, hearts 2 and 6). 
The evidence from these experiments that the stimulation is not caused by 
catecholamines can be summarized: - 
1. The qua! itative effect of adrenaline and noradrenaline on the heart 
is different from that of the unknown stimulating substance. A 
prolonged increase in heart rate and cardiac output occurs with the 
catecholamines (Figures 22,23, & 24. Their effect is generally 
longer-lasting, whereas the stimulatory substance causes a sharp, 
but transitory increase in the cardiac output and rate. With the 
unknown substance the effect on the blood pressure is also 
different (Figure 24 ). There is a sharp, regular increase in the 
systolic and diastolic pressures, with a slight increase in the pulse 
pressure at the maximum value of the systolic blood pressure. These 
effects quickly wear off. With the catecholamines there is an initial 
sharp increase in blood pressure similar to that caused by the unknown 
substance, but this increase is sustained and may last for many 
minutes. 
2. In order for the catecholamines to produce a similar effect to the test 
solution when perfused through the heart, the concentration required 
must be no less than 10-7 g/ml. in the test solution. Thus the isolated 
frog sartorius muscle, twitching in 2 ml. of the fluid, would have to 
produce 2x 10-7 g of catecholamine, while only being stimulated 
at two impulses per second for 30 minutes. 
3. Adrenergic blocking agents block the effects of adrenaline and 
noradrenaline on the frog heart, but they do not affect the response of 
- 61 - 
the same frog heart to the unknown stimulatory substance. 
From that evidence it can now be stated that the cause of the stimulatory 
effect on the frog heart is not release of catecholamines from the sartorius muscle. 
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ADENYLIC ACID DERIVATIVES AND THEIR ACTION ON THE MYOCARDIUM 
There is a considerable accumulation of knowledge about the biological 
actions of adenyl compounds on cardiovascular tissues of many species. Drury 
and Szent-Gyorgyi (1929) showed that adenylic acid produced heart block in 
the guineapig and lowered the blood pressure in the dog together with dilating 
the coronary arteries. Lindner and Rigler (1933) found that extracts from the 
bundle of His from the calf heart stimulated an hypodynamically-acting frog's 
heart. On attempting to isolate this compound they found it contained a pentose 
and a purine base. 
Later work of this nature suggested that the biological activity of many of 
the tissue extracts was really due to their adenosine content (Rigler and 
Schaumann, 1930; Rothman, 1930). Ostern and Parnas (1932) found that adenosine 
triphosphate and occasionally muscle adenylic acid increased the strength of the 
frog heart beat, while adenosine failed to do so; this result was also obtained on 
frog heart by Lindner and Rigler (1931) and by Drury (1932) on the rabbit heart. 
Flossner (1934) found that some nucleic acid derivatives increased while 
others decreased the amplitude of contraction of perfused frog hearts. At this time 
most workers agreed that the hearts of experimental animals whether perfused or 
in the intact animal remained in very good condition when subjected to injection 
of nucleic acid derivatives. Although these derivatives were known to be powerful 
coronary vasodilators, it was difficult for some workers " to be convinced that the 
improvement of the heart beat was always due to the action upon the coronary 
vessels. 
In 1950 Green and Stoner studied the action of the adenine nucleotides on 
the cardiovascular system in some detail. They found that adenosine monophosphate 
and adenosine triphosphate caused a bradycardia in the perfused isolated rabbit 
heart- they found that these compounds acted upon the sinu-atrial node, and 
that their action could be explained by the adenosine content. The amplitude of 
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contraction they found to be unaffected by adenosine; however, when adenosine 
triphosphate was perfused through the heart there was an immediate increase in 
the amplitude of the beat, followed by a depression, which in turn was followed by 
a sustained increase in the amplitude of contraction. This verified an earlier 
observation by Dubois-Ferriere (1945) working on perfused frog hearts. Later work 
has conclusively shown that adenosine triphosphate has an immediate positive 
inotropic effect on cardiac muscle which is succeeded by a bradycardia or a 
cardiac arrest (Meyer, 1951; Sekiya, 1953; Kanda et al., 1954; Chevillard and 
Guerin, 1955; Buday, Carr and Miya, 1961; Versprille, 1963). 
Results 
In order to test whether other triphosphates were capable of stimulating the 
frog heart, one experiment was performed where solutions of inosine triphosphate 
(ITP), uridine triphosphate (UTP), cytosine triphosphate (CTP) and guanosine 
triphosphate (GTP) were perfused through the frog heart. UTP and ITP had a 
marked stimulatory effect on the heart but no effect was produced by solutions 
of CTP or GTP. It is possible that these latter substances had degraded during 
prolonged storage. 
Solutions of the bases uridine, cytidine, inosine and adenosine were also 
perfused through the heart but no stimulation was produced (Table 7) . An 
interesting finding was that the solution of ITP caused a greater stimulation than 
that caused by inosine diphosphate on the same heart. Inosine monophosphate 
did not have any effect on this heart. 
Adenosine, in a concentration of 10-5 g/ml. caused a 3% fall in cardiac 
output and a 35% fall in heart rate when perfused through the heart. Figure 25 
shows that adenosine monophosphate, even in a very high concentration, did 
not stimulate the heart. A fall in rate and output is produced by 10-6 g/ml. 
and 10-5 g/ml. AMP. 
When a solution of ATP was perfused through thefrog heart it produced a 
similar type of stimulation to that produced by the stimulated muscle solution 
Table 7. 
The effect of perfusing various bases and nucleotides through frog hearts. 
Hearts Compound % Output Change % Rate Change 
10-5 g/mI. adenosine -30 -35 
1 10-5 g/m 1. AMP -25 -36 
10-5 g/ml. uridine 0 -25 
10-5 g/mI. UTP +220 +34 
10-6 g/mI. inosine 0 0 
10-5 g/ml. inosine 0 0 
10-4 g/ml. inosine 0 0 
10-6 g/mI. IMP -7 0 
10-5 g/ml. IMP -9 0 
2 10-6 g/mI. IDP +10 +28 
10-6 g/ml. ITP +20 +31 
10-6 g/mI. cytidine -5 -7 
10-6 g/m I. CM P 0 0 
10-6 g/mI. CTP 0 0 
10-6 g/mI. GTP 0 0 
10-9 g/mI. AMP 0 0 
3 10-7 g/m I . AMP -5 -12 
10-5 g/m 1. AMP -20 -24 
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Figures 28& 29. There was an immediate rise in systolic, diastolic and pulse 
pressures, causing a rapid increase in cardiac output. With high concentrations 
of ATP the heart rate was increased, reaching a peak value 2 minutes later. Usually 
the stimulated muscle solution produced a greater increase in the heart rate. 
A quantitative comparison of the action of ATP and stimulated muscle 
solutions is given in Table 10. 
Discussion 
The only substances found which have been able to stimulate the frog heart 
in a similar fashion to that of the stimulated muscle solution are 
a) the catecholamines and 
b) the triphosphates of various bases. 
The catecholamines as a cause of the effect have already been eliminated; 
however, it was felt necessary to proceed with further investigation into the 
possibility of whether the stimulatory substance was adenosine triphosphate, since 
this is probably the most commonly-occurring of the triphosphates in biological 
tissue. 
Although there is evidence to suggest that ATP is NOT released from 
skeletal muscle (Hilton and Greengard, 1962), nevertheless the qualitative 
similarity of the stimulation produced by both ATP and the test solution 
encouraged further investigation. 
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COMPARISON OF THE ULTRAVIOLET ABSORPTION OF TEST SOLUTIONS 
AND SOLUTIONS CONTAINING ADENOSINE COMPOUNDS 
Of the compounds which make up the bulk of the muscle structure, only 
two types have a marked selective light absorption in the ultraviolet range 
(250m, u - 300mp), namely the purine derivatives and the proteins. The purine 
derivatives are 95% adenylic acid derivatives (Caspersson and Thorell, 1942). 
The purine nucleus in these cases absorbs ultraviolet light strongly at 260 mp. 
Absorption of ultraviolet light by protein occurs at 280 mu (conditioned by tyrosine 
and tryptophan) but is not so strong as the ultraviolet absorption by the adenylic 
acid derivatives. 
Results 
Figure 26 shows the comparison of UV absorption sepctra of two resting 
muscle solutions, a stimulated muscle solution and a solution containing 10 
5 
g/ml. 
adenosine monophosphate made up in frog Ringer's solution. The resting solutions 
were obtained from muscles which had rested for 50 minutes and 120 minutes in 
2 ml. of Ringer's solution. The 50 minute resting solution shows a low optical 
density in the range 250mW - 280mA. The 120 minute resting solution has a higher 
optical density in this range. The optical density for the stimulated muscle solution 
is markedly raised in this range. The increase in optical density is due to the 
absorption of UV light by protein; more protein is liberated from stimulated than 
resting muscles (see Protein Section). The solution containing 10-5 g/ml. adenosine 
monophosphate shows a greatly prounounced, sharp peak of optical density at 
260m}l wavelength. 
The raised optical density in the range 250m}. t - 280m» caused by protein 
might mask small peaks of UV absorption resulting from small concentrations of 
adenosine compounds perhaps present in the test solution. With the Sephadex 
column technique (p. 34 Methods) it was possible to obtain a solution which was 
capable of stimulating the frog heart and which did not contain any protein 
0"6 Resting 0.6 Resting O. 6 Stimulated0.6 1O°G/ml 
Muscle Muscle Muscle Adenos(ne 
Solution Solution Solution monophosphate 
(120mins) (5Omins) 
0.5 0.5 0.5 0.5 - 
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Figure 26. 
Comparison of absorption spectra obtained from resting and stimulated muscle 
solutions with that from a solution of 10-5 g/ml adenosine monophosphate. 
(a) A solution in which a muscle rested for 120 minutes shows an optical 
density of 0.06 units between 250 mA and 280 mv.. t. 
(b) A resting solution of fifty minutes duration gives a lower optical 
density over the same range. 
(c) A stimulated muscle solution shows greater absorption over this 
range. 
(d) 10-5 g/ml adenosine monophosphate made up in frog Ringer's 
solution shows a pronounced sharp peak at 260 m}t wavelength. 
The increased optical density in the solutions is due to protein liberated from 
the muscle. More protein is liberated from the stimulated muscle than the resting 
muscle. 
Figure 27. 
Comparison of the UV absorption spectra of a solution of 10-6 g/ml ATP 
and a mixture of column fractions 3 and 4 which stimulated the frog heart. 











ATP 10-GG/ml. Column Fractions 
3 and 4. 
265 265 
Wavelength mu 
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(Figure 27). When the UV absorption spectrum of a mixture of column fractions 
3 and 4 (which stimulated the frog heart) was measured, a very slight peak 
appeared at 265mýi wavelength). This is shown in Figure 27. This suggested 
that nucleotides were present in the test solution, since these cyclic compounds 
absorb UV light at approximately this wavelength, depending on the type of 
solvent in which they are dissolved. Figure 27 shows the UV absorption spectrum 
of a solution of 10-6 g/ml. adenosine triphosphate made up in a similar frog 
Ringer's solution to that containing fractions 3 and 4. A more pronounced 
absorption peak is evident at the same position in the spectrum as that of the 
column fractions 3 and 4. 
This preliminary investigation was, of course, not in itself a valid 
identification procedure, but it is described here because it provided the line 
of further investigation. 
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COMPARISON OF THE ACTION OF APYRASE ON THE STIMULATED MUSCLE 
SOLUTION AND ON ADENOSINE TRIPHOSPHATE 
Potato adenosine triphosphatase (ATPase) was first described by Kalckar in 
1943. He was able to precipitate a substance out from watery extracts of potato 
which could split off two groups of phosphate from adenosine triphosphate. He 
also found that this reaction was activated by calcium ions. 
Meyerhof (1945) first suggested the name "apyrase" to describe those 
adenylpyrophosphatases which act on both ADP and ATP, splitting off two 
phosphate groups from the latter. A survey of modern literature shows that the 
two terms "apyrase" and ATPase" are often used interchangeably. 
The findings of Eiler and Lee (1951) and Van Thoai (1954) suggested that 
apyrase split ATP to ADP and that only after this phase had been completed did 
the formation of AMP take place. Traverso-Cori and Cori (1962) verified this and 
showed that AMP was not produced in the first 10 minutes of the reaction. 
Two enzymes have recently been separated from apyrase (Liebecq, Lallemand 
and Degueldre-Guillaume, 1963) which act on inosine triphosphate (ITP), 
guanosine triphosphate (GTP) uridine triphosphate (UTP), cytosine triphosphate 
(CTP) as well as on ATP. One enzyme converts thetriphosphate to the diphosphate, 
the other enzyme coverts the diphosphate to the monophosphate. 
Substrate Specificity of Potato Apyrase 
As already indicated by the work of Liebecq et al., the phosphate groups can 
be split from variously-based nucleotides, so the enzyme is not specific for 
ADENOSINE triphosphate. These workers also studied the action of potato apyrase 
on adenosine TETRAphosphate. It was found to be dephosphorylated very slowly 
by the two fractions of apyrase. A search of the literature has failed to reveal any 
other energy-rich substance containing phosphate radicals which is acted upon by 
apyrase. Krishnan (1949) found that no phosphate was liberated from muscle 
adenylic acid, yeast adenylic acid, sodium pyrophosphate, hexose 1.6 diphosphate 
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and -glycerophosphate. He showed that even in the crude stage the enzyme 
showed some degree of specificity towards ATP. 
Results 
Figure 28 shows the effect of perfusing a frog heart with a solution of 
10-6 g/ml. ATP. The initial sharp, stimulatory effect on the force of contraction 
is clearly seen in both the arterial pressure record and in the record of cardiac 
output. Immediately following this effect is a slight bradycardia. Perfusion of 
the heart with the same concentration of ATP, having incubated this portion with 
apyrase for 15 minutes, shows that the initial sharp effect has been abolished. 
Note that the fall in rate which followed the initial stimulatory effect has not 
been altered. The pure ATP solution was then perfused through the heart again 
to show that the sensitivity of the heart to ATP had not been affected in any way 
by apyrase. 
Figure 29 shows the effect of perfusing 0.5 ml. of a stimulated muscle 
solution through the same frog heart as shown in Figure 28. Once again an initial 
sharp stimulatory effect on the force of contraction is reflected in both the arterial 
pressure and cardiac output recordings. In this case a late increase in the heart 
rate has occurred. When 0.5 ml. of the solution is incubated with apyrase, the 
sharp stimulatory effect is abolished; the late rise in the heart caused by the 
stimulatory substance in the test solution has not been abolished by the apyrase. 
Ten solutions of ATP were perfused through eight frog hearts before and after 
incubation with apyrase (Table 8). Eight stimulated muscle solutions were perfused 
through eight frog hearts before and after incubation with apyrase (Table 9). 
In every case the initial stimulatory effect of both the ATP solutions and the 
solutions in which a sartorius muscle had twitched was abolished. In some cases 
the sharp increase in cardiac output was supplanted by a gradual rise in output, 
occurring much later after the perfusion; this was due to a late increase in the 
heart rate which occurs with solutions which have had insufficient time for 
incubation with apyrase. It became obvious that this late rate effect which 
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occurred after a test solution was incubated could cause the cardiac output to 
rise to an even greater level than that level reached when the stimulated muscle 
solution was perfused through a heart. Figure 30 shows the result of perfusing a 
frog heart with a solution of 5x 10-8 g/ml. ATP. This gave the usual stimulatory 
effect. Also shown is the result of perfusing the heart with solutions of the same 
concentrations of ATP having been incubated with apyrase (1 mg added to each 
ml, of ATP solutior) for 5,10 and 15 minutes. The sharp, stimulatory effect is 
abolished in all three solutions but an arrythmia has been introduced, the rate 
increase being greater when the incubation period is shorter (Table 8). 
Incubating the apyrase with frog Ringer's solution alone for 10 minutes has 
no effect on either the heart rate or cardiac output when this solution is perfused 
through the heart. 
Clearly some interference phenomenon is produced from the reaction 
ATP --_a_L'M! _ ADP when incubation does not proceed beyond 10 minutes. 
In this section it cannot be ruled out that this effect on the heart rate is due 
to ADP. It was considered unfruitful to perfuse the frog heart with standard 
preparations of ADP, since commercially prepared ADP is almost certain to contain 
a minute quantity of ATP. Since the frog heart is especially sensitive to ATP, any 
contamination of ADP with ATP will distort the frog heart response to perfused 
commercial ADP. Elaborate purification procedures would be necessary to obtain 
a pure ADP effect on the frog heart. 
Discussion 
The potato apyrase used in this work contained 0.9 units per milligramme. 
One unit will hydrolyse lu mole of the substrate per minute at pH 6.5 at 30°C 
(information supplied by Sigma Company). 
Molecular weight of ATP (disodium dihydrogen salt) = 623 
1, t, t mole = 0.623 x 10 
3 
9/ml. = 6.23 x 10 g/mI. 
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Table 8. The effect of perfusing solutions of ATP which have been incubated 
with apyrase for varying periods through frog hearts. 
Heart Concentration Time of % Output % Rate 
of ATP Incubation Increase Increase 
10-8 g/ml. -- 21 20 
10-8 g/mI. 5 minutes 13 40 
10-8g/mI. 10 minutes 10 40 
10-8 g/ml. 15 minutes 0 0 
5.0 x 10-8 g/m I. -- 24 0 
5.0 x 10-8 g/ml. 5 minutes 16 50 
2. 
5.0 x 10-8 g/ml. 10 minutes 16 52 
5.0 x 10-8 g/mI. 15 minutes 8 16 
10-6 g/mI. -- 60 0 
3' 
10 6 g/mI. 10 minutes 35 0 
10 6 g/mI. -- 32 -12 
4' 
10-6 g/ml. 10 minutes -4 -7 
10-6 g/ml. -- 37 0 
5' 10-6 g/mI. 10 minutes 0 0 
10-7 g/mI. 50 irreg. 
6. 10-7 g/mI. 10 minutes 
17 22 
2.5x107g/ml. -- 18 0 
2.5x 10-7 S/Ml. 10 minutes 11 17 
10 g/m I. -- 12 0 
7' 10-8 g/mI. 5 minutes 14 18 
5.0x108g/mI. -- 17 0 
5.0 x 10-8 g/mI. 5 minutes 20 20 
8. 10-7 g/mI. -- 27 0 
10 7 g/mI. 5 minutes 32 30 
10-7 g/mI. 10 minutes 18 24 
Small concentrations of ATP (not incubated with apyrase) only affect; 
the cardiac output, not the heart rate. When incubated with apyrase, the initial 
stimulatory effect disappears, but if the time of incubation is insufficient, then 
a separate rate increase occurs, about one minute later in the perfusion; this is 
sufficient to increase the cardiac output at the same time. 
- 70 - 
apyrase per ml., roughly 6x 10 
4 
g/ml. of ATP should be hydrolysed per minute. 
The incubation period required to abolish the effect of a test solution was one of 
a quarter of an hour at pH 7at30°C. ' 
Quantitative comparisons of the effects of ATP and the stimulated muscle 
solution on the frog heart (Table 10) would suggest that if the stimulatory effect 
is due to ATP, then it is at a concentration of certainly not more that 10-6 g/ml. 
in the stimulated muscle solution. So there seems to be no theoretical objections 
to the assumption that all the ATP in both stimulated muscle solutions and pure 
ATP solutions is hydrolysed. 
Apart from the pH being 7 instead of the recommended 6.5, the conditions 
for the destruction of ATP in the stimulated muscle solution seem to be ideal. The 
reaction is calcium dependant (Kalckar, 1943) and calcium, of course, is present 
in the solution; and its concentration remains unaltered throughout the period of 
stimulation (see calcium section). Liebecq et al. (1963) noted that the activity 
of potato apyrase was doubled in the presence of plasma proteins. The stimulated 
muscle solution contains 150 - 200 pg/ml. of protein (see protein section). 
The two-stage reaction of apyrase upon ATP is attributed to two components, 
an adenosine triphosphatase and an adenosine diphosphatase. Since these two 
components have been separated chromatographically (Liebecq et al. 1963), the 
possibility that a single enzyme is splitting off the terminal phosphate groups in 
two steps is remote. 
The incubation period for these components seems to be different. Van Thoai 
(1954) showed that AMP only appeared after incubation of ATP with apyrase for 15 
minutes. Traverso-Cori and Cori (1962) showed that alI of the ATP is converted to 
ADP in the first stage and they found that AMP is not produced in the first 10 
minutes of the reaction. So it seems that the incubation time required for the 
adenosine diphosphate component to produce AMP is at least ten minutes, at pH 
6.5 and 30°C. 
Unfortunately, although the action of each test solution on the frog heart was 
Table 9. 
The effect of perfusing the SMS through frog heart after incubation with 
apyrase. Time of incubation in every case 10 minutes. 
Before Incubation After Incubation 
Heart Solution 
% Output % Rate % Output % Rate 
increase increase increase increase 
1 1 25* 17+ 50* -- 
"Y 2 2 18* 0+ . 18* 25 
3 3 20 * 21+ 36 * 50 
4 4 36 * 28+ 42 * 30 
5 5 37 * -- 65 * -- 
6 6 24 * 4+ 14 * 15 
7 7 40 * 28+ 50 * 35 
8 8 32* 6+ 164- 12* 
Immediately after perfusion 
+2 minutes later 
Both occurring 2 minutes after perfusion. 
SMS stimulated muscle solution. 
In every case the initial stimulatory effect was abolished; unfortunately the 
late increase in the heart rate resulted in a late rise of cardiac output at the 
same time. This was due to the fact that each test solution was incubated with 
apyrase for only 10 minutes. 
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radically altered after incubation with apyrase, the late increase in the heart 
rate resulted in a late rise of cardiac output at the same time (Table 9). This 
effect can be attributed to the fact that each test solution was incubated with 
apyrase for only 10 minutes; the ideal time of incubation for complete 
inactivition of ATP is 15 minutes (Figure 27). 
The sharp increase in cardiac output before incubation occurred immediately 
after the period of perfusion into the heart. In every case this effect was 
abolished by apyrase (not evident from Table 9). After incubation this effect 
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COMPARISON OF THE BEHAVIOUR OF THE STIMULATORY SUBSTANCE 
AND ADENOSINE TRIPHOSPHATE IN A SEPHADEX COLUMN 
It was possible to perfuse Ringer's solution which had passed through a 
Sephadex column through a frog heart without disturbing the cardiac rhythm. 
Thus it became feasible to examine and compare the behaviour of ATP and the 
unknown stimulatory substance in the column. By perfusing fractions collected 
from the column through the heart the rate of elution of ATP and the unknown 
I substance through the column could be ascertained. 
Results 
A2 ml. sample of stimulated muscle solution was mixed with blue dextran 
and then eluted through a column run on eserinized frog Ringer's solution. The 
fractions collected from the column were those standardized for the maximum 
recovery of ACh (see section on "Behaviour of ACh in the Sephadex Column"). 
When these fractions were perfused through the frog heart, it was found that the 
typical stimulatory effect on the heart was produced by fractions 3,4 and 5. 
(Figure 31). 
The same procedure was carried out for solutions of ATP. A typical result 
is shown in Figure 32 . Just as with fractions 3,4 and 5 of the stimulated muscle 
solution, the column fractions 3,4 and 5 of the ATP solution stimulated the frog 
heart. 
In order to show that the elution patterns for the unknown substance and 
ATP were the same, smaller fractions were collected from the column. Figures 
33 and 34 show the result of one such experiment. 5x 10-7 g/ml. ATP were 
made up in frog Ringer's solution and 2 ml. of this solution was eluted through 
the column. After the initial 3 ml. fraction containing the blue dextran came 
through the column, 2 ml. fractions were collected thereafter. These fractions 
were then perfused through a frog heart (Figure 33) . The stimulatory effect is 
clearly seen in fractions 3,4,5,6, and 7; a graded pattern of stimulation is 
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Figure 35. 
Comparison of the behaviour of the stimulatory substance and ATP through 
five Sephadex columns. 
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seen, with the peak of stimulation occurring in fraction 5. 
Stimulated muscle solutions were obtained 'in the usual way from two frog 
sartorius muscles. The solutions of 2 ml. each were thoroughly mixed and 2 ml. 
of this mixture were put through the some column as the ATP solution. Once 
again 2 ml. fractions were collected from the column. The result of perfusing 
these fractions through the same frog heart as in Figure 33' is shown in Figure 34 
Although the stimulatory effect is not so marked, nevertheless it appears in the 
some fractions, the peak effect again being in fraction 5. 
Figure 35 shows a comparison of elution patterns of both stimulated muscle 
solutions and solutions of ATP through 5 Sephadex columns. The percentage 
increase in cardiac output produced by each fraction was used as an indication of 
the concentration of the ATP and the stimulatory substance. The width of each 
block represents the size of successive fractions collected, the height represents 
the percentage increase in cardiac output produced by each fraction. It is clear 
that the elution pattern obtained from this column chromatography procedure is 
the some for the unknown substance as " it is for adenosine triphosphate. 
1 
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THE USE OF THE FIREFLY LUMINESCENCE PROCEDURE FOR THE 
IDENTIFICATION OF THE STIMULATORY SUBSTANCE RELEASED FROM ACTIVE 
SARTORIUS MUSCLE 
When live fireflies (Photinus pyralis) are ground with sand and water, the 
extract obtained momentarily becomes luminescent; if the grinding is continued 
the light emission decays rapidly. If adenosine triphosphate (ATP) is added to 
this extract, a bright flash of light appears immediately and lasts for a 
considerable time, the intensity and duration of the flash depending on the 
concentration of the ATP. (McElroy, 1947). It was noted by McElroy that with 
high concentrations of ATP a bright glow is maintained for some time, followed 
by a slow decay, while with low concentrations of ATP there is an initial burst of 
light, followed by a prolonged decay in the light signal. 
Strehler and Totter (1952) thought that the firefly luminescence phenomenon 
could be adapted for the assay of ATP in living materials. Using refined light- 
measuring devices they emphasized that the system could be adapted to the 
measurement of ATP in very minute quantities. With a quantum-counting photo- 
multiplier at liquid nitrogen temperatures, they were able to measure 
concentrations of ATP as low as 10-9 g/ml. with an accuracy of 
± 5%. They also 
emphasized the simplicity of the method, and recommended its use for rapid 
survey of ATP in many fields of investigation. 
Principle of the Method 
The linear luminescence response of firefly extracts to added ATP is the 
basis of this method of ATP analysis. The following reaction is generally agreed 
upon: 
ATP + Mg 
++ + 02 + luciferin-H2 + luciferase = LIGHT. 
Mn++ ions can replace the Mgt ions and the oxygen content of the air is 
sufficient to support the reaction. In the presence of the enzyme luciferase the 
substrate for the reaction, luciferin, is oxidized with the production of light when 
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oxygen, Mg 
++ ions and ATP are present in excess. The optimum pH for the 
reaction is 7.8 and the maximum light intensity is observed at 26°C (Strehler 
and McElroy, 1957). 
Specificity of the Reaction 
The assay is specific for ATP. However, precursors of ATP will also produce 
light, provided that the appropriate enzymes for ATP formation are present. The 
purified enzyme preparation responds only to ATP. Adenosine diphosphate, 
creatine phosphate, acetyl phosphate, inos'ne triphosphate, uridine triphosphate, 
guanidine triphosphate and inorganic polyphosphates do not produce Iight when 
added to extract of firefly (Strehler and McElroy, 1957). 
Results 
Five separate stimulated muscle solutions were tested on the firefly extract. 
On,! two of these occasions two stimulated muscle solutions were pooled and 
thoroughly mixed together so that there would be enough of the test sample for 
estimation on the firefly extract and for perfusion through the frog heart before 
and after incubation with the enzyme apyrase. 
In all three cases the solution caused light to be emitted from firefly extract 
(Figure 36). In the cases where the solutions had been pooled, the same solution 
stimulated the heart in a similar manner to ATP, was modified in its action by 
apyrase, and caused light to be emitted from a firefly extract. When the effect 
of a pooled solution on the frog heart was matched with a solution of ATP it was 
found that the some concentration of ATP caused a similar light signal to be 
emitted from the firefly extract. Figure 37a shows the effect of perfusing graded 
concentrations of ATP solutions, ranging from 2.5x 10-8g/ml. to7.5x 10-7g/mI, 
through a frog heart. The lowest concentration of ATP causes a sharp, evanescent 
increase in the systolic blood pressure with no effect on the heart rate, while a 
concentration of 7.5 x 10 
7 
g/ml. causes an exceedingly sharp increase in the 
blood pressure, followed two minutes alter by. a gradual increase in heart rate. 
Graded effects are clearly seen with the intermediate concentrations. 
Figure 36. 
Comparison of the effects of stimulated muscle solutions and solutions of ATP on extracts of firefly. Deflection upwards from the baseline = light emitted. 
(a) A solution of 10 
8 
g/mLATP emitted a similar light signal to 
that emitted from a stimulated solution. 
(b) A solution of 5x 10-8 g/ml ATP gave the same light emission 
as two pooled test solutions from the same firefly extract. 
(c) The light emitted from a solution of 2x 10-7 g/mI. ATP is shown. 
The cuvette was removed from the light-measuring device for 
a few seconds and then replaced. During this time no light 
was detected. This verified that the light signal was cgming 
from no other source other than the solution. A stimulated 
muscle solution gave a similar emission of light from the same 
extract. In each case the voltage delivered to the photo- 
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Figure 37a. 
The effect of graded concentrations of ATP solutions when perfused through 
a frog heart. Note the late rate increase with the higher concentrations of ATP. 
The output trace is irregular due to a fault in the recording mechanism. 
Figure 37b. 
A recording of the same perfused heart as in37a. The stimulated muscle 
solution has :- 
1. been "bracketed" between solutions of ATP, 
2. had its effect modified by apyrase, 
3. given out a light signal from firefly extract (inset). 
(a) 
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Figure 37b is a recording of the same heart as in 37a. The effect of a 
stimulated muscle solution has been "bracketed" between concentrations of 
10-7 g/ml. and 5x 10-8 g/m1ATP. There is a late increase in the heart rate 
associated with the test solution, but not with the matching ATP solutions 
(Figure 38 ). This phenomenon has been noted before (Table 9 ). After 
incubation with apyrase, 10 
7 
g/ml. ATP does not give any effect; incubation 
of the stimulated muscle solution with apyrase caused a modification of the heart's 
reaction. The sharp increase in blood pressure has been abolished, but the increase 
-in 
heart rate persisted. That the effect has not been abolished completely (see 
Figure 29 for example) is probably due to insufficient time for incubation (see 
7 
discussion of incubation time in "apyrase" section). The 10 g/ml. solution of 
ATP-was again perfused through the heart in order to establish that the heart still 
retained its sensitivity to ATP. Apyrase, 1 mg/ml., incubated with frog Ringer's 
solution was perfused through the heart 12 minutes later. An increase in heart 
rate and output with cardiac irregularity occurred. This again was probably due 
to insufficient time for incubation. 
Figure 38 shows an enlargement of the lower left quadrant of Figure 37b 
The inset shows the light emission from firefly tail extract, an upward deflection 
from the baseline indicating a light signal. The firefly extract alone emitted a 
small steady signal; when the stimulated muscle solution was added there was an 
increase in the light emission. This was the same pooled test solution as that 
perfused through the frog heart shown in this figure. When a concentration of 
5x 10 -8 g/ml. ATP was added to another sample of the same firefly extract, a 
similar increase in the light signal was produced. The amplitude control of the 
pen recorder was increased for the second record, but there is a proportionately 
similar increase in the light signal emitted from the test solution and ATP solution 
than that emitted from the extract alone. 
The nature of the light signal would suggest that the light was being 
emitted from both the test solution and the ATP solution in the same pattern of 
Figure 38. 
An enlargement of the lower left quadrant of Figure 376. The frog heart 
trace "A" shows the qualitative similarity of the effect of the stimulated muscle 
solution to the effects of two ATP solutions. With the stimulated muscle solution 
there is an increase in the heart rate approximately 2 minutes later. This is not 
seen with the ATP solutions. 
The inset "B" shows the light emission when the same stimulated muscle 
solutions and a solution of 5x 10-8 g/mI. ATP are placed in contact with firefly 
extract. There is a proportionately similar increase in the light signal emitted 
from the test solution and ATP solution than that emitted from the extract alone. 
Stimulated 
10 g/mI muscle 5x10-8g/ml 





From these results it is concluded that ATP is present in the test solution 





DIAGRAM SUMMARIZING THE IDENTIFICATION PROCEDURE OF THE 
STIMULATING SUBSTANCE RELEASED FROM ACTIVE SARTORIUS 
MUSCLE 
Light absorption peak 
at 265 mu suggested a 
purine structure 
Protein 
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AN ESTIMATE OF THE AMOUNT OF ATP RELEASED FROM ACTIVE 
SARTORIUS MUSCLE 
It was possible to match the stimulatory effect of the test solutions to the 
effects of known concentrations of ATP on the some frog heart using the initial 
positive inotropic effect as a measure of the concentration of ATP in the 
stimulated muscle solution (Figures 28 & 29).. 
Results 
The effects of 13 test solutions were approximately matched to the effects 
of known concentrations of ATP on 13 frog hearts. Two test solutions were matched 
to ATP solutions using both the frog heart and the firefly technique; one solution 
was matched using the firefly technique only. (Table 10). 
The mean output of ATP estimated from 14 sartorius muscles was just less 
than 6x 10-7 g (range 2x 10-6 g -2x 10-8 g). No accurate estimate of ATP 
output per gramme of muscle tissue can be given, since the muscles were not 
weighed beforehand, but a fairly constant size of frog was used. An approximate 
value can be calculated from the weights of other sartorii weighed later in this 
work. The average wet weight was 50mg and certainly all muscles used did not 
weigh more than 100mg; if the lower figure is taken, the output of ATP per gramme 
of wet muscle is 12, ug. Since about 30% of the weight of these muscles is 
contributed by extracellular fluid (Dydynska and Wilkie, 1963), the output of ATP 
per g of dry muscle is 17, ug (0.027jimole). The intracellular amount of ATP has 
been estimated at 2- 4}amole per gramme of dry muscle (Marechal, 1964) so that 
there is roughly a 1% loss of intracellular ATP into the solution bathing the 
sartorius muscle. 
It can be seen from Table 10 that in 10 hearts out of 13 the test solution 
produced an increase in the heart rate. This rate increase usually reached peak 
value 2 minutes after the initial, sharp stimulatory effect. In six hearts out of 
13 the matching ATP solution had no effect on the heart rate, one solution 
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actually producing a fall in heart rate. In only two cases did the matching ATP 
solution produce a greater rise in rate than that caused by the stimulated muscle 
solution. An increase in the heart rate occurring two minutes after the perfusion 
can be produced with higher concentrations of ATP (Figure 37a). However, the 
concentrations of ATP required to match the initial stimulatory effect of the test 
solutions did not usually produce the rate effect caused by the test solutions. It 
is probable that the test solutions contained other material liberated from active 
skeletal muscle which acted on the conducting tissues of the heart rather than on 
the myocardium itself. 
Table 10. 
MEASUREMENT OF THE AMOUNT OF ATP RELEASED FROM THE SARTORIUS MUSCLE 
Heart % Increase in Cardiac Output % Increase in Heart Rate 
1 test solution 32 7 
2.5x107g/ml. ATP 40 4 
2 test solution 24 7 
10-6 g/ml. ATP 30 - 
3 5x108g/ml. ATP 27 - 
test solution 36 20 
10-7 g/ml. ATP 33 - 
(test solution was equivalent to 5x 10 
8 
g/mi. ATP using firefly) 
4 test solution 56 4 
5. Ox 10-7 g1ml. ATP 60 5 
5 test solution . 45 
12 
107g/ml. ATP 35 - 
6 test solution 12 - 
107g/ml. ATP 15 -9 
7, test solution 25 - 
5.0 x 10-7 g/m I. 22 - 
8 test solution 11 24 
5.0x108g/ml. ATP 11 - 
9 test solution 18 10 
5.0x107g/ml. ATP 21 24 
10 test solution 35 15 
5.0x107g/ml. ATP 30 10 
11 test solution 28 
107g/ml. ATP 36 - 
12 1Ö g/ml. ATP 33 3 
test solution 36 8 
(pooled two) bracketed 
2.5x1Ö7g/mI. ATP 49 8 
13 test solution 18 15 
5.0x108g/ml. ATP 30 3 
(test solution was equivalent to 10-8 g/ml. ATP using firefly) 
14 test solution equivalent to 2.0 x 10 g/ml. ATP using firefly 
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THE SOURCE OF ATP RELEASED FROM SKELETAL MUSCLE 
Accidental Sources of ATP 
Adenine nucleotide material has been shown to be present in abundance 
intracellularly (Glick, 1946). The ATP released from skeletal muscle, described 
here, could have many sources. Damaged muscle cells could release significant 
amounts of ATP into a surrounding bathing solution. Distortion and rupture of 
connective tissue cells during the contraction process could also result in some 
efflux of intracellular ATP into the bathing solution. 
Evidence from penetration of the frog muscle cell with micro-electrodes has 
shown that even after repeated punctures of the same cell, the resting membrane 
potential remained around 80 mV (Ling and Gerard, 1949). This suggests that 
the membrane seals itself off in some way after the removal of the microelectrode. 
The utmost care was taken in the dissection of the sartorius muscle in this work and 
in every case the muscle was carefully washed and left to soak in a "washing" 
solution for 10 minutes before the period of stimulation. The contents of any 
grossly damaged cell would presumably be completely washed out during this 
procedure. 
Another argument against cellular damage as a cause of the presence of 
ATP in the test solution can be made by citing the results obtained concerning the 
potassium efflux from the sartorius muscle. Any gross cellular damage would allow 
large amounts of intracellular potassium to pass into the surrounding bathing 
solution. In fact no obvious rise in the potassium level in resting muscle solutions 
was found. The average increase of 25% in potassium in the stimulated muscle 
solutions is consistent with the normal potassium efflux associated with the 
propagated action potential (Hodgkin and Horowicz, 1959). 
Red blood corpuscles are known to have high concentrations of ATP in their 
surrounding membranes(Whittam, 1960). If any red blood corpuscles were not 
initially, washed out and became haemolysed during the period of stimulation, 
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ATP might be detected in the bathing solution. 
The only argument presented here against the source of the ATP being 
ruptured envelopes of haemolysed red blood corpuscles is that the careful washing 
procedure, coupled with a virtually bloodless dissection, left no obvious 
collections of RBCs within the muscle bundles. After the period of stimulation 
the bathing solution was slightly opaque (presumably due to the output of protein 
from the muscle), but contained no obvious collections of red blood corpuscles. 
The Sarcoplasmic Reticulum as a Source of ATP 
It is proposed here that the source for the ATP released from the sartorius 
muscle is the transverse tubular system of the sarcoplasmic reticulum. The nature 
of this system will now be described briefly. 
Observations under the electron microscope (Bennett and Porter, 1953; 
Porter 1956; Edwards, Ruske, Sonza-Santos and Vellejo-Freire 1956; Porter 
and Palade 1957) have revealed the presence of an intricate system of internal 
tubes in skeletal muscle fibres. This system has been given the name "sarcoplasmic 
reticulum". 
Several investigators have suggested that this reticulum may provide a rapid 
pathway for the inward spread of the depolarization wave from the external 
membrane during electrical excitation of the musc le fibre. 
A summary of the anatomy of this system is given . in 
Figure 40. 
H. E. Huxley (1964) and S. Page (1964) have shown in elegant electron 
microscopic studies that the central element (T-system) of the triad formation in 
frog muscle fibres is accessible to particles as large as ferritin and colloidal gold 
(diameters 110 Ao and 200 A0 respectively, Figures 41 & 42). This gave the first 
direct evidence of continuity between the lumen of the triad tubules and the 
extracellular space in frog skeletal muscle. 
IEndo (1966) has recently investigated the properties of the sarcotubular 




The system consists of two types of channel which do not communicate directly 
with each other or with the main part of the muscle sarcoplasm. One part of this 
system has the form of narrow channels, 200A - 300A in diameter, running along- 
side each myofibril for nearly all of its length. In the case of the frog sartorius 
muscle these channels are interrupted at the level of the Z lines. Opposite the 
I bands the narrow channels open out into a broader terminal region of about 
1,000A in width. 
The other part of the reticulum has transversely-orientated tubules and is 
termed the "T-system". These tubules occur at the level of the Z lines in frog 
sartorius muscle and are possibly continuous for considerable distances across the 
muscle fibre. 
Where the terminal regions of the longitudinal system come into contact with 
the transverse system, a structure known as a "triad" is formed. Thus a triad 
consists of a central channel (part of the T-system) flanked on either side by the 
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A longitudinal section of frog sartorius muscle (x50,000) which had soaked 
for one hour in a ferritin solution before fixation. The ferritin has only penetrated 
the T, -system of the sarcoplasmic reticulum. Note the relationship of the T-system 
of tubules to the position of the dark Z line. 
(Figures 38 and 39 reproduced by kind permission of Professor H. E. Huxley and the Editor of "Nature". ) 
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A higher magnification (x 145,000) of the "triad" structures seen in the 
previous figure. The granules of ferritin molecules are clearly seen in the lumen 
of the transverse tubules. 
Figure 42b. 
A longitudinal section through a transverse tubule at the same magnification. Portions of the T-system can be seen leading away from this triad structure. 
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(Figure 42a and 42b reproduced by kind permission of Professor H. E. Huxley and the Editor of "Nature"). 
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into and out of a periodically arranged system of tubules which were situated at 
the level of the Z line. He concluded that the dyes have some access to a 
component of the triad system. The molecular weight of the dyes used was of 
the order 600, yet he found in a single muscle fibre preparation that they could 
diffuse into and out of the fibre within a period of two minutes. By studying the 
flow rate of these dyes into the fibre he concluded that most of the resistance 
offered by the tubule to the dye was evenly distributed along the length of the 
tubule. There did not seem to be any obstruction to the diffusion of the dye at 
the entrance of the tubule. 
Endo estimated that the size of the space into which the dyes were 
diffusingwas 1%- 2% of the fibre volume. This figure lies between the figure of 
0.2% calculated for the volume of the central canal of the triad system and the 
figure of 5% calculated for the whole triad system (Page, 1964; Peachey 1965). 
During the process of muscular contraction the T-system must undergo a 
reduction in its lumen volume. As clear entry and exit of large molecules to and 
from this system has been demonstrated, it is possible that the nucleotides are 
squeezed out of the T-system into the extracellular space where they are free to 
diffuse to the local arterioles. The "pumping" action proposed here implies that 
the muscle should be able to contract and relax before the most effective release 
of ATP is achieved. The findings of Hilton (1962) in his human forearm experiments 
seem to support this hypothesis. No ATP was found in the perfusates of muscles 
which were not allowed to contract, but in the experiment where they were 
allowed to contract, a great amount of ATP was detected. This large amount 
probably has two components; that amount which was released from damaged 
tissue, since the method employed two needles embedded into the contracting 
muscle belly, and the "physiological" amount released from muscle which was 
being allowed to contract, and hence was pumping adenosine triphosphate out 
from the sarcotubular system. 
Other evidence to support this hypothesis is readily available. Many workers 
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(Caspersson and Thorell, 1942; Engstrom, 1944; Perry, 1952; Hill, 1959 - 1960) 
have tried to display a special site for ATP within the muscle cell in relation to 
the actin-myosin complex. 
Caspersson and Thorell (1942) used the technique of photographing living 
skeletal muscle from various species under an ultraviolet microscope. The wave- 
length was adjusted to 257 mµ so that the high specific absorption of the purine 
ring would outline the position of the adenylic acids. 
They found that in living muscle fibres before exercise a clear picture of 
sharply differentiated light and dark bands running across the muscle fibres was 
obvious; after vigorous exercise the living muscle fibre showed that the sharp 
differentiation between these bands was, in their own words, "more or less 
smudged out". In resting muscle fibres they found that the substances which 
strongly absorbed the UV light were most concentrated nearest to the I band of 
the sarcomere. In muscle which had been fatigued from exercise they found that 
the A band of the sarcomere showed extremely fine longitudinal striations. These 
appeared most clearly nearest to the I band and diminished in clarity towards the 
m iddle of the A band. 
They felt that the only explanation for such a picture was that the strongly 
absorbing material located near the I band had travelled towards the middle of the 
A band through a very fine series of longitudinal channels. However, it is 
proposed here that the material was, in fact, moving in the other direction, that 
is, from the A band into the I band. The corollary to'this view is that the 
adenine nucleotides are synthesized in the A band and pass along the longitudinal 
tubules into the I band. At this stage a transfer mechanism for the nucleotides 
to pass from the longitudinal system to the T-system must be presumed, although no 
connections between the systems have yet been demonstrated. 
A. Engstrom (1944), using a microincineration technique for locating 
phosphates, showed that the high UV absorption of the isotropic band coincided 
in position with his newly-found source of phosphate ash. In frog's muscle nearly 
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one third of the total phosphorus is in the form of adenine nucleotide, so it is 
likely that Engstrom had outlined one situation of adenine nucleotides in skeletal 
muscle. S. V. Perry (1952) has shown that about 10% of the total adenine 
nucleotide in rabbit muscle is bound to the myofibrils and can only be freed by 
acid. The other 90% of adenine nucleotide is free and occupies the sarcoplasmic 
space. 
D. K. Hill (1959)' provided yet another means of approaching the problem 
of localization of nucleotides in skeletal muscle. Hill developed a method of 
incorporating tritiated adenine into frog's skeletal muscle. He showed that the 
labelled material inside the muscle cell was largely adenosine triphosphate. He 
was able to obtain autoradiograms from freeze-dried and fixed specimens, -,, by 
staining for the striations at the same time, he could locate more accurately the 
position of the adenine nucleotides with reference to the sarcomere. He found 
that about 70% of the nucleotide lay within the I band of the sarcomere and he 
noted one surprising feature; this nucleotide seemed to have "a transverse freedom 
of movement within the muscle fibre". He put forward the suggestion that the 
facility for this transverse diffusion could be provided by the sarcoplasmic, 
reticulum. . 
Summary and Conclusions - 
A combined survey of the works considered above reveals the following 
chain of evidence: - 
(a) Adenine nucleotides and, according to D. K. HiII, principally 
adenosine triphosphate, are found to be concentrated at a certain 
part of the sarcomere; namely, at the Z line in the isotropic band. 
(b) Also lying in this region of the sarcomere is the transverse tubule 
system of the sarcoplasmic reticulum. 
(c) The "transverse freedom of movement" of the adenine 
nucleotide material described by Hill in the region of the Z line 
correlates with the experiments of H. ' E. ' Huxley, S. Page and 
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M. Endo who have all demonstrated the free movement of large 
molecules within the transverse tubular system. These molecules 
are also able to pass freely between the extracellular space and 
the transverse tubules. 
(d) Caspersson and Thorell noted that the pattern of adenine 
nucleotide material in the muscle fibres changed after the muscle 
had been exercised. Whereas before exercise the nucleotides were 
concentrated in the I bands, after exercising the muscle they found 
that the A band showed exceedingly fine longitudinal striations, 
which became clearer, when the I band region was approached. 
They concluded that the material had moved from the I band 
through a series of fine, longitudinal channels towards the middle 
of the A band. 
To the above list of experimental findings can now be added the evidence from 
the present work that ATP is released from an active frog sartorius muscle. 
Since adenine nucleotide material is present in the region of the Z line and 
has been shown to have the transverse mobility by D. K. Hill (1960), and since the 
T-system of the sarcotubular reticulum lies at the position of the Zline, it does 
not seem unreasonable to assume that the adenine nucleotides are lying in the T 
tubes. There does not seem to be any obstruction to the extracelluar space from 
the T-system, so that any ATP lying in the Týtubules would be easily "pumped" 
out by contracting skeletal muscle. 
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THE EFFECT OF APYRASE ON THE FROG HEART RESPONSE TO ACh 
In order to assay the small amount of ACh released from sartorius muscle 
on the frog heart preparation, elimination of the stimulatory effect is essential. 
From the identification procedures used to establish that the stimulatory substance 
in the solution bathing the muscle is adenosine triphosphate, it appears that the 
most convenient way of eliminating the ATP effect on the frog heart from the 
test solution is by incubating it with, apyrase for 15 minutes. 
The effect of apyrase on the sensitivity of the frog heart to ACh, however, 
was not known, and therefore the following experiment was designed. 
A frog heart was perfused with a finely graded series of ACh concentrations 
and a concentration-response curve was obtained. The same series of solutions 
of ACh was then incubated in a waterbath at 30°C for 10 minutes and a 
concentration-response relation on the some frog heart was again obtained. A 
controlled series of incubated ACh solutions alone were perfused through the frog 
heart and concentration response curves were obtained for the cardiac output and 
heart rate. 
Figure 43 shows the percentage inhibition of the cardiac output and heart 
rate for the normal ACh series, the ACh series incubated with apyrase and the 
incubated ACh control series. In this particular heart the threshold concentration 
of ACh was 2.5 x 10-9 g/ml. This minimal concentration required to inhibit the 
heart remained the some in the incubated control series, but the threshold 
concentration required to inhibit the heart after the solutions of ACh had been 
incubated with apyrase was markedly raised to above 7.5 x 10-9 g/ml. ACh. 
This has been found in 2 other heart experiments. 
Figure 44 shows part of a recording of a perfused frog heart showing the 
effect of incubating two solutions of ACh with apyrase. The cardiac output is 
easily seen to be reduced when the solutions of 10 
$ 
g/ml. and 1.5 x 10-$ g/ml. 
of ACh after incubation with apyrase are perfused through the heart. The effect 
Figure 43. 
The effect of apyrase and incubation on the frog heart's sensitivity to ACh. 
(a) The percentage output inhibition (ordinate) is plotted against the 
concentration of ACh applied to the heart (abscissa). 
(b) The percentage rate inhibition (ordinate) is plotted against the 
concentration of ACh applied to the same heart (abscissa). 
Note that the response of the heart falls when ACh which has been 
incubated with apyrase is perfused through the heart. This effect could be due to 
(1) destruction of ACh by apyrase 
(2) alteration of the sensitivity of the myocardium by the apyrase in 
the perfusate. 
It is likely that an ATP-ase such as apyrase will depress the sensitivity of 
active tissue such as myocardium. 
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of these solutions of ACh when incubation alone takes place are seen to be the 
same as the normal series. 
Discussion 
The three experiments on the frog heart response to ACh were all performed on 
frog hearts which were very insensitive to the action of ACh. However the apyrase 
does seem to depress the response of the frog heart to ACh quite substantially, 
even in these insensitive hearts. This suggests that the effects of incubating 
smaller amounts of ACh with apyrase would be more profound and a great deal 
of the advantage of using a sensitive preparation to ACh is wasted. So the 
problem of assaying ACh released from the frog sartorius muscle on the frog heart 
is for from being solved. 
It is to be noted here that incubation of pure ACh solutions at 30°C for 10 
minutes surprisingly does not cause hydrolysis of ACh. Diluted solutions of ACh 
have been regarded in the past as being very unstable, but this view has to be 
modified in the light of these findings. 
PART II 
THE ASSAY OF ACETYLCHOLINE RELEASED FROM 
THE NEUROMUSCULAR JUNCTION 
THE ISOMETRIC ' 
LEECH MUSCLE STRIP 
AS AN ASSAY PREPARATION- 
FOR ACETYLCHOLINE 
-ýý 
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INTRODUCTION 
The, Pharmacology of Leech Muscle 
In 1918 Fuehner introduced the leech (Hirudo medicinalis) as a suitable 
bio-assay object for the estimation of physostigmine (eserine). The complementary 
actions of acetylcholine and eserine enabled the eserine tobe estimated in small 
quantities in the presence of acetylcholine. 
Minz (1932) used the leech muscle to estimate small quantities of 
acetylcholine. Again the sensitivity of the muscle was increased by having the 
eserine present. 
Feldberg and Krayer (1933) showed that the anterior part of the body wall 
musculature was 2 to 4 times as sensitive to acetylcholine as the posterior body 
wall musculature, in the presence of eserine. 
All of the above investigations emphasized the difficulties encountered with 
spontaneous contractions of the preparation and even in cases where spontaneous 
activity was at a minimum, the problem of adequate, if not complete, relaxation 
between tests was never really solved. The concentrations of eserine required, 
together with an apparent seasonal variation to eserine, seemed to raise further 
difficulties. For instance Feldberg and Krayer noted that in December and 
January a concentration of 5x 10 
6 
g/ml. eserine was "without influence" on the 
muscle, but in February and March this same concentration of eserine produced 
powerful contractions so that they had to dilute the eserine to 5x 10 
7g 
ml. in 
order to obviate this spontaneous activity. Minz noticed that from November to 
March varying concentrations of eserine (5 x 10-6 g/ml. to 5x 10 
7 
g/ml) only 
caused a slight and gradual increase in tone. He allowed the eserine to exert this 
effect and found it satisfactory'towork on top of this arbitrary baseline. 
Variations in the dissection of the leech also seemed to alter the experimental 
conditions. Fuehner (1918) showed that if the ventral wall of the leech was not 
removed, thus leaving the main chain of nervous tissue, small spontaneous 
0 
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contractions are likely. Probably for the same reason Minz advised against the 
use of a tube of muscle, that is, simply a section taken from the middle of the 
body, the anterior and posterior suckers being removed. Minz also noted that 
An these preparations spontaneous activity was initiated by slight mechical 
stimulation, even when changing the solutions. 
The use of the isotonic preparation of the leech for ACh assay became 
widespread after the realization that ACh was a chemical transmitter at 
neuronal and myo-neuronal junctions; but Macintosh and Perry in "Methods 
in Medical research" (1951) remark that the leech muscle strip is "a valuable 
object for the identification of ACh and for rouch quantitative work where 
, 
high sensitivity is required. Intolerably slow when many samples must be 
tested" . 
The problem of quicker and more consistent relaxation was approached in 
one way by M. F. Murnaghan in 1958. He investigated the influence of 
morphine on the relaxation of the eserinized leech. Paton et al. had shown in 
-1957 that the addition of morphine to the electrically stimulated guinea-pig 
, ileum had the effect of decreasing the output of ACh. - Mumaghan found that 
,a specific concentration of morphine was necessary to: - 
1. facilitate relaxation and 
2. have no appreciable effect on the sensitivity of the muscle 
to ACh in the presence of eserine. 
Again an isotonic system was used. 
In 1961 Szerb devised the micro-leech preparation using a tiny strip of 
the anterior dorsal muscle and testing it in a bath of volume 0.05 ml. He found 
that with an isotonic lever system undiluted Locke's solution caused fast 
spontaneous movements. However, when the muscle strip was mounted 
isometrically after the optimum tension had been found isotonically, quicker 
relaxation and a steady baseline were obtained. 
-90- 
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Anatomy and Physiology of Leech Muscle 
The structure of the leech muscle (Hirudo medicinalis) has recently attracted 
the attention of electron microscopists and many interesting details have been 
brought to light by their investigations. 
The light microscopy of the muscle fibres of worms was described as `early" as 
1891 by Apathy. However, most of his observations were carried out on Ascaris, 
only a few results from Hirudo were obtained. 
The muscle fibre of Hirudo represents a special type of muscle. Sometimes, 
it is difficult to make a clear, distinction between smooth and striated muscle. 
The locomotory muscles in annelids are designated "helical smooth", showing some 
features of both smooth and straited muscle. In leeches all muscles appear to be 
of this type (Mann, 1962). 
The muscle coat consists of a circular, an oblique and an innermost 
longitudinal layer. The longitudinal fibres are very long, 10 cros up to 20 cms, 
have a helical course around the fibre axis, have a high degree of contractility 
and are rapid in action. A speed of two contractions per second has been 
recorded from them. Schwab (1949) states that the individual muscle cells have 
an extension of 5- 15 mm. The degree of shortening is said to range from 80% 
as a maximum to 50% in the normal ambulating leech. 
When the muscle is viewed under the low power of a light microscope the 
transverse section shows large collections of hollow cells which are compressed 
together (Figure 45). Each cell consists of a cortex of the contractile element 
which surrounds the sarcoplasmic core in which are situated the nucleus and many 
mitochondria. The diameter of the cells in a transverse section can vary from 
I- 20 microns. This has been taken to indicate that the very long cell is a 
tapering one. The contractile cortex contains longitudinal myofilaments. These 
are arranged into discrete bundles which are seen to have a radial formation in 
the transverse section. Also present in the transverse section are the so-called 
"cross filaments" so clearly demarcated in the electron micrographs of Röhlich 
Figure 45. 
(a) Transverse section of leech muscle strip (X 120) showing large 
collections of hollow muscle cells which are compressed together. The pigmented 
cells seen at the lower left of the picture are cells bordering the gut which take up 
ingested red blood corpuscles. 
(b) The lower half of the picture shows a longitudinal section of the hollow 
muscle cells lying just under the epithelium (X 300). In 2 cells the central nucleus 
can be seen laying in the clear lymph space within the cell. 
The lower half shows a collection of glandular cells used for lubricating 
the leech epithelium. 
Stain : methyleneblue. 
(Section cut and stained by the Histology division, physiology Department, 
University of Glasgow). 
100» (b) loop (a) 
- 91 - 
(1962). These elements are thought to have either the function of being supportive 
tissues or of being active contractile parts which serve to prevent excessive 
thickening of the fibre during its longitudinal shortening. 
Pucci and Afzelius (1962) have displayed an orderly sarcotubular system in 
5 leech species. This system seems to have a close connection with the cell 
membrane or sarcolemma. 
Thus the leech musculature used for the assay of acetylcholine is an advanced 
and highly organised piece of tissue with the reputation of exhibiting some specificity 
towards acetylcholine in the presence of eserine without obvious interference from 
other substances(Maclntosh and Perry, 1951). 
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RESULTS 
When the leech muscle strip was mounted isometrically it developed tension 
as soon as a suitable concentration of ACh was applied. It was possible to allow 
ACh solutions to act for as little as 45 seconds on the muscle strip and yet obtain 
step-wise responses to graded concentrations of ACh. Figure 46 shows the result 
of allowing each solution of ACh to remain in contact with the muscle until the 
maximum tension had been achieved. Note the immediate development of 
tension as soon as the ACh solution was applied to the muscle at zero time. The 
record was obtained by superimposing the records of 5 responses of the same leech 





each case the records of developing tension are well separated, so that 
discrimination between each response to a differing concentration of ACh is quite 
clear, regardless of the time allowed for each solution to be in-contact with the 
muscle strip. After a period of 45 seconds the records are well separated. Test 
solutions were drained from the bath at this point and the tension of the muscle 
strip was equated with the concentration of ACh applied. The effect of the ACh 
on the leech muscle could thus be obtained in 45 seconds, and, with the lower 
concentrations of ACh, couId bewashed out in just as short a time. So it was 
possible to obtain a concentration-response relationship of a leech muscle strip 
to ACh very rapidly. Figure 47 shows the response of 2 leech muscle strips to 
graded concentrations of ACh. The effect of each test solution is preceded by a 
bizarre, but constant, increment in tension; this is due to the leech muscle strip 
lying up against the side of the bath momentarily just before the test solution of 
ACh is applied. After allowing the test solution to remain in contact with the 
leech muscle for 45 seconds, the pen recorder motor is stopped and the test 
solution drained from the bath. Thereafter the leech muscle is thoroughly rinsed 
with leech solution until the original baseline tension is obtained. A concentration- 
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Concentration response curves of a single leech muscle preparation which 
was kept in the bath of leech Ringer's solution for 24 hours, hr = hours. Con- 
centration response curves to acetylcholine are plotted at 0,2 and 24 hours. 
Note that the threshold sensitivity is unaltered, as is the general shape of the 
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Histogram showing seasonal incidence of high sensitivity of leech muscle 
strips to ACh. The number of muscle strips tested in each month is shown at the 
base of each column. The total height of each column indicates the percentage 
out of this number responding to 10 
10 
g/ml. ACh or lower concentrations. The 
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strip after 45 seconds against the concentration of ACh producing that tension. 
It was found that the sensitivity of the leech muscle to ACh remained constant 
over many hours, and it is to be noted that no oxygenation of the leech-Ringer's 
solution was necessary. Figure 48 shows concentration response curves obtained 
from a single leech muicle preparation at 0,2 and 24 hours and the concentration- 
response curve retains its original shape, which makes the leech muscle strip a 
useful bioassay object for ACh during any prolonged assay experiment. 
Fifty leech muscle strips were used to obtain initial and "24 hour" 
concentration-response curves. Twenty-five muscles retained their sensitivity, 
8 of these actually becoming more sensitive after 24 hours. The other 25 muscles 
became less sensitive after 24 hours; the greatest loss in threshold sensitivity was 
from 10-11 g/ml. ACh to 10-9 g/ml. ACh. 4 
Seasonal Sensitivity 
Earlier investigators (Minz, 1932; Feldberg and Krayer, 1933) had noticed 
a seasonal variation to the anticholinesterase, eserine. It was possible that a 
seasonal variation to ACh might also exist. 
. 
One hundred and seventy leech muscle strips from separate leeches had their 
response to threshold concentrations of ACh determined in the presence of 10-5 g/ml. 
eserine over the period July, 1964 to December, 1966. The responses of muscles 
in 1964 were measured isotonically using a Gimbal lever and a smoked drum; 
all other muscles had their responses measured isometrically.. Figure 49 shows 
the variation of the response to threshold concentrations of ACh for each month 
of the year. An incidence of low sensitivity appears in May and June, whereupon 
the sensitivity appears to increase gradually, reaching a peak in November and 
December, then dropping sharply again in the period February and March. 
The Action of Morphine on the Leech Muscle Strip 
The method of relaxing the leech muscle with the use of morphine, as 
advocated by Murnaghan (1958), prompted the initiation of some experiments 
designed to study the action of ACh and morphine on leech muscle. 
Murnaghan cites the work of Paton et al. (1957) who showed that morphine 
had the effect of depressing the output of ACh in guinea-pig ileum. The rationale 
behind Murnaghan's original method for relaxing leech muscle was presumably that 
some form of constant"intrinsic" production of ACh was responsible for the main- 
tenance of the leech muscle tone; . if this intrinsic production of ACh is depressdd 
by morphine, the muscle will lose its tone and relaxation will occur. This whole 
procedure, of course, was directed at facilitating the management of an ISOTONIC 
system. 
When the leech muscle strip was prepared for an assay procedure by soaking 
in morphine solutions (see Methods), it was noted that in every case the muscle 
had almost completely relaxed when set at a constant length in the bath. In three 
experiments the leech muscle was set up in the bath and a morphine solution was 
applied to the muscle in the presence of eserine. The alteration, in tension was 
then continuously recorded. Figure, 50 (lower trace) shows the effect of applying 
a solution of 5x 10-5 g/ml. morphine in leech Ringer's solution to a muscle strip 
which had a resting tension of 1.5 grammes. The tension fell to 0.5 grammes two 
minutes after the application of the morphine solution. This rate of tension fall was 
similar to that found in the other two experiments. 
Muscle strips which had been left to soak overnight were found to have 
relaxed considerably and did not relax further when morphine solutions were applied 
to them. 
The Effect of Curare on the Leech Muscle Strip 
Curare selectively blocks the action of ACh on leech muscle (Dale et al., 
1936). This blocking action of. d-tubocurarine, was used in the present work to 
identify ACh contained in test solutions obtained from active and resting rat 
skeletal muscle. A study was made of the action of curare alone on the leech 
muscle strip. 
In every experiment used to assay test solutions obtained from rat hemidiaphragm 
muscles, curare was applied to the leech muscle strip to establish that the action of 
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test solutions was. due to the presence of ACh. In each case the leech muscle was 
observed to relax quickly after the application of curare. 
Figure 51 shows a continuous recording of the tension produced by a leech 
muscle strip which had been soaked in eserinized leech Ringer's solution overnight. 
Increasing concentrations of ACh from 10 
10 
g/ml. to 10-$ g/ml. cause a steady 
rise in the muscle tension in spite of vigorous washing between doses. The tension 
rose from 1.2 grammes to 2.2 grammes. When a solution of 10-5 g/ml. curare was 
put into the bath the tension of the leech muscle strip fell from 2 grammes to 1 
gramme in a period of two minutes. 
In Figure 50 (lower trace, last test) the application of curare to another 
leech muscle strip shows the some rate in fall of tension: a fall of 1 gramme over 
a period of two minutes. 
An unexplained finding occurred with two muscle strips; after soaking the 
muscle overnight in eserinized Ringer's solution, the application of curare did not 
block the action of ACh. 
The Comparison of the Action of Morphine and Curare on a Single Leech Muscle 
Strip. 
In one experiment the action of morphine and curare was compared on the 
some leech muscle strip. In this case the relaxation caused by morphine 
proceeded at the some rate as that caused by curare. It had already been noted 
that after a muscle strip had been allowed to soak overnight and had reached a 
low level of tension, the application of curare or morphine did not promote further 
relaxation. 
Figure 50 shows a continous recording of the tension developed by a leech 
muscle strip which had an initial low tension. With the baseline steadily rising, 
a series of responses to graded concentrations of ACh was initiated. After a 
concentration of 10 
8 
g/ml. ACh was put into the bath and its effect seen and 
washed out, the leech muscle strip started to develop a steadily increasing tension. 
This tension, reached a constant value as seen in the lower trace. After a 
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satisfactory control with leech Ringer's solution, morphine in a concentration of 
5x 10-5 g/ml. was put into the bath. This caused the expected rapid fall in 
tension. After two minutes the morphine was drained out of the bath and the 
muscle strip was washed and then soaked in Ringer's solution for 15 minutes. 
During this time the muscle strip regained most of its original tension. After a 
satisfactory control, a solution of 10 
5 
g/ml. d-tubocurarine was put into the 
bath. This caused a similar fall in the tension of the leech musclestrip to that 
seen with the morphine solution, i. e. a loss of 1 gramme of tension in*a period 
of two minutes. 
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DISCUSSION 
It was found that the leech muscle strip showed two types of contraction 
(expressed by development of tension); a "quick" type which is always produced 
by a concentration of ACh well above the amount causing a threshold response in 
the leech muscle, and a second type of slow, steady contraction, not obviously 
initiated by any ACh applied to the muscle strip. The quick type of contraction 
could produce an increase in tension of 1 gramme in less than 30 seconds, while the 
slow contraction produced a tension of no more than 100 milligrammes in 1 minute. 
It was found that a perfectly satisfactory response curve could be achieved 
in spite of the simultaneous occurrence of a slow contraction (or a steady increase 
in "tone"); the slow contraction did not seem to have any effect on the response 
of the leech muscle to concentrations of ACh well above the amount causing a 
threshold response, as manifested by the quick type of contraction. Thus any 
assay can be confidently undertaken on an isometric leech muscle preparation even 
when the baseline is not a horizontal one. 
The interpretation of the response of the leech muscle to "threshold" 
concentrations of ACh has proved throughout this work to be difficult (Figure 47). 
In some cases the first sola ion of ACh applied to the muscle produced an increase 
in tension which was extremely difficult to wash out. Occasionally it was 
impossible to restore the original tension of the muscle strip (Figure 48). The rate 
of increase in tension was equivalent to that of the slow contraction and it seemed 
that the initial small dose of ACh applied to the muscle strip could set off a slow 
type of contraction which was unaffected by immediate and prolonged washing. 
This effect could be misinterpreted and taken to mean that a quick contraction had 
been initiated by a very small concentration of ACh (see the effect of 10-11 g/mI. 
ACh in Figure 50 . However the effect of a quick contraction is easily and rapidly 
washed out. 
The response of the leech muscle to the drugs curare and morphine has suggested 
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the following theoretical scheme for the behaviour of the leech muscle in the 
presence of ACh when low concentrations of ACh are applied. 
A "store" of ACh is postulated. The nature and situation of this store need 
not be discussed at this stage, but the main reason for this postulate is that there 
seems to be a constant source of ACh within the muscle which is available to 
maintain the muscle tonus. This ACh will be termed "intrinsic" as opposed to 
"extrinsic" ACh applied to the outside of the muscle. In order to diminish or 
abolish muscle tone, either the synthesis of intrinsic ACh can be blocked by 
morphine, or its peripheral action on the muscle fibre can be blocked by curare 
(Figure 52). 
Extrinsic ACh can take two pathways. It can pass into the ACh store if the 
store is deficient, or it can pass directly to the muscle fibre and cause a quick 
contraction; or it can pass along both pathways, contributing to the store of 
intrinsic ACh and causing a quick contraction of the leech muscle fibre. 
In a muscle which has fully repleted stores of ACh, all, or nearly all, of the 
extrinsic ACh contributes to the quick contraction of the leech muscle (Figure 
On the other hand, if extrinsic ACh is applied toa. leech muscle with greatly dim in) shed 
stores, then all, or nearly all, of it will contribute to the replenishment of these 
stores (Figure 52) ; if the concentration of ACh applied is a small one, then only 
after the stores have been repleted will a quick contraction be produced. If the 
amount of extrinsic ACh is large, only a certain amount of it can be utilized by 
the stores, the remainder "spills over" causing a quick contraction of the muscle 
fibres. This should be taken as the true response to threshold concentration of 
acetylcholine of that particular leech muscle strip. From this point onwards the 
stores are slowly incorporating applied extrinsic ACh. '`- The baseline may 
indicate that the muscle tone is still gradually rising, but the increasing doses of 
extrinsic acetylcholine are now producing a graduated series of quick contractions, 
thus giving rise to a satisfactory concentration-response relationship. 
In an isotonic system where a muscle strip has been allowed to contract fully, 









Normal situation before soakinq in 
morphine solutions 
Extrinsic Ry ýa Ach - --l. ta,. LJ 
Figure 52. Diagram to represent the "store" hypothesis of ACh in leech muscle. 
The leech muscle fibre is represented by an upright rectangle. The ACh store 
is represented by a shaded circle when replete and a "crenated" circle when depleted 
of ACh. 
A. (Upper diagram) shows that a steady production of ACh from fully repleted 
stores is responsible for maintaining muscle tone. This process can be blocked by 
morphine or curare. 
A. (Lower diagram) shows the effect of applying extrinsic ACh to the leech 
muscle in which the stores are fully replete. Muscle tone is fully maintained by 
ACh from the store; extrinsically-applied ACh is not taken up by the store and has 
its total effect on the leech muscle directly. 
B. (Upper diagram) shows that with a depleted ACh store there is poor 
maintenance of muscle tone. 
B. (Lower diagram) shows that when extrinsic ACh is applied to a muscle 
with depleted stores of ACh most of it is taken up by the stores, while only a fraction 
of the applied ACh has a direct effect on the leech muscle fibre. 
Directly-acting ACh causes a quick contraction, ACh liberated from the store 
causes a slow contraction ("tone"). 
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the time taken to return to its original baseline with continuous fluid exchange may 
be 30 minutes or longer. At threshold doses of ACh it is difficult to know whether 
this prolonged washing procedure is 
(a) diminishing the intensity of a minimal quick contraction or 
(b) depleting the intrinsic stores of ACh, so that the underlying 
muscle tone was being altered. 
If the situation was (a), then the washing procedure might not completely wash out 
the effect of the quick type of contraction, and the next dose of ACh would have 
its effect superimposed on the previous effect. If the situation was (b), then the 
depleted ACh stores would take up some of the externally applied ACh in the next 
solution and the baseline would shift once again, confusing the true threshold 
response of the muscle to ACh. 
With the isometric system, any ACh causing a quick contraction can be 
washed out of the muscle strip so much more quickly that it becomes obvious when 
the muscle tone is altering; it has been found that with vigorous washing over a 
short time course the baseline tension does not alter if the postulated stores of 
ACh are fully replete. The quick contraction produced by a concentration of 
ACh just above threshold value can be quickly and easily washed out. 
Comparison to the Micro-Leech Preparation 
Although both leech preparations are set up isometrically, the micro-leech 
preparation requires more skill and experience compared to the simple dissection 
and mounting procedure adopted here. 
With the present system the test solution is only allowed to come into contact 
with the muscle strip for 45 seconds before the washing procedure is started. 
Probably this means that centrally-situated muscle fibres in the strip do not receive 
any ACh. If only a small proportion of leech muscle fibres are responding to the 
ACh, then this system is a pharmacological equivalent of the micro-leech 
preparation of Szerb (1961). 
The micro-preparation was intended for exceedingly small test samples. This 
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would have the effect of concentrating any ACh released from, say, a cervical 
ganglion preparation stimulated in 0.1 ml. of fluid. However when other inter- 
fering substances are likely to be concentrated as well, no application for this 
method can be found in assaying ACh output from the neuromuscular junction. 
SUMMARY 
1. An isometric leech muscle preparation has been devised for the quantitative 
assay of ACh. 
2. The preparation is simple to set up and can maintain a steady tension over 
a period of 24 hours. 
3. The sensitivity of the preparation to ACh can also remain constant through- 
out a 24 hour period. 
4. A seasonal variation to ACh is evident, the most sensitive period occurring 
during November and December. 
5. Two types of contraction seem to occur in leech muscle (in response to 
ACh). A slow contraction can take place which is postulated to be 
caused by the production and release of an intrinsic supply of ACh. A 
fast type of contraction occurs in response to suitable concentrations of 
ACh applied to the muscle externally. 
6. At "suprathreshold" concentrations of ACh the muscle tone (slow 
contraction) does not interfere with the fast response of the leech muscle 
strip. Thus a concentration-response relationship can be established 
despite the simultaneous occurrence of a slow contraction. 
ASSAY OF ACETYLCHOLINE 
RELEASED 
FROM RAT DIAPHRAGM 
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INTRODUCTION 
The release of ACh had been studied extensively by several workers with the 
use of the nerve-muscle rat hemidiaphragm preparation (Bulbring, 1946). It was 
used initially in this work to test the efficacy of the isometric leech muscle as a 
reliable assay preparation for ACh, since values for the amount of ACh released 
from rat diaphragm are already well established (Krnjevic and Mitchell, 1961; 
Krnjevic and Straughan, 1963; Mitchell and Silver, 1963). 
The Assay Procedure 
Since all test solutions were to be subsequently assayed on the leech muscle 
preparation, it was convenient to stimulate the muscles in mammalian tissue fluid 
substitutes which were easily converted by dilution to a Ringer's solution suitable 
for leech muscle. Eleven hemidiaphragms were stimulated in leech Ringer's 
solution so that no dilution was necessary. This unphysiological procedure was 
adopted as a preliminary test for the leech assay technique rather than for the 
accurate measurement of the ACh release from rat diaphragm muscle. 
Where stimulation took place in Locke's solution the conversion to leech 
solution for assay was accomplished by diluting 1: 1.4 with distilled water. It was 
found at a later stage in the work that the leech muscle did not lose any sensitivity 
to ACh when suspended in a medium of Krebs' solution which had been diluted 
1: 1.4 with distilled water. This allowed the hemidiaphragm muscles to be 
stimulated in continuously-oxygenated Krebs' solution which could then be 
converted simply to "modified Krebs' solution" for the assay on the leech. 
In the unoxygenated series (Table 11) assay of the test solution was performed 
by matching their effects on the leech muscle with known amounts of ACh - 
chloride made up in leech Ringer's solution. Where possible, "bracketing" of the 
test solution between the effects of known concentrations of ACh was carried out 
and the effect of the test compared to the concentration-response curve obtained 
at the start of the experiment. 
Rate of stimulation 
10/s. o for 20 min 
20%. o for 20 min 
20/sec for 20-min 
10/NO for 20 sin. 
20/.. o for 20 min 
Table of ACh. output from Rat Dianhraam 






4 oil LEECH 
2. Locks mammalian 
2 s4 Lecke aammaliaf 
20/sec for 20 min 2 ml LEECH 
Unoxygenated Series 
Table 11. 
Output of ACh. 
per hemidiavh. 
2.2 x 10'89 
2.2's 10'8g 
1.5 x 10-8g 
1.5 x 10'8g 
c. 8 x 10-8g 
2.0 x 10'8g 
1.4 x 10'89 
, 
0.8 x 10'8g 
0.8 x 10'89 
2.8 x 10-8g 
1.0 x 10-8g 
2.0 x 10-8g 
1.0 x 10-8g 
1.0 x 10-8g 
"3.0 
x lo'g 
2.0 x 10'8g 
2.0 x 10-8g 
2.0 x 10'89 














2.5 x 10-9g" 
2.5. x 10'9g 
4x 10'99 
2.5 x 10"9g 
Täblel2. 
OUTPUT OF ACh FROM RAT HEMIDIAPHRAGMS INTO KREBS' 
SOLUTION (ng) 
Stimulation took place at 20/sec for 20 minutes followed by a period of 5 
minutes soaking. Resting solutions were obtained by soaking the muscle for a 
period of 25 minutes. Dotted lines connect values successively obtained from 
the some hemidiaphragm. 
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In the oxygenated series (Table 12) where the muscles were rested or stimulated 
in oxygenated Krebs' solution, a more rigid procedure was adopted. An initial 
concentration-response relationship was obtained for ACh in the leech muscle 
strip to be used for the assay. The leech muscle lay in Krebs' soltuion diluted 
1: 1.4 with distilled water. After conversion of the test solution by diluting 1: 1 .4 
with distilled water, its effect was "bracketed" between the effect of two known 
concentrations of ACh. The test solution was then diluted by half with converted 
Krebs' solution and again "bracketed" between the effects of known concentrations 
of ACh. The leech muscle was then soaked in curare for 20 minutes. The test 
solutions were again applied to the 'leech muscle strip. 
An example of an assay procedure is shown in Figure 53. The leech muscle 
strip was bathed in Krebs' solution diluted 1: 1 .4 with distilled water. The rat 
hemidiaphragm was stimulated at 20 impulses per second in 2 ml. Krebs' solution 
for 20 minutes. The upper trace of Figure 53 shows the initial concentration- 
response relationship of the leech muscle to ACh. The threshold response occurred 
when a concentration of 5x 10 
10 
g/ml. ACh was applied to the leech muscle. 
The lower trace shows the response of the leech muscle to "bracketing" concentrations 
of ACh and to the test solution after it had been converted to modified Krebs' 
solution by. diluting 1: 1.4 with distilled water. The effect of the test solution (T) 
was "bracketed" between the effects of 5x 10-9 g/ml. ACh and 2.5 x 10-9 g/ml. 
ACh. Three minutes later the test solution diluted by half (T/2) gave an effect 
which was "bracketed" between the effects of 10-9 g/ml. and 2.5 x 10 
9 
g/ml. 
ACh. After the leech muscle had soaked in a solution of 10-5 g/ml. curare for 
20 minutes, the response to these solutions was abolished. 
A graphic record of the result of this assay procedure is shown in Figure 54 
The initial concentration-response curve has been obtained by plotting the tension 
developed by the leech muscle strip against the concentration of ACh applied (+). 
The tensions developed by the leech muscle in response to the "bracketing" 
solutions of ACh lie close to the initial concentration-response curve obtained 
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Initial concentration-response relation for action of ACh on tension of an 
isometric leech muscle strip (+). Test solution from rat hemidiaphragm undiluted 
(T) and diluted by half (T/2) have given tensions equivalent to concentrations of 
3x 10-9 g/ml. ACh and 1.5 x 10-9 g/ml, respectively. Each test "bracketed" 
between tests with ACh at same time in experiment (0 0, see Figure 
Diaphragm stimulated at 20 impulses/sec for 20 minutes in 2 ml. Krebs' solution; 
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21 hours previously. 
The test solution (T) was found to be equivalent to 3x 10 9/m I. ACh. 
The test solution diluted by half gave a response equivalent to 1.5 x 10-9 g/ml. 
ACh. Since the hemidiaphragm was originally stimulated in a2 ml. volume 
which was diluted to 2.8 ml., the output of ACh from the muscle was 
3x2., 8x 10-9 g, i. e. 8.4ng. 
Identification of ACh 
Only one test was used for the identification of ACh. (see General 
Discussion). When the leech muscle was soaked in a solution of 10-5 g/mI. 
d-tubocurarine for 20 minutes this completely blocked the action of known amounts 
of ACh applied to the muscle strip. The action of curare on the test solution, 
however, was not so well defined. In every case the tension of the curarized 
leech muscle strip had returned to its original baseline after a period of 45 seconds 
in contact with the test solution; however, in most cases the baseline tension 
fluctuated immediately after the application of the test solution (Figure 55). An 
interfering substance invoking an extremely quick contraction of the leech muscle 
was present in the solution which had surrounded a twitching hemidiaphragm. This 
finding was present in results reported by Krnjevic and Mitchell in 1961 (see 
Discussion). 
Applications of diluted test solutions to the leech muscle strip aided the 
identification of the ACh. In each case the test solution diluted by half caused 
approximately the same effect as half the concentration of ACh which matched the 
effect of the undiluted test solution (Figure 54). Dilution of the test'solution would 
also reduce the effect of any interfering substances present which might alter the 
sensitivity of the leech muscle preparation to ACh. 
The Effect of Increased Potassium Concentration on the Leech Muscle 
In order to exclude potassium as the cause of the residual quick contraction 
provoked by the test solution when applied to the curarized leech muscle strip, 
graded concentrations of K+ in leech solution were applied (Figure 56). Normal 
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Leech Ringer's solution contained 3mM of K+. When a concentration of 6mM K 
was applied to the muscle, relaxation occurred. Further addition of a solution 
containing 8mM K+ applied immediately afterwards produced a further relaxation 
of the leech muscle. While this excluded K+ as a cause of the early contraction 
effect, it stressed the importance of excluding substances, released from active 
skeletal muscle, other than ACh which could distort bioassay estimations (see 
Discussion). 
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RESULTS 
The ACh output of 53 hemidiaphragm muscles was measured on the 
isometric leech muscle preparation (Tables 11 and 12). The muscles were 
stimulated indirectly at 10 impulses/sec or 20 impulses/sec in 2 ml. or 4 ml. 
of leech solution, Locke's solutions or continuously-oxygenated Krebs' solution. 
The spontaneous release of ACh from 14 muscles was measured; nine muscles 
were soaked in 2 ml. of unoxygenated Krebs' solution and five muscles were 
soaked in 2 mi. of continuously-oxygenated Krebs'ssolution. 
The ACh Release into 2 ml. Volumes of Locke's and Kreb's Solutions 
A comparison of the Tables "A" and "B" in Figure 57 shows that 
the ACh output from hemidiaphragms stimulated at 20/sec for 20 minutes 
in 2 ml. of Locke's solution is significantly less (. 05>P> . 01) than that 
released under the some conditions of stimulation into 2 ml. of Krebs' 
solutions. The mean output into 2 ml. Locke's solution was Eng while 
the mean output into Krebs' solution was 14ng. This difference could be 
attributed to either the type of Ringer's solution surrounding the active 
muscle or the fact that continuous oxygenation took place in the Krebs' 
solution during the period of stimulation, whereas the Locke's solution was 
bubbled with oxygen beforehand, but not during the stimulatory period. 
Both Ca ++ and Mg 
++ ions affect the ACh release at the endplate 
region, Ca increasing the output, and Mg depressing it (Fatt and 
Katz, 1952). The Ca + concentrations in the Locke's and Krebs' solutions 
were 2.2 mM and 2.5 mM respectively. This small difference is not likely 
to reduce the output into Locke's solution. No Mg 
++ 
was present in the 
Locke's solution, while 1.2 mM Mg++ was contained in the Krebs' solution. 
This difference would encourage a greater release of ACh into the Locke's 
solution than into the Krebs' solution, the reverse of the results obtained. 
Figure 57. Output of ACh (ng) from hemidiaphragm muscle stimulated at a 
frequency of 20/sec for 20 minutes. 
"A" "B" IIC'I 
Locke's Solution Krebs' Solution Leech Solution 
2 ml. volume 2 ml. volume 2 ml. volume 
7 18 5 
7 17 5 
7 8 5 
7 11 2.5 
7 13 2.5 
3 11 4 
10 2.5 
population -6 20 population -7 range 
D -1 52 mean -6 
7S 22 
range 2.5 -7+ 
. . . population -9 mean -4S. D. 0.98 
range 8- 22 ± 
mean - 14 S, D. 4.69 
"D" "Ell "P 
Locke's Solution Krebs' Solution Leech Solution 
4 mI. volume 4 ml. volume 4 ml. volume 
20 15 30 
14 23 20 
8 31 20 
8 35 20 
28 24 population -4 10 17 
20 15 range 20 - 30 + 
10 17 mean - 24 S. D. - 4.58 
10 12 
population -9 population -9 
range 8- 28 + range 
12 - 35 + 
mean - 14 S. D. - 6.56 mean - 21 S. D. - 6.70 
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It is to be noted here that even less ACh is released into 2 ml. of 
leech solutions than into 2 ml. of Locke's solution (compare Tables "A" 
and "C", Figure 57. 
The ACh Release into 4m1. Volumes of Locke's and Krebs' Solutions 
Tables "D" and "E" of Figure 57 show that the mean output of ACh 
from hemidiaphragm muscles into 4ml. volumes of Locke's and Krebs' solutions 
was 14ng and 21ng respectively. This significant difference (P<. 05) suggests 
that lack of oxygenation during stimulation of the muscle in the Locke's 
solution has an important influence upon the release of ACh from the rat 
diaphragm. However, the mean output of 24ng into a4 ml. volume of 
unoxygenated leech solution is similar to that put into oxygenated Krebs' 
solutions (Table "F", Figure 57) suggesting that some other factor, such as 
tonicity of the bathing solution, may be operative in the regulation of the 
release of ACh. 
The Comparison of Amounts of ACh Released into 2 ml. and 4 ml. of Locke's 
Solution 
The mean output of ACh into 2 ml. of Locke's solution was 6ng (Table 
"A"). Under the same conditions of stimulation and oxygenation the mean 
output into 4 ml. of Locke's solution was 14ng (Table "D"). This difference 
is highly significant (P<. 01) and strongly suggests that the volume of 
surrounding fluid affects the quantity of ACh released from an active hemi- 
diaphragm muscle. 
The Comparison of Amounts of ACh Released into, 2 ml. and 4 ml. of Krebs' 
Solution 
. Tables "B" and "E" of Figure 57 show the comparisons of 
ACh release 





amounts released into the 2 ml. and 4 ml. volumes were 14ng and 21 ng 
respectively. This clear difference (P<O. 1) again suggests that the greater the 
volume of fluid surrounding the muscle, the greater is the output of ACh from the 
muscle, other circumstances remaining constant. This phenomenon could have 
many explanations (see Discussion); only three are listed at this point. 
1. A diffusion gradient for ACh will tend to approach equilibrium more 
quickly in a smaller volume of surrounding bathing solution. This 
would result in less diffusion of released ACh into the surrounding 
solution. 
2. Every impulse delivered down the motor nerve might not liberate a 
normal amount of ACh from the nerve terminal. 
3. All of the impulses delivered down the motor nerve may not reach 
the endplate. This type of nerve block can be produced by anoxic 
conditions, which might occur more quickly in a small volume of 
fluid (see Discussion). 
In the present work only the existence of the last of these possibilities could 
be tested. Hemidiaphragms were stimulated at a different frequency and their 
outputs measured. 
ACh Output from Muscles Stimulated at 20/sec and 10/sec into 4 ml. Volumes of 
Locke's Solution 
Hemidiaphragms were stimulated at a frequency of 10/sec and their outputs 
were compared with those having been stimulated at 20/sec. Figure, 58 gives 
comparative tables for these results. Tables "P" and "Q" of Figure 58 show that 
the mean outputs of ACh into 41ml. volumes of Locke's solution from muscles 
stimulated at a frequency of 10/sec and 20/sec were 16ng and 14ng respectively. 
The mean outputs of ACh, into 2 ml. volumes of Locke's solution when the muscles 
were stimulated at 10/sec and 20/sec were 5.5ng and Eng respectively (Tables "R" 
and "S"). 
From these figures it can be concluded that under these experimental conditions 
Figure 58. Output of ACh from hemidiaphragm muscles stimulated at frequencies 
of 10/sec or 20/sec for 20 minutes. 
11 1311 IIQ II 
Locke's Solution Locke'sSolution 
frequency 10 sec frequency 20 sec 









range 8- 22 
mean - 16 S. D. - 5.29 
10 
population -9 
range 8- 28 
mean - 14 S. D. - 6.56 
Locke's Solution Locke's Solution 
frequency 10 sec frequency 20 sec 







mean - 5.5 S. D. - 1.66 population -6 
range 3-7 
mean -6S. D. - 1.52 
0 
Figure 59. The output of ACh (ng) from hemidiaphragms resting or stimulated 
in 2 ml. Krebs' solution. 
Resting Muscle Resting Muscle Stimulated Muscle 
Solutions Solutions Solutions 
Oxygenated Unoxygenated Oxygenated 
7 12 18 
17 8 17 
4 12 8 
5 10 11 
2 11 13 
population -5 
3 10 





mean -7 6 22 
population -9 population -9 
range 3- 12 range 8- 22 
mean -8 mean - 14 
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varying the frequency of stimulation from 10/sec to 20/sec does not alter the 
amount of ACh released from active hemidiaphragm muscles. 
The Spontaneous Release of ACh from the Hemidiaphragm 
Fourteen hemidiaphragm muscles were soaked in'2 ml. volumes of Krebs' 
solution for a period of 25 minutes. No significant difference (P>5) was found in 
the output of ACh between solutions which were not oxygenated and those which 
were oxygenated (Figure 59). The spontaneous release of ACh from muscles 
resting in 2 ml. is half of that liberated from muscles stimulated in 2 ml. of Krebs' 
solution. It is interesting to note that the mean resting release of ACh into 2 ml. 
volumes of Krebs' solution was 7ng and ; that the mean output of muscles stimulated 
at a frequency of 20/sec into 2 ml. of Locke's solution was 6ng (see Discussion). 
-109- 
DISCUSSION 
Output of ACh from Stimulated Muscles 
The output of ACh into 2 ml. of oxygenated Krebs' solution is probably 
significantly less than the output into 4 ml.. Also, the output into 2 ml. of 
unoxygenated Locke's solution is significantly less than the output into 4; ml. 
The output into leech solution was also. found to be greater into the larger volume 
of surrounding solution. This constant finding could have many causes. 
The greater volume of fluid surrounding the muscle will increase the 
diffusion gradient of ACh so that the smaller volume of bathing solution would 
impair the diffusion of released ACh from within the musculature into the 
surrounding solution. The diffusion pathway may a Iso be distorted because the 
. hemidiaphragm is unsupported in the surrounding fluid during stimulation. 
Unknown substances may be released during muscle activity which interfere 
with the assay procedure. These interfering "metabolites" would exist in a higher 
Tconcentration in the 2 ml. solutions and might have a depressant effect on the 
sensitivity of the leech muscle to ACh. The experiment performed showing that an 
`increase in the K+ concentration in the solution surrounding the leech muscle 
causes relaxation of the leech-muscle strip is one example of an interfering 
substance which would have to be considered. It has been established that K+ 
comes out of the stimulated muscle into a surrounding bathing solution (see section 
on K+ release from sartorius muscle), so that any test solution obtained from a 
stimulated hemidiaphragm muscle would be likely to have a raised K+ concentration. 
. When this solution is applied to the leech muscle strip, any contraction caused by 
, ACh present in the solution would be offset by the effect of relaxation produced by 
the high K+ concentration. However, in this work the test solutions were diluted 
by half with modified Krebs' solution so that the higher level of K+ would be 
diluted somewhat. 
The undiluted stimulated muscle solutions did not have their effects on the 
- ino- 
leech muscle , completely 
blocked. The effects of test solutions diluted by 
half were completely blocked by curare. Although this effect of incomplete 
blocking was not commented on by Kmjevic and Mitchell (1961), nevertheless 
their specimen trace of the action of the test solution on an isotonic leech 
muscle strip clearly shows that the action of the test solution was not completely 
blocked by curare, while the matching ACh solution had its effect completely 
abolished. Krnjevic and Mitchell comment: - "when simple solutions of ACh 
were compared with those in which the muscle contracted, it was found that the 
latter caused irregular variations in baseline, and also in ACh sensitivity". They 
suggested that "disturbing factors" were released mainly during contraction of the 
muscle fibres. A biologically active substance, ATP, has been shown to be 
released from active skeletal muscle (this Thesis, Part I); however, investigations 
in the present work have shown that ATP in low concentrations does not affect 
the leech muscle. 
The stimulation of a muscle in 2 ml. volume of solution would presumably 
induce a state of hypoxia more quickly than stimulation of the muscle in 4 ml., 
if oxygenation throughout the stimulatory period was inadequate. Krnjevic and 
Miledi (1957,1958,1959) have described a type of failure of neuromuscular 
propagation occurring during repetitive stimulation of the phrenic nerve. They 
showed that the most likely sites for this "pre-synaptic block" were either points 
where the nerve to the muscle branches, or the narrow region just before the 
terminal expansion of the nerve fibres. They found that this block could be 
overcome if the stimulation was either stopped or reduced in rate. They concluded 
that the block was probably caused by anoxia of the intramuscular portion of the 
motor nerve. 
When the muscle is stimulated in a volume of 2 ml., early pre-synaptic 
block may occur, thus reducing the number of impulses releasing ACh from the 
nerve terminals. Since the ACh output into 4 ml. of unoxygenated, Locke's 
solution was significantly lower than the output into 4 ml. oxygenated Krebs' 
solution, under the present experimental conditions the oxygen content of the 
Locke's solutions may have been inadequate. 
Comparison of the output of ACh from muscles stimulated at 10/sec or 
20/sec in 2 ml. or 4 ml. of Locke's solution showed that the output did not 
significantly increase at the higher frequency of stimulation. This would again 
suggest that early pre-synaptic block was occurring as xi result of hypoxia. If 
this were so, a frequency of 20/sec would be converted into an effective 
frequency of, say, 10/sec or less, thus giving a falsely low reading of ACh 
output for the frequency of 20/sec. 
Once again it would have to be considered that the low output of ACh 
obtained with the high frequency of stimulation might be due to the hypoxic 
muscle tissue releasing substances into the test solution which would tend to 
depress the sensitivity of the leech muscle strip to ACh, hence reducing the 
value obtained for the ACh output in the assay procedure. 
A disturbing finding in this work was that the ACh output from resting 
hemidiaphragm muscles into 2 ml. volumes of Krebs' solution was about the 
same (7ng) as the output from hemidiaphragms stimulated "at 20/sec'in 2 ml. 
volumes of Locke's solution (6ng). (Compare Table "A" in Figure 574with 
Figure 59). It must be concluded from this that all, or nearly all, ` of the 
impulses were blocked when a hemdiaphragm was stimulated in 2 ml. of Locke's 
solution at a frequency of 20/sec. 
The only set of results obtained here that can be compared with results 
of other workers are those obtained from stimulating the muscles in 4 ml. volumes of 
continuously-oxygenated Krebs' solution. Krnjevic and Straughan (1963) found a 
mean release of 35ng after a period of 20 minutes stimulation at a frequency of 
20/sec into a3 ml. volume at 37°C. The mean release found here using the 
same frequency of stimulation, over the some period of time, was 21ng (Figure 57 
Table "E"). A reduction in output might be expected since the present experi- 
ments were performed at room temperature. 
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Krnjevic and Mitchell (1961) stimulated hemidiaphragm muscles at room 
temperature for 5 minutes at a frequency of 5/sec and calculated an ACh. 
release of 10- 
17 
mole/impulse/nerve ending. If this rate of ACh release is 
transferred to the present conditions of stimulation (20/sec for 20 minutes), in 
a rat hemidiaphragm muscle with an estimated 10,000 nerve terminals (Krnjevic 
and Miledi, 1958), the total output of ACh from the muscle would be 343ng 
if every impulse reached the nerve endings and the synthesis of ACh was adequate. 
The total amount of ACh actually released from the muscle in Krnjevic and 
Mitchell's experiments is calculated below: 
Stimulation frequency = 5/sec for 5 minutes. Number of impulses = 1,500. 
If 10-17 mole/impulse/nerve ending ACh was released, then the total 
amount of ACh released in a muscle with 10,000 nerve endings = 1,500 x 
10-17 x 104 pmole=2l. 4 ng. 
This figure agrees with the mean output found in the present work when a 
muscle was stimulated in 4 ml. Krebs' solution at 20/sec for 20 minutes. From 
a comparison of the durations of stimulation, it would seem that the bulk of ACh 
may be released from the muscle in the first 5 minutes of stimulation at a 
frequency of 20/sec. Thereafter it may be postulated that the rate of synthesis of 
ACh at the nerve terminal is unable to keep up with the amounts of ACh released 
initially. 
APPENDIX 
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SEPARATION OF ACETYLCHOLINE FROM OTHER TISSUE PRODUCTS BY 
MOLECULAR SIEVE CHROMATOGRAPHY' 
The following section describes the behaviour of small concentrations of 
ACh in a Sephadex column (see Methods). This method of separation was initially 
adopted in this work in order to isolate ACh from other substances which may be 
present in the stimulated muscle solution and which might prevent an accurate 
estimation of ACh on the frog heart. 
Since a very small amount of ACh released into a test solution was 
anticipated, small concentrations of ACh-chloride were put through the column. 
In order to detect the ACh in the fractions from the column, a bioassay technique 
was needed. The isometric leech preparation and the frog heart perfusion system 
were used for this purpose (see Methods). 
Results 
By adjusting the volumes of the fractions collected from the column, it was 
found that about 75% of ACh put into the column could be'recovered in= a3 ml'. 
fraction coming 4.5 ml. after the initial blue"dextran fraction, i. e. this 4.50. 
volume contained no blue dextran and very little ACh; ` 
In ten experiments 2 ml, of a'solution of ACh=chloride together with 0.1 ml. 
blue'dextran were put through a column which had been packed in and was 
continuously eluted with, leech Ringer 's'solution. 'The blue dextran fraction was 
followed through the column and the 3 ml, containing itJwas collected: The next 
2 ml. 'fraction collected (fraction' 1) contained no ACh. ' The next 2.5 ml. 
fraction (fraction 2) contained a very small amöünt 
pof AChýand the following 
3 ml. fraction (fraction 3) contained the bulk of the ACh originally put into the 
'column. No ACh was found in any subsequent fraction. 
Figure 60 shows an assay of these fractions on the leech muscle preparation. 
2 ml. of 2.5 x 10-8 g/ml. ACh-chloride were put, into the column. Fraction 1 (F1) 
did not affect the leech muscle. Fraction 2 (F2) matched the effect of a 
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concentration ä 2.5 x 10-9 g/ml. ACh. Fraction 3 (F3) gave an effect which lay 
between the effect of 1.5x 10-8 g/ml. and 10 
8 
g/ml. of ACh. When diluted by 
half (F3/2), fraction 3 matched the effect of 5x 10-9 g/ml. of ACh. The 
percentage recoveries of ACh in fractions 2 and 3 were 12% and 75% respectively. 
An example of an assay of the column fractions on the perfused frog heart 
is shown in Figure 61 . After 2x 10 
7 
g/ml. of ACh were mixed with blue 
dextran and put through the column, the usual fractions were collected. Fraction 1 
did not affect the heart. The effect of perfusing fraction 2 through the heart was 
matched by the effect of 5x 10 
9 
g/ml. ACh. Fraction 3 matched the effect of 
3.5 x 10-8 g/ml. ACh. The calculated percentage recovery in this case was 
6.25% in fraction 2 and 50% in fraction 3. 
Table 13 shows a compilation of results for the standardization of the 
behaviour of ACh in the column, using the isometric leech preparation and the 
frog heart perfusion system for the estimation of the small amounts of ACh in the 
eluted fractions. It can be seen from this table that there is a wide scatter of 
results obtained for the estimated amounts of ACh eluted into fractions 2 and 3. 
This is mainly due to the fact that the estimation of the ACh was performed by 
direct matching with known amounts of ACh in both' r the frog heart and the leech 
preparation. This is not an accurate procedure and further work is needed in 
order to determine more precisely the distribution of ACh between fractions 2 and 
3. ' However, in no case out of 13 columns tested was ACh detected in any other 
fractions but 2 and 3, and as such this method can certainly be adopted for 
complete separation of ACh from substances of very large molecular weight, or 
a partial separation of ACh from substances of smaller molecular weight. 
Figure 60. 
The development of tension of a leech muscle strip to concentrations of 
ACh contained in fractions from a Sephadex column. The lower trace is a direct 
continuation of the upper one. D= change of solution in the leech bath S= 
recording motor switched to slow speed. The tension in grammes is shown at the 
left of the trace. Each test solution is allowed to act for 45 seconds. 
Calculation of Percentage ACh Recovery 
2 ml. of 2.5 x 10 
8 
g/ml. ACh are put into the column. Thus the total 
amount of ACh put into the column =5x 10-8 g. Assay of fraction 3 (F3) shows 
that it contains a concentration of 1.25 x 10-8 g/ml. ACh. Since this fraction 
has a volume of 3 ml., the total amount of ACh contained in fraction 3 is 
3x1 . 25 x 10-8 g=3.75 x 
10- g. Percentage recovery in fraction 3 is 
3.75 x 10-8 x 100 = 75. Assay of fraction 2 (F2) shows that it has a concentration 
5x108 
of 2.5x 10-9 g/ml. ACh. Since fraction 2 has a volume of 2.5 mi., the total 
amount of ACh contained in fraction 2 is 2.5 x 2.5 x 10-9 g=6.25 x 10-9 g. 







































Assay of column fractions for ACh on the frog heart. 
The lower trace is a direct continuation of the upper one. An initial 
concentration of 2 ml of 10-7 g/ml. ACh, made up in frog Ringer's solution, was 
put through a column continuously eluted with frog Ringer's solution. The usual 
fractions were collected and then perfused through a frog heart. 
Fraction 1 had no effect on the heart. Fraction 2 matched the effect of 
5x 10-9 g/mI. ACh. The effect of fraction 3 was matched by a concentration of 
3.5x 10-8 g/mI. ACh. 
Calculation of Percentage Recovery 
2 ml. of 10-7 g/ml. ACh areput into the column. Thus the total amount 
of ACh put into the column =2x 10-7 g. Assay of fraction 3 shows that it contains 
concentration of 3.5 x 10-8 g/ml. Since this fraction has a volume of 3 ml., the 
total amount of ACh contained in fraction 3 is 3x3.5 x 10-8g = 1.05 x 10-ßg. 
Percentage recovery in fraction 3 is 1.05 x 10-7 x 100 = 509/6 Assay of fraction 
2x10-7 
2 shows that it has a concentration of 5x 10-9 g=1.25 x 10-$ g. Percentage 
recovery in fraction 2 is 1.25 x 10-8 x 100 = 6.25% 
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A PHYSIOLOGICAL ROLE FOR THE RELEASE OF ATP 
FROM CONTRACTING MUSCLE 
ATP as the Mediator of the Local Autoregulation Reflex 
In 1880 Gaskell put forward the proposition that local vasodilatation resulted 
from some product of muscular activity. Anrep and V. Saalfeld (1935) found that 
potent vasodilator substances appeared in the venous blood emerging from a 
contracting muscle. Since that time the local regulation of bloodflow through 
skeletal muscle has been attributed to many products of metabolism. The adenine 
nucleotides have long been known to be powerful vasodilators (Drury and Szent- 
Gyorgyi, 1929; Wedd, ' 1931; Wedd and Drury, 1934; Gillespie, 1934; Fleisch and 
Weger, 1937; Folkow, 1949; Green and Stoner, 1950; Winbury -et al. 1953; 
Wolf and Berne, 1956) and it was suggested by Rigler (1932) and by Bildings and 
Maegraith (1937) that ATP possessed vasodilator properties potent enough for its 
consideration as a normal vasodilator metabolite.. In view of the importance of 
ATP in muscle metabolism and the close correlation between metabolic activity 
of skeletal muscle and its bloodflow, ATP has been considered as a potential 
candidate for the 'role of mediating the local autoregulation reflex (Folkow, 1949; 
Hilton,, 1959; Folkow and Oberg, 1961; Kjellmer and Odelram, 1965). 
Folkow, Haeger and Kahlson (1948) observed that intro-arterial injection 
of 10 
7g 
of ATP was sufficient to produce a significant vasodilatation in the 
hindlimbs of a cat. Folkow (1949), investigating the vasodilator action of ATP in 
various regions, found that the threshold dose for the vasodilator effect on muscular. 
cutaneous and intestinal vessels of the cat, and coronary vessels of the dog, ranged 
from -5 x 10 
8g 
to 10-7 g of ATP injected intra-arterially. 
The release of adenine nucleotides during muscular contraction has never, up 
to the present work., been consistently established. Hilton and Greengard (1962) 
searched for evidence that ATP is released from skeletal muscle. The method that-:: 
they used to detect the ATP was a fluorimetric one developed by Greengard (1956); 
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it enabled them to detect concentrations of less than 10-7 /ml ATP. They perfused 
the gastrocnemius muscle of the cat with Locke's solution and found no evidence of 
release of ATP during muscular contractions. They tried collecting the fluid which 
was seeping out of the muscle during stimulation, but again did not detect ATP. They 
perfused human forearm muscles with Locke's solution in vivo through two needles 
embedded in the muscle bellies, allowing the muscles to have their own blood supply, 
and found in one experiment that ATP was present in the perfusate in a concentration 
of 3x 10-6 g/ml during the contraction period. However, when the muscles were 
held under tension with a minimum of contraction taking place, no ATP was found in 
the perfusate. Hilton attributed this to the fact that less tissue damage was occurring 
in the isometric preparation and felt reasonably certain that ATP was not released from 
contracting muscles in amounts which could cause a significant degree of hyperaemia. 
It is difficult to estimate the dilution occurring in any perfusion experiments, 
particularly in one of this type, where the size of the vascular bed is not a constant 
factor. Also, the greater the vasodilatation, the greater the dilution will be of the 
vasodilators in the collected perfusates. In the experiments of Hilton and Greengard 
dilution of ATP beyond the threshold of their methodiof detection may have occurred. 
In the present work some frog hearts have been found to be sensitive to concentrations 
of 10-9 g/ml ATP. 
ATP as a Humoral Stimulator of the Heart 
The stimulating effect of ATP on frog heart shown in this work is in accordance 
with the findings of Buday, Carr and Miya (1961) who showed that low concentrations 
of ATP (8 x 10 
IA) 
produced an increased *systolic force in the frog heart with a 
concurrent bradycardia. This confirmed the earlier investigations on perfused frog 
hearts (Ostern and Parnas, (1932); Gillespie, (1934); Meyer (1951) and Porro, 
(1952). ). 
On intravenous injection ATP is rapidly destroyed, persumably in the lungs 
(Folkow, 1949). Although ATP is destroyed in the circulation, this destruction does 
not appear to occur in the blood. Folkow (1949) mixed1mg of ATP with 1 ml of whole 
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blood and allowed the mixture to stand for two minutes at 370 C. This procedure did 
not change the vasodilator properties of the ATP when injected intra-arterially into 
cat and dog. 
If indeed ATP is released into the bloodstream in vivo, from contracting 
skeletal muscle, it is possible that this is an additional humoral aid to the force of 
contraction of the myocardium during muscular exercise. The destruction of ATP in the 
lungs would seem to indicate that no recirculation of the ATP was possible; however 
the release of ATP into the blood returning to the right atrium from the limb muscle 
beds ("the muscle pump") may be an important factor in augmenting the force of 
contraction of the right atrium and so eventually increasing the cardiac output. 
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THE IDENTIFICATION AND RELEASE OF ACh FROM SKELETAL MUSCLE 
Conditions of Stimulation 
For the estimation of ACh released per impulse per motor nerve ending, it 
is obviously of vital importance to ensure that every impulse delivered down the 
nerve should reach the nerve terminal. The presynaptic block discovered by 
Krn: jevic and Miledi (1957,1958,1959) which is shown to occur at high 
frequencies of stimulation presents a difficult problem. The block can be partial 
or complete and is thought to be precipitated by anoxia. If ACh release is 
measured from muscles which have been stimulated indirectly at high frequencies, 
any calculation of the ACh output based on the assumption that every impulse 
reaches the nerve terminal is erroneous. Lower frequencies of stimulation would 
solve this problem, but of course, the amount of ACh produced would never be 
sufficient for any quantitative estimation. 
A convenient method of recording the number of impulses which did reach 
the nerve terminal is based on the curarized muscle preparation. While the muscle 
fibres are paralysed, activation of the nerve terminals is still possible and release 
of ACh is unimpaired. A microelectrode can thus be inserted near to an endplate 
region. This maneouvre allows monitoring of the endplate potentials to take place 
without any danger of breaking the microelectrode. Thus release of ACh could be 
directly related to the number and size of the endplate potentials produced, rather 
than to the number of impulses delivered down the nerve; the problem of 
presynaptic block would then be avoided. 
Presence of Interfering Substances 
Since the bulk of electrophysiological evidence concerning the neuro- 
muscular junction has been obtained from the post-synaptic region, any attempt 
to correlate the pharmacological events with electrical events places great 
importance on the general theory of receptor sites. If a receptor site on the 
post-synaptic membrane has a molecular configuration suitable for the ACh 
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molecule, other molecules of similar shape could become attached to the 
receptor site indiscriminately. An obvious example of this is given by every 
competitive blocking drug acting at the neuromuscular junction. Whittaker 
(1963) has given a most comprehensive review of the substances, allied to ACh, 
which can act as potent depolarizing agents at cholinergic receptor sites. Any 
parallel release of other, unknown, substances along with ACh at the nerve- 
muscle junction which could act as alternative depolarizing agents at the same 
receptor sites cannot be excluded. Since the bioassay systems used to estimate 
the amounts of ACh are, by definition, cholinergic systems containing ACh 
receptor sites, the assay procedure by itself may be misleading in that the 
unknown substances will also combine with receptors as well as the ACh in the 
test solution. Interference of this sort not only obscures the quantitative 
estimation of ACh, but also raises the inevitable question of whether it is just 
ACh which is involved in the natural transmission process. 
Identification of ACh 
The small amounts of ACh available for bioassay are, of course, insufficient 
for exclusive chemical analysis. Recourse has thus to be made to other, indirect, 
methods of identification. Chang and Gaddum (1933) described the following 
regime: 
1. Inhibition of cholinesterase in the test solution (leech muscle, frog 
heart, denervated skeletal muscle, cat blood pressure etc. ) usually 
increases the response obtained. 
2. The presence of blood or tissue extract decreases or destroys the 
activity of ACh, and this destruction is prevented by cholinesterase 
inhibitors. 
3. ACh is quickly destroyed by hydrolysis in an alkaline medium. 
4. Boiling for several minutes in weakly acid solution does not destroy 
ACh. 
5. Atropine, curare and nicotine individually block certain specific 
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pharmacological actions of ACh, but they do not interfere with the 
release of ACh at nerve terminals. 
6. The responses of various biological indicators to ACh bear a definite 
quantitative relation to each other, and the chemical mediator 
being studied must give these same relative values before it can be 
accepted as ACh. 
Any substance capable of attaching itself to the cholinergic receptor site and 
producing a depolarizarion of the membrane is likely to be acted upon in the same 
way as ACh by cholinesterase, an alkaline medium or an anticholinesterase. 
Blocking agents which effectively block ACh will almost certainly have some 
blocking effect on any substance which can act on the same receptors. A 
quantitatively similar response on different tissues produced by the chemical 
mediator being studied could conceivably be mimicked by a related compound; 
the graded response is a function of the density of the receptors, so that any 
substance capable of combining with the cholinergic receptor could produce a 
quantitatively similar response in various biological indicators. The identification 
of ACh released from rat diaphragm in this work involved only the use of curare. 
This certainly blocked the action of the substance in the test solutions which 
caused the leech muscle to contract; the other, conventional, piece of evidence 
to suggest that ACh was present in these solutions was that the dilution by half of 
the test solutions was equivalent to half of the ACh solution matching the undiluted 
test solution; however, again this is a function of the density of the receptor 
sites in the leech muscle, not a precise identification of ACh contained in any 
test solutiön. 
The insurmountable problem in the positive identification of very small 
amounts of ACh would appear to be that the cholinergic receptors in one piece of 
tissue are used to identify the depolarizing agent released from another tissue which 
is cholinergically innervated. Less traditional techniques, such as gas chromato- 
graphy, mass spectroscopy, electron spin resonance and other powerful tools now in 
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routine use by the physicists may be used in future in order to establish 
positively that it is ACh which is released from the neuromuscular junction. 
Future Work 
Although the molecular seive chromatography procedure was standardized 
for ACh in this work, no immediate use of this technique was made. It is 
proposed to combine this separation technique with the leech and frog heart 
assay procedures for the estimation of ACh released from the rat diaphragm. In 
order to have an accurate estimation of the number of impulses actually reaching 
the nerve terminal, the rat diaphragm preparation will be curarized and the 
endplate potentials will be continuously monitored. An accurate correlation 
of the number of impulses and the amounts of ACh released is needed before 
other problems of ACh synthesis and the source are investigated. 
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Release of adenosine triphosphate from active skeletal muscle 
By T. FORRESTER. Institute of Physiology, University of Glasgow and the 
Boyd Medical Research Institute, Glasgow 
In a previous communication (Boyd & Forrester, 1965) it was shown that 
active frog sartorius muscle liberates a substance which has a pronounced 
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Fig. 1(a). The response of a frog heart to perfusion with ATP and with Ringer's 
solution in which a twitching sartorius muscle was bathed. (b) The emission of 
light from firefly tail extract when exposed to ATP and the stimulated muscle 
solution used in (a) above. 
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It has now been established that this stimulatory effect was not due to 
changes in the potassium or the calcium concentrations in the Ringer's 
solution bathing the twitching sartorius muscle, nor was it due to release 
of catechol amines from the muscle, since the effect was not blocked by 
adrenergic blocking agents. 
It appears that the stimulatory effect on the heart is produced by 
adenosine triphosphate (ATP) released from active muscle. The evidence 
is as follows : 
1. The action of ATP on the frog heart is qualitatively similar to that 
of the stimulated muscle solution (Fig. 1 a). 
2. In a chromatography procedure the stimulatory substance is eluted 
through a Sephadex column in the same fractions as adenosine triphosphate. 
3. The enzyme `apyrase' catalyses the reaction ATP-AMP (Kaltkar, 
1943). Adenosine monophosphate does not stimulate the heart. When a 
solution of ATP is incubated with apyrase, its stimulatory action on the 
heart is greatly modified. When a stimulated muscle solution is incubated 
with apyrase, its stimulatory action is also modified in the same manner. 
4. Using a modification of the luciferase method of assaying the ATP. 
(Strehler & McElroy, 1957) it has been shown that the stimulated muscle 
solution causes light to be emitted from a firefly tail extract (Fig. 1 b). 
The time course of the emitted light from the test solution was similar 
to that of a known solution of ATP in a similar concentration. 
From these results it is concluded that ATP is released from active frog 
skeletal muscle in vitro. 
This work was financed in part by an M. R. C. grant. The cost of equipment was defrayed 
from the D. C. Andrews Fund and the Rankin Fund of the University of Glasgow. 
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An Isometric leech muscle preparation with stable sensitivity for 
the assay of acetylcholine 
By T. FORRESTER. Institute of Physiology, University of Glasgow 
The change in length of a strip of muscle from the anterior dorsal wall 
of the leech (Hirudo medicinalis) is commonly used as a specific test for 
acetylcholine. This has the disadvantage that completion of a test with 
washing out of acetylcholine may take as long as 30 min, whilst the initial 
and final lengths of the strip may be completely different. This makes the 





Fig. 1. The tension developed by an isometric leech muscle strip when exposed to 
graded concentrations of acetylcholine. Note the stability of the base line. Thre- 
shold concentration of acetylcholine was 10-9 g/ml. which caused an increase in 
tension of 50 mg in 45 sec. D, bath drained and refilled. S, paper drive stopped. 
With an isometric system the effect of a test solution of acetylcholine 
can be seen and washed out in less than 1 min, and a constant base line is 
more easily achieved (Fig. 1). This makes it possible to obtain finely 
graded responses to small steps of concentration (Fig. 1). Concentration 
response curves constructed at intervals over a period of 24 hr show that 
the sensitivity of the leech muscle to acetylcholine does not alter signi- 
ficantly. 
The preparation in use at the present time consists of a muscle strip of 
roughly 40 x2 mm mounted in a2 ml. bath. Tension developed by the 
muscle strip in response to a dose of acetylcholine is measured by a tension 
transducer (type FTO 3 C, Grass Instrument Co. ). Amplification was 
[P. T. O. 
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adjusted so that a change of tension of 50 mg could easily be recorded 
(Fig. 1). 
The minimum concentration of acetylcholine causing significant in- 
crease in tension in different muscle strips varied from 10-11 g/ml. to 
10-8 g/ml. of acetylcholine. Most preparations had a threshold response at 
about 10-9 g/ml. acetylcholine (Fig. 1). 
The specificity, sensitivity and reproducibility of the concentration- 
response relation of this isometric preparation makes it very suitable for 
the assay of concentrations of 10-9 g/ml. to 5x 10-9 g/ml. of acetylcholine, a 
range in which most other conventional procedures are somewhat un- 
reliable. 
The identification of acetylcholine. Raising the pH of a test solution, 
heating to 90° C and readjusting the pH and temperature is said to destroy 
acetylcholine. However, when this is done with a control solution, the 
leech muscle relaxes quickly. This effect could mask the action of acetyl- 
choline which was, in fact, still present in the solution. A more satis- 
factory test consists of soaking the preparation in 10-5 g/ml. D-tubocurarine 
for ten minutes. This abolishes the leech muscle response to acetylcholine 
and can be reversed by washing for 30 min. 
This work was financed in part by an M. R. C. grant. The cost of equipment was defrayed 
from the D. C. Andrews Fund and the Rankin Fund of the University of Glasgow. 
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Purification of chemical transmitter substances by column' 
chromatography 
By I. A. Bovu and T. FORRESTER. Institute of Physiology, University of 
Glasgow 
Release of chemical transmitter substances from biological tissue is 
usually accompanied by the release of many other substances which can 
interfere with the quantitative estimation of the transmitter. 
A column chromatography procedure was developed in an attempt to 
separate acetylcholine released from active skeletal muscle from other 
factors, such as protein and nucleotides (Forrester, 1966a). 
A column of Sephadex (type G-25, Pharmacia, Sweden) was used. This 
column can separate completely substances of molecular weight 5000 and 
over from substances of smaller molecular weight. Generally, the smaller 
the molecule, the more slowly it is eluted through the column. 
The dimensions of the column are important, since these determine the 
extent to which various components of smaller molecular weight in the 
test solution can be separated. If the column is too large, excessive dilution 
of the various components occurs which is inconvenient if, for example, 
they are to be assayed subsequently. If the column is too small, inadequate 
separation of the components occurs. 
A glass tube of internal diameter 14 mm with a sintered glass base was 
packed with Sephadex G-25 suspended in Ringer's solution to a height of 
13.5 cm. A substance with molecular weight greater than 5000, which is 
visible (e. g. blue dextran), is used to standardize the column. If 2 ml. of a 
mixture of blue dextran and a known concentration of acetylcholine is put 
through this size of column, the blue dextran is eluted into a fraction of 
exactly 3 ml., while almost 100 % of the acetylcholine is recovered in a 
later fraction of 3 ml. clearly separated from the blue dextran by a fraction 
containing neither substance. 
The separation and recovery of acetylcholine are independent of its 
concentration; assay of the fluid eluted through the column for acetyl- 
choline on an isometric leech preparation (Forrester, 1966b) showed that 
this method may be used to extract concentrations of acetylcholine as low 
as 10-9 g/ml. from, for example, a tissue perfusate. 
In the specific problem for which this technique was developed, the test 
solution obtained from active skeletal muscle contained protein, acetyl- 
choline released from nerve endings and nucleotides. The chromatography 
procedure removes the protein so that spectrophotometric identification 
of nucleotides in later fractions is possible; the liberated acetylcholine is 
[P. T. O. 
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recoverable only slightly diluted and almost free of nucleotide material so 
that its quantitative estimation is facilitated. 
This work was financed in part by an M. R. C. grant. 
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THE IDENTIFICATION AND ASSAY OF 
ACETYLCHOLINE AND ADENOSINE TRIPHOSPHATE 
RELEASED FROM ACTIVE SKELETAL MUSCLE. 
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SUMMARY 
The assay of ACh released from the neuromuscular' junction was 
attempted using the frog sartorivs muscle as the source of-ACh and the 
frog heart preparation of Boyd and Eadie (1961) as the bioassay object. 
It was theoretically possible to measure the small quantity of ACh 
(10-10 g/ml. ) which was expected to be released from the sartorius 
muscle stimulated at 2 impulses/second for 30 minutes, since 30% of 
frog hearts are sensitive to concentrations of 10 
11 
g/ml. ACh between 
the months of December and March (Boyd and Pathak, 1965). 
At the onset of the project an unusual finding was encountered. 
Ringer's solution in which twitching muscles were bathed always 
produced a marked increase in the force of contraction of the frog 
heart. Solutions obtained from resting muscles augmented the 
contractions to a lesser degree. Solutions from indirectly-stimulated 
muscles paralysed by curare had a similar stimulatory action' to 
solutions obtained from resting muscles. It was also found that a 
similar stimulatory effect was produced when fluid which had surrounded 
an active rat hemidiaphragm was perfused through the frog heart. 
The stimulatory effect was not due to. changes in the potassium or 
calcium in Ringer's solution bathing the twitching sartorius muscle, nor 
was it due to release of catecholamines from the muscle, since the 
-2- 
effect was not blocked by adrenergic blocking agents. The stimulatory 
effect on the heart is produced by adenosine triphosphate released from 
active skeletal muscle in vitro, the evidence being as follows: - 
1. The action of ATP on the frog heart is qualitatively 
similar to that of the stimulated muscle solution. 
2, ' In a chromatography procedure the stimulatory substance 
is eluted through a Sephadek column in the same 
fractions as ATP. 
3. The enzyme "apyrase" catalyses the reaction ATP - 
AMP. Adenosine monophosphate does not stimulate the 
heart. When a solution of ATP is incubated with 
apyrase, its stimulatory action on the frog heart is 
greatly modified. When a stimulated muscle solution 
is incubated with apyrase, its stimulatory action is 
also modified in the same manner. 
4. Using a modification of the luciferase method of 
assaying ATP, it has been shown that the stimulated 
muscle solution causes light to be emitted from a 
firefly tail extract. The time course of the emitted 
light from the test solution was similar to that of a 
known solution of ATP in a similar concentration. 
-lt is. suggested that ATP is normally released from active skeletal 
-3- 
muscle in vivo and, being a powerful vasodilator, may be the mediator 
of the local autoregulation reflex. It is further suggested that ATP may 
be released into the bloodstream in vivo in order to augment the force 
of contraction of the myocardium during muscular exercise. 
In order to increase the accuracy of. the quantitative estimation 
of ACh and also to aid in its identification, another method of bio- 
assay was developed using the isometric leech muscle preparation. 
This preparation was convenient to set up, showed constant sensitivity 
and stability over a long period of time and enabled a concentration- 
response relationship for ACh to be obtained within 30 minutes or less. 
This encouraged greater accuracy in the quantitative estimation of 
ACh. A seasonal variation in the sensitivity of the leech muscle to 
ACh was also apparent, the period of greatest sensitivity being in 
November and December. 
The output of ACh released from active and resting rat hemi- 
diaphragm muscles was studied using the isometric leech muscle pre- 
paration. Results for the resting outputof ACh agreed with those of 
previous workerss, but the amounts ofACh recovered from muscles stim- 
ulated indirectlywer considerably less than those previously obtained. The 
total amount ofACh released from the muscle. into a solution surrounding the 
muscle was found to be reduced in a smaller volume of surrounding bath- 
ing solution. This evidence, together with the fact that no alteration 
-4- 
in output occurred when the muscles were stimulated at a different 
frequency, suggests that nerve conduction block was occurring to an 
unknown degree and that this block was precipitated by anoxia. 
The behaviour of small concentrations of ACh was studied in"a 
molecular sieve column chromatography procedure. This was done by 
eluting Ringer's solution containing ACh through a Sephadex column 
and assaying the subsequent fractions on the frog heart and the leech 
muscle. By this method the separation of ACh from other produces 
of muscle metabolism can be effected, either in solutions which have 
surrounded active muscles, in tissue perfusates or in tissue extracts. 
It is concluded from this work that before any accurate 
quantitative study of ACh released from the neuromuscular junction 
can be undertaken, the conditions of-stimulation must be rigidly 
controlled. Also, the release of other substances from active skeletal 
muscle into a solution bathing the muscle, for example, adenosine 
triphosphate, may interfere with the assay procedure and so may 
result in the wrong interpretation of the amounts of ACh actually 
released from the neuromuscular junction. 
